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11 77w history of science, like the history ofall human ideas, is a history of 
irresponsible dreams, ofobstinacy, and oferror. But science is one of the 
ve? yfew human activities - perhaps the only one - in whidt errors are 
systematically criticised andfairly often, in time, corrected. This is why we 
can say that, in science, we often learn from our mistakes, and why zve can 
speak clearly and sensibly about making progress there. 11 
Sir Karl Raymund Popper, 1960. 
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SUMMARY 
The primary objectives of these experiments were to determine the effects 
of Creatine (Cr) supplementation on body composition and exercise performance 
in individuals of varying training and health status. 
The afin of the first experiment was to determine the effects of Cr 
supplementation on muscle strength endurance and maximal performance in a 
group of resistance-trained males. This was achieved by comparing the effects of 
20 g Cr-day-1 for 5 days against the equivalent dose of a glucose polymer 
(placebo) in a group of 32 resistance trained individuals. The results of 
Experiment 1 demonstrated that Cr supplementation did not result in a 
significant increase in peak force or total work during repeated isometric 
contractions in resistance-trained individuals. However, this was due to the 
"non-responders" in the Cr group masking the effects of the remaining group 
("responders"). When the Cr group was confined to only the "responders" to Cr, 
Cr supplementation resulted in significant increases in peak force and total force. 
This finding was further supported by the positive correlation between estimated 
muscle Cr uptake and increase in exercise performance, again suggesting that the 
efficacy of Cr supplementation is highly dependent on muscle Cr uptake. A 
negative correlation between training history and estimated muscle Cr uptake 
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was also found in Experiment 1, suggesting that training status may be a 
determinant of muscle Cr uptake potential. 
The second experiment was designed to use strategies previously shown to 
opfin-dse muscle Cr uptake and, hence, the potential to enhance exercise 
performance. The effects of 4 weeks of Cr supplementation allied with four 
weeks of resistance-training on isokinetic, isometric and isotonic strength were 
examined in previously non-resistance-trained humans. The results of 
Experiment 2 indicated that Cr supplementation in combination with strength 
training was effective in increasing isokinetic and isometric muscle strength but 
not 1 Repetition Maximum (1 RM) or training volume in subjects whose 
intramuscular [Cr] and body mass were significantly increased (i. e. responders). 
Furthermore, the greater the Cr uptake and associated increases in body mass, 
the greater were the exercise performance gains. Cr-stimulated increases in body 
mass and total body water compartments (TBW & ICW) were also observed. 
The aim of the third experiment was to examine the effects of Cr-induced 
hyperhydration on cardiovascular, metabolic, and thermoregulatory responses to 
exercise, and on the capacity to perform prolonged exercise in the heat. The 
results of Experiment 3 suggest that Cr supplementation was effective in 
increasing predominantly intracellular water (ICW) and reducing cardiovascular 
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and thermoregulatory responses during prolonged exercise in the heat. The 
attenuation of these responses with Cr resulted in a significant increase in time to 
exhaustion (pre to post); this effect was only seen in subjects whose estimated 
intramuscular Cr levels were significantly increased following Cr 
supplementation (i. e., "responders" to Cr supplementation). 
The aim of the fourth and final experiment was two-fold: firstly, to determine the 
effects of Cr loading on upper and lower body strength, upper and lower body 
strength endurance, and body composition; and secondly to examine the effects 
of Cr supplementation in conjunction with a standard pulmonary rehabilitation 
regimen on the above-mentioned variables in a group of patients with moderate 
to severe COPD. The results of Experiment 4 show positive results (lower body 
muscle strength, muscle endurance and upper body muscle endurance) with 
regard to the ergogenic potential for Cr in this patient group (both short-and 
long-term). However, it remains to be determined whether or not the 
performance benefits observed in the present study will have a positive impact 
on the patient's daily activities and, more importantly, their quality of life. 
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The results from all four experiments provide strong evidence that Cr 
supplementation is an effective strategy for: 
i) Increasing body mass in subjects ranging from highly trained 
athletes (Experiment 1& 3) to patients with moderate to severe 
COPD (Experiment 4). However the exact mechanism behind 
these Cr stimulated increases remains to be determined. 
ii) Experiments 1-3 show Cr supplementation to be an effective 
ergogenic aid, only in subjects whose estimated muscle Cr 
uptake was significantly elevated following supplementation. 
The failure of many studies to characterise the Cr group on this 
basis could help explain the reasons behind the conflicting results 
with regard to the ergogenic effect of Cr supplementation. 
iii) And finally, the results of Experiment 4 point towards a possible 
role for Cr supplementation in the rehabilitation process for 
patients with COPD, with this study being the first to show 
improvements in muscle strength and endurance following 
intervention in this patient group. 
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CHAPTER ONE 
General Introduction 
GENERAL INTRODUCTION 
Introduction 
Fatigue is an inevitable consequence of sustained physical activity, with 
fatigue commonly defined as an inability of muscle to maintain the required 
force or power output (Edwards, 1981). The physiological, psychological and 
biochemical processes that result in fatigue have been an area of extensive 
research for many years. Although still far from fully understood, the 
mechanisms behind exercise fatigue have become clearer in recent years. The 
underlying mechanisms vary according to the mode, duration and intensity of 
exercise, training, nutritional and motivational status of the subject, and also 
with environmental conditions in which the exercise is carried out. In recent 
years, researchers have attempted to characterise the fatigue process under all 
the above-mentioned conditions. A widely studied fatigue protocol is that of 
exercise performed to the limit of tolerance at an exercise intensity of 50-60% of 
maximum oxygen uptake (ýro, under thermo, neutral conditions. 
Mechanisms that have been associated with fatigue during this type of exercise 
include depletion of intramuscular glycogen stores and hypoglycaemia e. g. 
Coyle et al (1985). At this exercise intensity, muscle glycogen is the primary 
substrate utilized (Bergstrom & Hultman, 1967), and although exercise can 
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continue once glycogen stores become depleted, it can only be at a reduced 
intensity, and the criterion of fatigue is thus met. 
At the other end of the exercise spectrum is short-duration high intensity 
exercise. The causes of fatigue during this type of exercise have also been 
extensively investigated, yet are stiff not fully characterised. Fatigue during this 
type of exercise was initially attributed predominantly to factors such as 
intracellular accumulation of inorganic phosphate (Pi) and/or hydrogen ions 
(H+) (e. g. Maughan et al, 1997). However, Katz et al (1986) and, more recently, 
Hultman et al (1990) demonstrated that fatigue during short-term, high intensity 
exercise was associated with a low intramuscular phosphocreatine concentration 
([PCr]), rather than a high lactate concentration ([La-]). This led both groups of 
researchers to suggest that substrate availabifity (PCr), as opposed to product 
inhibition, might be the important determinant of fatigue during high-intensity 
short duration exercise. Furthermore Hultman et al (1990) demonstrated that PCr 
depletion coincided with the decline in isometric force during a single bout of 
intermittent electrical stimulation. As a result, the decline in ATP production 
during this type of exercise has been attributed to a reduced capacity to 
resynthesize ATP, due to the depletion of PCr stores (Soderlund et al, 1991). 
Exercise physiologists have examined strategies for delaying the fatigue process 
in order to further understand the mechanistic basis of fatigue. In recent years, 
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for example, researchers have attempted to delay fatigue through the use of 
nutritional ergogenic aids. It has been well established that carbohydrate 
supplementation prior to and during exercise can delay the onset of fatigue and 
thus increase performance during prolonged sub-maximal exercise (Coyle et al, 
1985; Coggan & Coyle, 1989) but, until recently, there has been little systematic 
investigation of the effects dietary supplementation may have on the 
performance of high-intensity exercise. However, over the last decade 
researchers have began to examine the potential effects of creatine (Cr) 
monohydrate supplementation on the fatigue process during high-intensity short 
duration exercise. 
Historical Background 
Creatine was first identified in 1835 by a French scientist caRed Chevreul 
(Dermant & Rhodes, 1999). However, it was not until 1847 that Lieberg 
confirmed its presence as a regular constituent of flesh extracted from mammals 
(Needham, 1971). Following this, Lieberg also reported that the flesh of wild 
foxes kiRed in the chase contained 10 times as much Cr as that of captive 
creatures, therefore concluding that Cr accumulation was associated with 
muscular exercise (Dermant & Rhodes, 1999). At around the same time, Heintz 
and Pettenkofer discovered a substance in the urine which Lieberg later 
confirmed as being creatinine (Crea), which is now known to be a by-product of 
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Cr degradation. However it was not until the early twentieth century that 
researchers started to examine the effects of Cr ingestion on muscle [CrI. Around 
this time, it was also discovered that not all the ingested Cr was retrieved in the 
urine, leading researchers to conclude that the body retained some of the 
ingested Cr (Dermant & Rhodes, 1999). The first documented studies to confirm 
this were by Denis (1912) and Folin (1914) on the muscle of cats. These 
researchers both reported that, following Cr ingestion, muscle [CrI increased by 
-70%. In 1927 and 1929, Fiske and Subbarow reported the presence of labile 
phosphorus in resting cat muscle, which they subsequently called creatine 
phosphate or phosphocreatine (PCr). The same researchers also showed that, 
during electrical stimulation of skeletal muscle, [PCr] decreased for a period of 
time, then returning to resting levels following a rest period. The results of these 
several studies, taken together, thus lead to the subsequent identification of free 
intramuscular Cr (Crfe,, ) and PCr, and also highlighted their potential role in 
skeletal muscle metabolism (for discussion see Balsom et A 1995). However, it is 
only within the last decade or so that systematic research into the effects of Cr 
supplementation on muscle metabolism and performance has been undertaken. 
Biochemistry of Creatine 
Creatine (Cr), or methylguanidine-acetic acid, is a naturally occurring 
compound synthesized from three amino acids: arginine, glycine, and 
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methionine. This process (transamidination) starts with the transfer of an 
amidine group from arginine to glycine, which leads to the formation of 
guanidinoacetate and ornithine, and is a reversible reaction catalysed by the 
enzyme glycine-amidine-transamidinase. Cr is then formed by the addition of a 
methyl group from (S)-adenosyhnethionine (transmethylation), which requires 
the enzyme methytransferase for the irreversible reaction (Figure 1.1) (Devlin, 
1992). The enzymes involved in the synthesis of Cr are located in the kidney, 
liver and pancreas. However, as the main site of Cr utilisation is skeletal muscle 
(95% of the body's total creatine concentration is found in skeletal muscle) 
(Walker et al, 1979), Cr must be transported from its site of synthesis to its site of 
utilisation (skeletal muscle) via the blood stream (Figure 1.2). Having arrived at 
its site of utilisation, uptake of Cr occurs against a concentration gradient. Cr 
enters muscle cells via Na+-dependent sarcolemmal transporters (Zorzano et al, 
2000). The endogenous production and dietary intake of Cr is matched by the 
degradation of PCr and Cr to creatinine (Crea) at a rate of 2.6 % and 1.1 % per day, 
respectively (Wyss and Kaddurah-Daouk, 2000). Once Crea is formed, it enters 
the circulation by diffusion and is eliminated from the body through glomerular 
filtration (Figure 1.2). 
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Figure 1.1: Synthesis of Creatine (Wyss and Kaddurah- 
Daouk, 2000) 
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Figure 1.2: Overview of Creatine Supplementation (Wyss 
and Kaddurah-Daouk, 2000) 
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Creatine Transporters 
Specific Cr transporters present in the sarcolemma facilitate Cr entry into 
muscle cells. Skeletal muscle takes up Cr by a mechanism that depends on Na+. 
Cr transport is catalysed in humans by two Cr transporters, named CRT-1 and 
CRT-2, which are encoded by different genes (Zorzano et al, 2000). Because the 
Michaelis constant of Cr uptake lies in the physiological range of plasma [Cr], 
oral Cr intake would be expected to stimulate Cr uptake by muscle cells via 
enhanced membrane Cr transport. Furthermore, increased Cr uptake appears to 
result in intracellular Cr accumulation, in its free as well as in its phosphorylated 
form. There are many unanswered questions with regard to the function of 
muscle Cr transporters, such as the precise mechanism of transport, structure/ 
function relationships, and control of the subcellular distribution and activity of 
the carrier. It has been reported that Cr supplementation in rats down-regulates 
the expression of CRT-1 in skeletal muscle, whidi is in agreement with the above 
mentioned observation that extracellular Cr down-regulates Cr uptake. 
Creatine Supplementation and High-intensity Short Duration Exercise Performance 
Despite early research into the possible effects of Cr supplementation on 
muscle metabolism, it was not until 1992 that researchers began to reinvestigate 
the possible effects of Cr loading on human skeletal muscle metabolism (Harris et 
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al, 1992). Harris et al (1992) were the first to investigate whether Cr 
supplementation could increase [TCrj of human skeletal muscle, and whether 
such an increase in plasma [Cr] might ultimately lead to an increase in total Cr 
content ([TCr]) of skeletal muscle, as had previously been suggested. Thus Harris 
et al (1992) supplemented a group of subjects with 5g Cr for 4-6 times a day for 3 
or more days. Muscle biopsies were taken from the vastus lateralis pre and post 
supplementation. Although the supplementation dosage and duration were not 
standardised, this study provided important information with regard to Cr 
supplementation and muscle Cr uptake (Harris et al, 1992). Firstly, muscle biopsy 
analysis showed that following Cr supplementation the [TCr] increased from 
126.8 to 148.6 mmol/kg dry mass, with the increases in PCr accounting for 20- 
40% of the total increase. Secondly, the increase in muscle [TCr] was reported to 
vary significantly among subjects. This was attributed to subject heterogeneity 
with regard to Cr uptake, i. e. some subjects being "responders" and others "non- 
responders". However, the difference in dosage regimens might also account for 
some of this variability. In addition, subjects with the lowest initial [TCr] showed 
the greatest Cr uptake following supplementation. Finally, the greatest 
intramuscular uptake of Cr was reported to occur over the initial days of 
supplementation (urinary analysis showed 40,61 and 68% of the supplemented 
dose was recovered on days one, two and three, respectively), with the authors 
suggesting there might be a limit to the amount of Cr that can be stored within 
muscle. 
10 
This seminal work by Harris et al (1992) was the catalyst for the subsequent 
plethora of studies that have examined the effects of Cr supplementation on 
muscle metabolism and performance. Many researchers have confirmed the 
increases in muscle [TCr] following Cr supplementation. For example, Greenhaff 
et al (1994) observed increases of 15 -32% (29±3 mmol/kg dry mass) in [TCr] 
following 5 days of Cr supplementation. Other studies that have also found 
similar increases in [TCr] and PCr following Cr supplementation using various 
techniques ranging from muscle biopsy analysis to 31phosphorus nuclear 
magnetic resonance imaging (31P-MRS) (Balsom et al, 1995; Casey et al, 1996; 
Green et al, 1996; Hultman et al, 1996; Smith et al, 1998; Vandenberghe et al, 1997). 
The effects of Cr supplementation on performance have also been examined. 
Greenhaff et al (1993) were the first to investigate the potential role of Cr 
supplementation as an ergogenic aid. They examined 12 physically active, but 
not highly trained young male subjects. Following familiarisation, knee extensor 
performance was measured on an isokinetic dynamometer before and after 5 
days of Cr supplementation (20 g d-1). Subjects performed 5 sets of 30 maximal 
voluntary contractions (unilateral knee extensions) with 1 minute between bouts. 
This study demonstrated that the 5 days of Cr supplementation increased total 
peak torque during the 2nd and 3rd bout of contractions, with a strong tendency in 
the 4th set. Peak torque generation was also significantly increased during the 
final 10 contractions in the lst bout and during contractions 11 - 20 in the 5thbout. 
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Consistent with these results, significantly lower plasma [ammonia] (an accepted 
marker of muscle adenine nucleotide loss) after the 4th and 5th bouts was 
reported. 
In the same year, Balsom et al (1993) confirmed the results of Greenhaff et al 
(1993). In this study, subjects performed an exercise protocol that consisted of ten 
6-s bouts of high-intensity cycle-ergometer exercise, with 30 s recovery between 
repetitions (subjects being instructed to attempt to maintain a pedaHing 
frequency of 140 rpm). This exercise protocol was carried out pre and post 6 days 
of Cr loading at a dosage of 20 g-d-1. Subjects where found to better maintain the 
target pedal frequency following Cr supplementation, compared to the placebo 
group (Figure 1.3). 
Many researchers have subsequently continued to examine the effectiveness of 
Cr supplementation as an ergogenic aid. For example other reported benefits 
resulting from Cr loading include increases in maximal voluntary contraction 
(MVC) and muscle endurance capacity (Maganaris & Maughan, 1998), improved 
anaerobic sprint performance during repeated bouts of exercise (Casey et al, 1996; 
Green et al, 1996, Balsom et al, 1993; Earnest et al, 1995), and increased 
performance during single exhausting bouts of high intensity exercise (Earnest et 
al, 1995; Rossiter et al, 1996). However, not A studies have reported Cr to have 
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Figure 1.3: Effect of Cr supplementation on muscle 
performance during high-intensity cycling 
(Balsom et al. 1993) 
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an ergogenic effect. For example, several studies found no ergogenic benefit of Cr 
loading on either intermittent (Odland et al, 1997; Febbraio et al, 1995; Gilliam et 
al, 2000) or continuous (Redondo et al, 1996; Burke et al, 1996; Cooke et al, 1995; 
Deutekom et al, 2000) exercise tests. 
The mechanism of action by which Cr supplementation improves performance is 
still not fully understood. However, the two most commonly proposed to date 
are a higher pre-exercise intramuscular [PCr] and/or a higher rate of PCr 
resyntheis between bouts of exercise (Greenhaff et al, 1994). The energy required 
to perform brief explosive-type exercise is almost exclusively provided by the 
high-energy phosphate stores in skeletal muscle (Fitch et al, 1974). As the PCr 
stores become depleted, performance rapidly deteriorates which reflects the 
inability to rephosphorylate ADP to ATP at the required rate (Hultman et al, 
1990). The increased intramuscular PCr store post-supplementation is proposed 
to act as a temporal energy buffer which, in turn, would decrease reliance on 
anaerobic glycolysis. Increases in the resting [PCr] may allow subjects to 
complete more work during short-duration high intensity exercise (Casey et al, 
1996). Secondly, many authors (Harris et al, 1992; Greenhaff et al, 1993; Soderlund 
et al, 1994; Balsom et al, 1993; Balsom et al, 1995) have proposed that Cr 
supplementation would increase the rate of PCr resynthesis from mitochondrial 
ATP, during recovery, consequent to the elevated muscle Cr content (Harris et al, 
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1992) increasing the rate of flux through the creatine kinase reaction at the 
mitochondrial membrane. 
Greenhaff et al (1994) followed up their initial study (Greenhaff et al, 1993) to 
more directly investigate the effects of Cr supplementation on PCr resynthesis in 
skeletal muscle. In this study, the authors electrically stimulated the anterolateral 
portion of the thigh (vastus lateralis) in 8 male subjects. Following the electrical 
stimulation, a pressure cuff was inflated around the thigh (259 mmHg) to 
occlude blood flow and a muscle biopsy then obtained. The cuff was then 
deflated and further muscle biopsies were obtained at 20,60 and 120 s. Subjects 
were supplemented with 20 g-d-1 of Cr for 5 days, and then returned to the 
laboratory to repeat exercise protocol. The results of this study showed that Cr 
supplementation increased the rate of PCr resyntheis by 42% during the second 
minute of recovery (Figure 1.4). In addition, only those subjects who evidenced a 
substantial increase in resting muscle [TCr] following Cr supplementation 
showed an increased rate of PCr resynthesis during recovery; those whose 
muscle [TCr] increased only marginally (<10 mmol-kg-1-dry weight muscle) 
showed very little change in PCr resynthesis. 
Since this work by Greenhaff and co-workers (1994), several other groups of 
researchers have investigated the effects of Cr supplementation on PCr 
resynthesis but with conflicting results. For example, Yquel et al, (2002) 
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Figure 1.4: Phosphocreatine and free creatine 
concentrations obtained after 0,20,60 and 120 
s of recovery from intense contractions before 
(open symbols) and after (closed symbols) Cr 
ingestion (Greenhaff et al. 1994). * and ** 
indicates difference between pre and post- 
supplementation (P<0.05 and P<0.01, 
respectively). 
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examined the effects of 6 days of Cr supplementation on muscle power, muscle 
PCr resynthesis, Pi and pH during repeated bouts of maximal dynamic plantar 
flexion exercise. The authors used 31P-MRS to assess the changes in skeletal 
muscle high-energy phosphate status during five bouts of 8s interspersed with 
30 s recovery, followed by 6 bouts of 8s and 7 bouts of 16 s separated by 1 and 2 
min, respectively. Subjects were tested pre and post 6 days of Cr 
supplementation. Following supplementation, muscle power increased by 5% 
from bouts 3 to 7 and muscle PCr resynthesis increased during the 10 min 
recovery period. These results are in agreement with the earlier results obtained 
by Greenhaff et al (1994), with the authors concluding that the observed increases 
in muscle power were the result of a lower accumulation of inorganic phosphate 
and a less-acid intramuscular pH during exercise, and a higher rate of PCr 
resynthesis in recovery. Smith et al (1998) also verified the results obtained by 
Greenhaff et al (1994), using 31P-MRS. They showed muscle PCr resynthesis was 
increased following Cr supplementation in middle-aged and younger persons 
after subjects performed single-leg knee extension dynamic exercise. 
However, not all studies have reported a more rapid increase in PCr resynthesis 
in recovery from intense exercise following Cr supplementation (Vandenberghe 
et al, 1999; Francaux et al, 2000). Vandenberghe et al (1999), used 31P-MRS to 
examine the effects of Cr supplementation on muscle PCr breakdown and 
resynthesis and muscle performance during high-intensity intermittent knee 
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extensions. Interestingly, these authors found a significant increase in 
performance following Cr supplementation, despite Cr supplementation not 
affecting PCr breakdown or resynthesis during and after isometric muscle 
contractions, respectively. 
Creatine and Training 
In parallel with the investigations described above, several groups have 
explored the influence of Cr supplementation on the outcomes of exercise 
training programmes. The physiological basis underlying a possible ergogenic 
effect of Cr supplementation on strength training is primarily two-fold. Firstly, 
Cr supplementation has been shown to increase, for example, the numbers of 
repetitions that can be completed per set (Earnest et al, 1995; Volek et al, 1997). 
Secondly, Cr supplementation has been shown to increase the rate of PCr 
resynthesis during the second minute of recovery from intense intermittent type 
exercise (Greenhaff et al, 1994). Theoretically, both these physiological changes 
could allow an individual to train at a greater intensity compared to training 
without the use of Cr supplementation. 
Becque et al (2000) examined the effects of 6 wk of Cr supplementation combined 
with resistance training (elbow flexors training twice a week with training loads 
0.. that began at 6 Repetition maximum (RM), the maximum weight that can be 
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lifted 6 times and progressed to 2 RM). In this study, Cr supplementation during 
elbow flexor training lead to significantly greater increases in 1 RM elbow flexor 
strength, upper arm muscle area (7.9 cm2), and fat-free mass (FFM) compared to 
training alone. Vandenberghe et al (1997) (10 wk resistance training programme, 
where subjects trained their upper and lower body 3 hr. wk-1), also reported 
positive effects of Cr supplementation when combined with resistance training, 
compared to resistance training alone. In this study, maximal strength of the 
trained muscle groups, maximal intermittent exercise capacity of the elbow 
flexors, and FFM increased 20 - 25%, 10 - 15% and 60% more, respectively, than 
the group that trained without Cr supplementation. Cr supplementation 
combined with resistance training (varying duration 4-12 wk. ) has also been 
shown to increase bench press lifting volume (Kreider et al, 1998), total sum of 
bench press, squat and power clean lifting volume (Kreider et al, 1998), total 
work performed during five 6-s sprints (Kreider et al, 1998), 1 RM squat and 
bench press (Volek et al, 1999), average lifting volume in the bench press (Volek 
et al, 1999), muscle strength (Willoughby & Rosene, 2001). Additionally, all the 
above studies reported significantly greater gains in FFM following Cr 
supplementation when combined with resistance training compared to resistance 
training alone (Kreider et al, 1998; Volek et al, 1999; Willoughby & Rosene, 2001). 
However, not all studies have reported positive effects on muscle strength 
following combined Cr supplementation and resistance training. Francaux and 
19 
Poortmans (1999) examined the effects of 6 weeks of resistance training in 
conjunction with Cr supplementation on isokinetic squat force and found that Cr 
ingestion did not induce a greater increase in force compared to resistance 
training alone; isokinetic force increased by about 6% after training in both the 
placebo and Cr groups. However, there are several concerns with this study: 
there was no measure or estimate of Cr uptake; and questions must be asked 
about the training "stimulus" (i. e. only 30 % of MVC in session 1, increasing 
progressively to approximately 43 % of MVC in the final training session). 
Similarly, Bermon et al (1998) examined the effects of Cr supplementation in 
conjunction with 7 weeks of resistance training on strength and strength 
endurance in 32 elderly subjects. They also found that Cr supplementation did 
not provide any additional benefit to maximal dynamic strength compared to 
resistance training alone. 
Creatine and Endurance Exercise 
In contrast, there has been little systematic study of the effects of Cr 
supplementation on endurance performance. Although the majority of research 
to-date has examined the role of PCr as a temporal energy buffer and its effects 
on short-term high intensity exercise, it has recently been proposed that [PCrJ 
may play a pivotal role in the control of muscular oxygen consumption and 
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puhnonary oxygen uptake 
OrOA (Whipp & Mahler, 1980, Barstow et al, 1994; 
McCreary et al, 1996; Rossiter et al, 1999). 
In recent years, a number of researchers have investigated the dynamic profiles 
of ý70 2 and [PCr] in humans, in order to investigate the control of muscle02 
consumption. Barstow et al (1994) and McCreary et al (1996) were two of the first 
groups of investigators to examine this in humans, following on from the work 
by Mahler (1985) in frog muscle. However, as pointed out by Rossiter et al (1999), 
the above-mentioned studies were not without methodological constraints. For 
example, in the paper by Barstow et al (1994), despite reporting similar time 
constants for [PCr] depletion and increase in V02with square-wave exercise, the 
authors utifised different muscle groups operating over different metabolic 
ranges to examine the time constants for [PCr] and 
ý702. Therefore Rossiter et al 
(1999) furthered the initial work by Barstow et al (1994) by simultaneously 
measuring the kinetics of [PCr] and Vo, during moderate intensity exercise of 
the m. quadriceps muscle in a NMR magnet. The time constant for intramuscular 
[PCr] depletion (35 s, range, 20 - 64 s) was almost identical to the time constant 
for the V02 kinetics (phase 11, only) (36 s, range, 20 - 68 s). This study further 
supported the possible role of [PCr] in the control of'ý02. As previously 
mentioned, the ergogenic potential of Cr supplementation is based on the 
premise that, following Cr supplementation, resting levels of [PCr] are elevated. 
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Therefore, based on the work of Rossiter et al (1999), the observed increase in 
resting [PCr] following Cr supplementation might have the potential also to alter 
the kinetics of 
ý70 
2 and hence of muscle 02 consumption. To date, only one 
study has examined this possibility Gones et al, 2002). Jones et al (2002) examined 
the effects of 5 days of Cr loading (20 g d-1) onV02 during moderate and heavy 
exercise. Cr loading caused a significant reduction in 
ýr02 during heavy exercise 
but not moderate exercise; a finding that warrants further investigation. 
Other studies have also examined the effects of Cr supplementation on muscle 
bioenergetics during incremental and submaximal. exercise tests with negative 
results. For example, Stroud et al (1994) and Balsom, et al (1993) reported no 
significant effect on respiratory gas exchange 
OrOVýrC02, RER) variables 
following Cr supplementation, with Stroud et al (1994) also reporting no effect on 
blood Vactate]. 
Exercise in the Heat and Creatine Supplementation 
While the majority of the available research suggests that Cr 
supplementation has no ergogenic effect on endurance exercise, recently some 
researchers have began to investigate the potential role for Cr supplementation 
during exercise in the heat due to the already mentioned Cr stimulated changes 
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in body composition. To date, 3 studies have examined the effect of Cr 
supplementation on performance during exercise in the heat (Vogel et al, 2000; 
Volek et al, 2001; Kern et al, 2001). Volek et al (2001) examined the effect of Cr 
supplementation on acute cardiovascular, renal, temperature and 
fluid-regulatory hormonal responses during 35 min of exercise in the heat (37 OC, 
80 % relative humidity), which was immediately followed by three 10-s sprints. 
In this study, the authors found a significant increase in body mass (0.75 kg) 
following Cr supplementation, which led to a significantly greater peak power 
during all three 10 s sprints, compared to no change in the placebo group. No 
significant change in heart rate, blood pressure, and sweat rate responses was 
observed following Cr supplementation, indicating that it is unlikely that Cr 
significantly influenced temperature regulation during 35 min of exercise in a hot 
hun-dd environment. Furthermore, no abnormal responses in several measures of 
renal function were found during rest and exercise. 
More recently Kern et al (2001) examined the effects of 28 days of Cr 
supplementation on heart rate and core temperature during 60 min of exercise at 
an intensity equal to 60% 
ýF02 
max at 37 'C and 25 % relative humidity. They 
observed significantly greater gains in body mass and Total Body Water (TBW) 
compared to the placebo group, with a consequent attenuation of core 
temperature during post-supplementation. The increases in body mass and TBW 
observed in the above study and the attenuation in rectal temperature were of 
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similar magnitude as those observed in the present study. However, in the study 
by Kern et al (2001), subjects exercised for a fixed period of time (60 min) and 
therefore we are unable to evaluate if the decrements in core temperature had 
any effect on performance during exercise in heat. 
Enhancing Muscle Creatine Uptake 
As already mentioned, one of the preliminary findings from Harris et al. 
(1992) was that the ergogenic and metabolic effects of Cr supplementation seem 
to be dependent on the magnitude of the associated increase in muscle TCr. More 
specifically, Greenhaff et al (1994) and Casey et al (1996) suggested that an 
increase in muscle [TCr] in excess of 20 mmol-kgý-dry weight muscle is required 
to elicit an ergogenic effect on muscle power output and post-exercise PCr 
resynthesis. Casey et al (1996) also observed that changes in both maximum work 
production and total work production following Cr supplementation were 
correlated with muscle Cr uptake. As a result of this positive correlation between 
Cr uptake and increase in performance observed by Casey et al (1996) and 
Greenhaff et al (1994), researchers have explored strategies that might have the 
potential to facilitate muscle Cr uptake during Cr supplementation, thus leading 
to greater gains in performance. 
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To date, two main strategies for enhancing muscle Cr uptake during 
supplementation have emerged. Firstly, the early work of Harris et al (1992) was 
the first study to examine whether Cr uptake by skeletal muscle could be 
increased by exercise. Thus, Harris et al (1992) employed 1 hour of one-legged 
cycling exercise per day for 4-7 days and demonstrated enhanced Cr uptake in 
the exercising leg by 54 %, whilst little effect was observed in the non-exercising 
leg. The precise mechanism(s) for the exercise-induced increase in muscle Cr 
uptake is still unknown, although an increase in blood flow to the exercising 
muscle and/or changes in the sarcolemmal transport kinetics of Cr were 
suggested by the authors as the most plausible explanations. Subsequently, 
however, Robinson et al (1999) suggested that the results obtained by Harris et al 
(1992) should be treated with caution, citing: the relatively small number of 
subjects studies, the variation in the supplementation regimens, and the 
inclusion of vegetarians. Robinson et al (1999) therefore studies 14 subjects who 
performed one-legged cycling exercise to exhaustion with muscle biopsies 
(vastus lateralis) taken from the exercised and non-exercised leg immediately 
after exercise, 6 hr and 5 days post-recovery. They showed that a greater muscle 
[TCrj was achieved in the exercised limb, but disputed the hypothesis of Harris 
et al (1992) that increased muscle blood flow was a possible cause for the 
increased TCr in the exercised limb. This was made on the basis that no 
differences were observed at the 6 hr muscle biopsy between the exercised and 
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non-exercised limbs when differences in blood flow to the limbs would be at 
their greatest. 
An additional strategy shown to enhance muscle Cr uptake is the ingestion of 
carbohydrate in combination with Cr. Insulin, at supra-physiological 
concentrations, has previously been shown to increase muscle Cr uptake in rat 
skeletal muscle cells in vivo (Haughland and Chang, 1975). More recently, supra- 
physiological [insulin] has also been shown to stimulate Cr uptake in a mouse 
myoblast cell line (Odoom et al, 1996). Subsequently many researchers began to 
examine the effects carbohydrate supplementation may have on muscle Cr 
uptake in humans. In 1996, Green et al (1996) examined this in human subjects: 
group A, consumed Cr alone; group B consumed Cr combined with a 
carbohydrate-containing solution; group C consumed Cr combined with a 
carbohydrate-containing solution and also performed 1 hr of cycling exercise at 
70% of their 'ýO 2 MaX on the morning of each day; and group D consumed a 
solution free from Cr and carbohydrate. Evidence for an enhanced muscle Cr 
uptake associated with carbohydrate came from a markedly reduced peak 
plasma [Cr] and area under the plasma Cr/time curve in subjects consuming 
carbohydrate-containing solution in combination with Cr supplementation 
(groups B& C), compared with subjects who consumed Cr alone (group A). 
Urinary Cr excretion was also shown to be lower in groups B and C, compared to 
that of group A. Green et al (1996) thus concluded that (a) whole-body Cr 
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retention was increased as a consequence of Cr being combined with 
carbohydrate (Figure 1.5) and (b) the response occurred as a consequence of an 
insulin-mediated increase in skeletal muscle Cr uptake. In addition, as insulin 
has also been shown to increase muscle blood flow (Baron et al, 1994), the 
carbohydrate-stimulated increase in muscle Cr uptake in humans could result in 
part from an insuhn-mediated increase in muscle blood flow and thereby muscle 
Cr availability. However, in the study by Green et al (1996), subjects had to 
ingested 94g of carbohydrate (in the form of simple sugars) to achieve 
physiologically high plasma [insulin] during the 1st hour after ingestion, which 
proved to be close to the limit of subject palatability and this study was also 
unable to identify the exact [insulin] necessary to stimulate muscle Cr uptake. It 
was for this reason, Steenge et al (1998) went on to try and identify the [insulin] 
necessary to stimulate muscle Cr uptake. Steenge et al (1998) infused insulin at 
rates of 5,30,55, or 105 MU. M-2. MM-1 M combination with 12.4 g-d-1 of Cr. This 
study confirmed the findings of Green et al (1996) showing that, during infusion 
rates of insulin at 55 and 105 mU. rrr2. lnin-1, muscle [Cr] increased by 4.5±1.4 and 
8.3±1.0 mmol-kg-1-dry weight muscle respectively, and plasma [Cr] was lower at 
specific time points compared with the lower infusion rates. This study 
demonstrated that insulin can enhance muscle [Cr] uptake in humans but only 
when at physiologically high or even supra-physiological concentrations. The 
authors also suggested that the mechanism behind this response was likely to be 
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Figure 1.5: Individual muscle total Creatine [TCr] after 
ingestion of 5g Cr alone or 5g Cr followed 30 
mins later with 93g simple carbohydrate 
(Green et al. 1996) 
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a result of an insuhn-mediated increase in muscle Cr transport rather than an 
increased rate of vascular Cr delivery. 
Creatine and health 
As with any relatively new ergogenic aid, especially one suggested to be 
as potent as Cr supplementation, questions concerning health effects have arisen. 
To date, the only documented side effect resulting from Cr supplementation has 
been a significant weight gain (Earnest et al, 1995; Green et al, 1996; Greenhaff et 
al, 1994; Maganaris & Maughan, 1998; Terrillion et al, 1997; Becque et al, 2000; 
Kreider et al, 1998; Harris et al, 1992; Poortmans and Francaux, 1999). However, 
there have been numerous anecdotal reports reporting gastrointestinal, 
cardiovascular and muscular problems following Cr supplementation. Therefore, 
researchers have examined the effects of Cr supplementation of various health 
markers over short -, medium-, and long-term supplementation. 
For example, Robinson et al (2000) examined the effects of Cr supplementation 
(20 g-d-1 of Cr for 5 days, followed by 3 g-d-1 of Cr for nine weeks) on various 
markers of muscle damage, and indices of haernatological, hepatic and renal 
function. No clinically significant changes were observed in any of these 
variables. Another study examining the effects of short to medium Cr 
supplementation on blood lipids was carried out by Volek et al (2000). These 
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authors examined the effects of Cr supplementation in combination with heavy 
resistance training on fasting serum creatinine, lipoproteins, triglycerides and 
reported changes in body function. Again, following Cr supplementation and 
training for 12 weeks, there were no adverse effects of training or 
supplementation on fasting serum creatinine, serum total cholesterol, 
HDL-cholesterol, LDL-cholesterol, triglycerides or reported changes in body 
function. 
In contrast, Earnest et al (1996) showed Cr supplementation to have a positive 
effect on blood lipid profile. This study showed that 8 weeks of Cr in conjunction 
with an exercise programme consisting of resistance training actuaRy increased 
HDL- cholesterol by 13%. 
Waldron et al (2002) also examined the effects of concurrent Cr supplementation 
and resistance training on markers of hepatic function. Subjects were loaded for 5 
days (0.3 g. kg-l-d-1 of Cr) foUowed by 5 weeks of maintenance (0.03 g. kg-l-d-1 of 
Cr) during which subjects weight-trained. Hepatic stress was assessed through 
measurement of serum concentrations of alanine amino transerase (ALT), 
aspartate amino transferase (AST), alkaline phosphatase (AP), blood urea 
nitrogen (BUN), albumin, creatinine, and direct and total bilirubin (DB and TB). 
This study concluded that, following Cr loading and maintenance, 
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concentrations of the measured variables did not change, with all variables 
remaining widtin normal clinical ranges. 
FinaRy, Mihic et al (2000) examined the short- to medium-term effects of Cr 
supplementation on health variables. In this study, the authors examined the 
effects of acute Cr loading (20 g-d-1 of Cr for 5 days) on blood pressure, plasma 
creatinine and plasma creatine kinase in a group of 30 men (n=15) and women 
(n=15). Cr supplementation was found to have no negative effects on blood 
pressure, plasma creatinine, estimated creatinine clearance or plasma creatine 
kinase activity. 
However, some studies have raised questions over the long term safety of Cr 
supplementation. For example, Pritchard and Kalra (1998) recently proposed that 
oral Cr supplementation may lead to renal dysfunction. Poortmans and Francaux 
(1999) and Schilling et al (2001) therefore subsequently examined the effects of 
long-term Cr supplementation on various health markers. For example, 
Poortmans and Francaux (1999) measured creatinine, urea and plasma albumin 
clearances in consumers of Cr supplementation of durations varying from 10 
months to 5 years against a control group. The results of this study showed there 
were no statistical differences between the control group and the Cr group for 
plasma contents and excretion rates of creatinine, urea and albumin. Clearance of 
these compounds also did not differ between the two groups, implying a lack of 
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effect on glomerular filtration rate, tubular reabsorption and glomerular 
membrane permeability. Subsequent to this, Schilling et al (2001) also examined 
the long-term safety of Cr supplementation. In this retrospective study, the 
authors examined markers of health, incidence of reported side effects and 
perceived training benefits in athletes supplementing with Cr for 0.8 to 4 years. 
The authors subjected the athletes to a standard clinical examination including 27 
blood chemistries; subjects also answered a questionnaire on dietary habits, Cr 
supplementation, medical history, training history and perceived benefits of 
supplementation. The data ftom this study again suggested that long-term Cr 
supplementation did not result in any adverse side effects. 
Creatine and body composition 
As already mentioned, the only consistently reported side effect with 
regard to Cr supplementation (short- and long-term) is an increase in body mass 
(Earnest et al, 1995; Green et al, 1996; Greenhaff et al. 1994; Maganaris & 
Maughan, 1998; Terrillion et al, 1997; Becque et al, 2000; Kreider et al, 1998). 
Although the exact mechanism behind this Cr-related increase in body mass is 
unknown, two possible mechanisms have been proposed. 
The first possible cause stems form the early work of Ingwall. et al (1972 & 1974). 
The first of these studies (IngwaH et al, 1972) presented evidence that Cr 
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supplementation was involved in the control of muscle protein synthesis. In 
1974, Ingwall. et al (1974) followed up their initial study and found that increasing 
the amount of Cr availability to differentiating skeletal muscle cells both in vitro 
(in monolayer culture) and in vivo (explants maintained in organ cultures) 
stimulated the rate of myosin heavy chain synthesis two-fold. 
Further support for this hypothesis came from the work by Sipila et al (1981). 
This experiment was designed to examine the effects of Cr supplementation as a 
treatment for gyrate atrophy of the choroid and retina. In this condition, marked 
progressive atrophy of the Type Il skeletal muscle fibres is consistently reported, 
with the authors stating that deficient formation of Cr may be a pathogenic 
component of this disease which may lead to a shortage of cellular PCr energy 
stores. Seven patients were supplemented with 1-5g creatine daily for one year. 
on completion of the study, Type II muscle fibres increased from 34.1±7.1 to 
49.9±7.0 I. LM, with the authors suggesting that these changes where a direct result 
of a Cr stimulated increase in protein synthesis. 
The other possible mechanism is that the increase in body mass following Cr 
supplementation is due to an increase in water retention (Hultman et al, 1996). 
This theory stems from the work of Hultman et al (1996). In this study, these 
authors observed a 0.6 L decline in urinary volume which occurred at the onset 
of Cr ingestion, and suggested that the increase in body mass during acute Cr 
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loading is likely to be attributed to body water retention. The authors also noted 
that the time course of the urinary volume changes paralleled the time course of 
muscle Cr uptake documented by Harris et al (1992). 
The exact mechanisms by which Cr supplementation increases total body water 
(TBW) and shifts fluid into the intracellular space still remain unclear. One 
possible cause is that osmotic flux of fluid into the intracellular compartment is 
caused by the increased [TCr] and [Cr] wifl-tin the muscle, thus increasing 
intracellular water (ICW) and hence TBW, ultimately increasing muscle volume. 
Ziegenfuss et al (1998) examined the effects of Cr supplementation on acute fluid 
volume changes following 3 days of Cr supplementation. In this study the 
researchers supplemented their subjects with Cr (0.35 g kg. FFM-1-d-1) for 3 days, 
and found Cr supplementation produced clear trends in fluid shifts, and by the 
end of day 3 increased TBW (2%) and ICW (3%), with no change in Extracellular 
water (ECW). 
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In view of all the above, the main objectives of fi-ds series of experiments were to 
investigate: 
i. In light of limitations in the pervious research (e. g. small sample size and 
inappropriate statistical analysis) the first experiment in this thesis was 
designed to examine the effects of Cr supplementation on strength 
endurance and maximal performance using an isometric bench-press test 
in a group of resistance-trained males. 
ii. Based on the results obtained from the first experiment, a second was 
designed to use strategies previously shown to optimise muscle Cr uptake 
and, hence, the potential to enhance exercise performance in previously 
non-resistance-trained humans on isokinetic, isometric and isotonic 
strength. 
iii. The results from Experiment 2 indicated a Cr-induced change in cellular 
hydration. Exercise in the heat has been shown to be criticafly dependent 
on hydration status and the aim of the third experiment was, therefore, to 
examine the effects of Cr-induced hyperhydration on cardiovascular, 
metabolic and thermoregulatory responses to exercise in the heat. 
Furthermore, the influence of Cr-induced hyperhydration on the subject's 
capacity to perform prolonged exercise in the heat was also examined. 
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iv. Skeletal muscle dysfunction is frequently observed in Chronic Obstructive 
Pulmonary Disease (COPD) patients. These patients suffer from 
significant loss of skeletal muscle mass and strength (reduced muscle 
mass is an important predictor of mortality). As Cr supplementation has 
the potential to increase muscle strength, muscle endurance and fat-free 
mass (FFM), the aim of the final study was to examine the effects of Cr 
supplementation in conjunction with a standard pulmonary rehabilitation 
on patients with moderate to severe COPD. The effects of Cr loading on 
upper and lower body strength, upper and lower body strength 
endurance and body composition were studied. 
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CHAPTER TWO 
General Methods 
GENERAL METHODS 
This chapter describes the general methodology used throughout this 
thesis. This thesis comprises of four main experimental chapters (chapters 3- 6). 
Methods specific to each of these chapters can be found in the relevant 
experimental chapters (chapters 3- 6). Only methods common to all experiments 
will be discussed here i. e., dietary analysis, urinary analysis, body composition. 
Subjects and Study Approval 
All experiments described in this thesis involved human volunteers. The 
subject groups used in this thesis were as follows: highly resistance-trained males 
(Experiment 1, chapter 3), non-resistance trained males (Experiment 2, chapter 4), 
endurance trained male cyclists (Experiment 3, chapter 5) and patients with 
moderate to severe chronic obstructive pulmonary disease (COPD) (Experiment 
4, chapter 6). Inclusion criteria for each subject group can be found in the 
individual experiment methods sections. 
Experiments 1-3 were approved by the University of Glasgow Ethics Committee; 
Experiment 4 was approved by the Glasgow Royal Infirmary Ethics board. The 
nature and purpose of each experiment was explained both verbally and in 
writing to each subject / patient prior to each experiment. Subjects were also 
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made aware that they could withdraw from the studies at any time without 
explanation. All subjects provided written informed consent prior to taking part 
in the experiment (Appendix 1). 
Experimental Design 
All four experiments followed a double-blind placebo controlled design. 
A significant limitation in this design is the lack of a crossover, i. e. subjects acting 
as their own controls. However, the use of a crossover design is problematic in 
the design of Cr supplementation studies. This is primarily due to the slow 
washout kinetics of Cr (4 -8 wks) from muscle, making it difficult to interpret 
results obtained from the placebo trial when administered as the second 
treatment, as can be seen from the study performed by Maganaris & Maughan 
(1998). Therefore for this reason a double-blind placebo controlled design was 
carried out with subjects in each group matched for body mass or performance 
(see individual experiment chapters for specific details). Much care was taken to 
ensure there was no order effect on performance by including a minimum of two 
familiarisations trials before subjects entered the experiment phase of each study, 
details of specific familiarisations are given in each Experimental chapter. 
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Familiarisation and Repeatability of Tests 
All subjects underwent at least two familiarisation tests except for 
Experiment 4 where due to the subject group (patients with moderate to severe 
COPD) used only one familiarisation trial was possible. During all familiarisation 
trials, subjects were taken through the exact experimental procedure and related 
protocols in order to fully familiarise the subjects with the experimental 
conditions and related exercise protocols (see individual Experimental chapters 
for spedfic criteria). 
Dietary Analysis 
Energy intake and diet composition were determined for each subject 
following completion of a weighed intake of varying duration, which was 
dependent on the specific study (see Experimental Chapters for details). During 
the weighed intake, subjects were asked to follow their normal diet (except for 
the extra carbohydrate contained in the experiment drinks) and weigh and 
record all food and drink consumed over the required period. Weighing scales 
accurate to ±1g were given to aH subjects. The weighed dietary intake was used 
to determine energy intake and dietary composition using a computerised 
version of McCance & Widdowson's food composition tables as revised by 
Holland et al (1991). These results were used to ensure any observed changes in 
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body composition and/or performance were not the result of changes in dietary 
intake. 
Urinary Analysis 
Urinary [Crea] and [Cr] in studies 1-3 were determined for each subject 
following 24 hour urinary collection of varying duration, which was dependent 
on the specific study (see Experimental Chapters for details). All urine was 
collected over a 24 hour period in a5L container provided by the investigators, 
subjects began urinary collection the day before supplementation in all 
experiments in order to obtain baseline results. The volume of urine collected for 
each 24 hour period was measured and mixed thoroughly, with two 
representative 20 ml samples being stored at -20' C for subsequent analysis of 
[CrI and [Crea] using a spectrophotometric enzymatic Crea Kit (Boehringer 
Mannheim MPR1 - Kit no. 839434) on a ABX Mira Plus Spectrophotometer (ABX 
Diagnostics, UK). The Crea content of the urine was measured by a sequence of 
four enzymatic steps as shown below: 
lst step: Creafinine + 
H20 creatinina Cr 
2nd step: Cr + H20 creating Sarcosine + Urea 
3rd step: Sarcosine + 
H20 + 02 sarcosine oxidase Glycine + HCHO + H202 
4th step: 
H202 + Phenol derivative + 4-aminophenazone INroxidase red 
benzoquinone imine dye 
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FoHowing the measurement of [Crea], the [CrI content of the urine was then 
measured which involved the removal of the first step of the above creatininase 
reaction, with the remaining three enzymatic reactions (2nd to 4th step) being 
completed as described by Oversteegen et al (1987). Total Cr excretion was 
corrected for any observed increase in Crea following supplementation. 
Estimated Cr uptake was calculated by subtracting the total Cr excreted, 
corrected for [Crea] excretion, from the total amount supplemented per day. 
Estimated intramuscular [Cr] (mmol-kg-1-dry weight muscle) was calculated 
based on an estimated muscle mass amounting to 40% of body mass and average 
muscle water content approximating 77% of wet weight (Bergstrom et al, 1971) as 
previously described by Maganaris & Maughan (1998). The method used to 
estimate Cr uptake in the present set of Experiments has previously been used as 
the sole method to estimate Cr uptake (e. g. Rossiter et al, 1996, Maganaris & 
Maughan, 1998) and in conjunction with the measurement of Cr uptake obtained 
from muscle biopsies (Harris et al, 1992, Hultman et al, 1996, Green et al, 1996). 
However this method is based on two major assumptions, firstly, 40% of body 
mass is muscle mass and secondly, average muscle water content is 
approximately 7% of wet weight. Utilising the 40% of body weight estimate of 
muscle mass is almost certainly an underestimation in some of our subject 
groups (Experiments 1-3). We therefore also analyzed the data using estimated 
muscle mass of ±5% (i. e. 35 and 40%) to estimate Cr uptake (for this we utilised 
the data obtained from Experiment 1). Utilising these two additional estimates of 
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muscle mass (35 and 45%) altered the absolute Cr uptake values; however, the 4 
subjects who were "non-responders" remained "non-responders" and the 17 
subjects remained "responders". In addition, we also recognise that the fixed 
muscle hydration level of 77% may also affect the results obtained especially due 
to the fact the Cr supplementation has been shown to increases cellular 
hydration levels. We therefore reanalyzed the data using estimated muscle 
hydration levels of ±- 30% (47 and 100%) to estimated Cr uptake, again for this 
we utifised the data obtained from Experiment 1. Utilising these two additional 
estimates of muscle hydration (47 and 100%) altered the Cr uptake values 
dramaticafly; however, the 4 subjects who were "non-responders" remained 
"non-responders" and the 17 subjects remained "responders". We have therefore 
opted to use the previously published and referenced 40% of body mass is 
muscle mass and average muscle water content is approximately 77% of wet 
weight. 
Body Composition 
Due to the reported changes in body composition following Cr 
supplementation, body composition analysis was completed in all four studies. 
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Body Mass 
Body mass was measured, wearing underwear/ swimsuit only, using a 
calibrated Seca electronic scale with precision of ± 0.01 kg (Seca, Isle of Man). The 
subjects/ patients stood on the platform, facing away from the scales, with their 
body weight evenly distributed between both feet. 
Body CoMRosition Measurements 
Body composition was measured using a bioelectrical impedance analyser 
(BIA) (Bodystat-1500, Bodystat Ltd, Douglas, UK in Experiments 1&4 and 
Bodystat-5000, Bodystat Ltd, Douglas, UK in Experiments 2& 3). This procedure 
allows measurement of fat mass (FM), fat-free mass (FFM), total body water 
(TBW) using the Bodystat-1500 irnpedance analyser and body water 
compartments (intracellular (ICW) and extracellular (ECW) water), using the 
Bodystat-5000 impedance analyser. 
Body composition measurement by bioelectrical impedance was performed on 
the right side, with subjects/ patients supine, and with their limbs slightly apart 
from the trunk. Two current-introducing electrodes were placed on the dorsal 
surfaces of the right hand and foot proximal to the metacarpal-phalangael and 
metatarsal-phalangael joints, respectively. Then two detector electrodes were 
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placed on the right pisiform pron-drience of the wrist, the proximal edge 
dissecting the u1nar tubercle, and between the medial and lateral maleoh, the 
proximal edge dissecting the medial malleolus. The impedance to current flow 
between the injector and detector electrodes was determined. These placements 
are standard placements for electrodes during measurement using BIA (van 
Loan, 1990). Preceding the electrode placement, the skin had been cleaned with 
70% alcohol to remove dead skin and dirt before electrode placement. BIA 
measures the opposition of body tissues to the flow of small (less than 1mA) 
alternating current. Impedance is a function of two components (vectors): the 
resistance of the tissues themselves, and the additional opposition (reactance) 
due to the capacitance of membranes, tissue interfaces, and non-ionic tissues. The 
measured resistance is approximately equivalent to that of muscle tissue. 
Throughout all experiments the National Institute of Health (NIH) 
standardisation procedures were followed (NIH, 1994) which were as follows: 
AH measurements were performed on a non-conductive surface in an 
environmental chamber (-23C) with the arms and legs slightly abducted (-301) 
from the trunk. Subjects were also required to abstain from alcohol, caffeine, and 
heavy exercise for 24 hrs prior to testing. Finally, subjects were given a 10 min 
supine equilibration period before each measurement. 
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BIA has recently become a popular method of estimating body composition due 
to it being a safe, convenient, portable method and its ability to perform frequent, 
rapid and non-invasive measurements (Koulmann et al. 2000). In recent years, 
many researchers have attempted to assess the validity and reliability of this 
method of estimating body composition. While there is still much debate with 
regard to the vahdity (hmits of agreement) of BIA estimation of body 
composition, the majority of researchers have concluded that BIA is a repeatable 
method (Kushner & Schoellor, 1986; Baumgartner et al, 1990; Koulmann et al, 
2000; Fornetti et al, 1999). Koulmann. et al (2000) reported the mean 
reproducibility for trial to trial intra-individual impedance measurements at 5 
kHz was 4.4% (coefficient of variation (CV)) and 2.2 % (CV) at 100 kHz, with 
these variations being slightly greater than those reported by Kushner & 
Schoeller (1986) (2.2 % week to week CV). 
In a separate investigation we assessed the short-term reliability (7 days) of BIA 
on 25 healthy male subjects for the measurement of FFM, TBW and ICW using 
Bland & Altman (1986) limits of agreement. In this study we found the mean bias 
and 95% confidence intervals to be -0.1 ± 0.9 kg, -0.2 ± 0.9 L and -0.1 ± 0.6 L for 
FFM, TBW and ICW, respectively. Further support for the short-term reliability 
of BIA can be seen in all four Experimental chapters when comparing the pre- 
post values obtained from the placebo groups. The non-significant change in any 
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of the BIA determined body composition variables obtained from the placebo 
group in Experiments 1-4 is further support for the reliability of BIA. 
Experimental Controls 
Subjects were also requested to eliminate caffeine and caffeine-containing 
foods from their diet over the loading period in all 4 experiments to minimize the 
possible inhibitory effects of caffeine on the ergogenic effect of Cr (Vandenberghe 
et al, 1996). In Experiments 1 and 3, subjects were required to maintain their 
normal training habits for the duration of the study. Experiments 2 and 4, 
subjects underwent supervised training and it was stressed that all other activity 
was to be kept within their normal habits. At the end of the all experiments, 
subjects gave verbal and written assurance that they had complied with these 
instructions. 
Cr Dosage and Carbohydrate 
All four experiments involved Cr and placebo supplementation. Due to 
variations in the experimental design and experimental needs, Cr dosages varied 
between experiments. Also due to the proposed stimulatory effect of 
carbohydrate on muscular Cr uptake (Green et al, 1996), subjects also consumed 
extra carbohydrate with their Cr dosages. In Experiment 1, subjects consumed 
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90g of glucose polymer in combination with Cr (as recommended by Green et al, 
1996); however this proved to be at the subject's limit of tolerance. Therefore, in 
subsequent experiments (2 - 4), subject's consumed a moderate amount of 
carbohydrate with their Cr dosage (35g per 5g Cr), and were also instructed to 
consume the Cr following meal times (additional carbohydrate). The exact Cr 
dosages and supplementation periods are stated in the methods section of each 
Experimental chapter. 
Data Analysis 
Due to the similar experimental design of all studies (placebo controlled) 
data analysis was similar for all experiments. 
Data was expressed as the mean ± s. d. or median (range), following a test for the 
normality of distribution. Statistical analysis was carried out using two-factor 
ANOVA for repeated measures, followed by Student' s paired Mest (within 
treatment effect, i. e., pre- vs. post-supplementation) and two-sample t-test 
(between treatment effect, i. e., magnitude of change in the Cr group or 
"responders" vs. the placebo group) if a main treatment or interaction effect was 
observed. An ANCOVA was used where necessary to normalise for differences 
in pre-supplementation results using the baseline value as the covariate. 
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Pearson's correlation analysis was used to assess the relationship between 
selected variables. Statistical significance was declared at P<0.05. 
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CHAPTER THREE 
(Experiment 1) 
Effects of Creatine Supplementation on Isometric Bench- 
Press Performance in a Group of resistance-trained 
Humans 
INTRODUCTION 
The energy required to perform brief explosive-type exercise is almost 
exclusively provided by the high-energy phosphate stores in skeletal muscle. As 
the phosphocreatine (PCr) stores become depleted, performance rapidly 
deteriorates, reflecting the inability to rephosphorylate adenosine diphosphate 
(ADP) to adenosine triphosphate (ATP) at the required rate (Hultman et al, 1990). 
Increasing resting levels of intramuscular creatine (Cr) by oral Cr 
supplementation (Harris et al, 1992) has been shown to increase intramuscular 
PCr levels and to accelerate the resynthesis of ATP during and following high- 
intensity, short-duration exercise (Balsom et al, 1995; Greenhaff et A 1994). 
In recent years, numerous studies have investigated the effects of Cr 
supplementation on exercise performance and body composition, but with 
conflicting results. A significant limitation in the design of Cr supplementation 
studies is that the use of a crossover design is problematic. That is, the slow 
washout kinetics of Cr from muscle makes it difficult to interpret results 
obtained from placebo trials when administered as the second treatment. This 
methodological problem has forced many investigators to use matched subject 
groups. Many such studies have aIso used too few subjects (i. e. < 20), thus 
increasing the chance of producing a Type II error (Tarnopolsky & MacLennan, 
2000). The risk of producing a Type II error is also increased if subjects 
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supplemented with Cr are not differentiated into "responders" and "non- 
responders" on the basis of measured or estimated Cr uptake (Casey et al, 1996; 
Greenhaff et al, 1994). Another problem inherent in using matched subject groups 
is the choice of appropriate statistical methods. For example, some of the positive 
findings in the literature (e. g. Birch et al, 1994 and Harris et al, 1992) have been 
questioned because of the use of multiple Mests instead of analysis of variance 
(ANOVA), therefore increasing the probability of committing a Type I error 
(Gilham et al, 2000). 
With the above concerns in mind, the balance of available evidence from Cr 
supplementation studies would suggest that oral Cr loading can increase muscle 
Cr content (Balsom et al, 1995; Harris et al, 1992; Hultman et al, 1996), increase fat- 
free mass (Becque et al, 2000; Kreider et al, 1998), improve anaerobic sprint 
performance (Casey et al, 1996; Green et A 1996) and promote greater gains in 
strength (Kreider et al, 1998; Maganaris & Maughan, 1998; Volek et al, 1997). 
Although the effects of Cr supplementation on exercise performance have been 
investigated in a number of different subject groups using a variety of different 
intervention strategies and exercise modes, little systematic investigation has 
been given to the effects of Cr supplementation on performance of isometric 
exercise. The aim of the present Experiment was therefore to determine the 
effects of Cr supplementation on strength endurance and maximal performance 
using an isometric bench-press test in a group of resistance-trained males. 
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Although the isometric bench-press test is unable to replicate the typical bench- 
press manoeuvre (i. e. the test is isometric, while the training or competitive 
manoeuvre is isotonic), it partly simulates the training adopted by resistance- 
trained subjects, and also allows force to be measured with a high degree of 
accuracy. 
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METHODS 
Subjects 
Thirty-two healthy resistance-trained males (Table 3.1), from whom 
written informed consent had been obtained, volunteered to take part in this 
Experiment which was approved by the local ethics committee. Subject eligibility 
was initially assessed by interview. No subject had a history of cardiovascular or 
respiratory disease and/or evidence of musculoskeletal injury. Subjects were 
recruited on the basis that they were engaged in a structured weight-training 
program at the time of recruitment. All subjects had at least 2 years training 
experience and were demonstrated not to have supplemented with Cr for at least 
8 weeks prior to the Experiment. Investigators did not reveal prior to interview 
that subjects would be excluded if they had supplemented with Cr in the last 8 
weeks. Eight subjects (four in each group) had previously supplemented with Cr. 
No Cr was detected in the baseline urine samples of any subject. Subjects 
typically undertook 3-4 resistive-training sessions per week, with an emphasis 
on major muscle groups. All subjects completed at least one heavy dynamic 
bench-press session per week (e. g. two warm-up sets at -50% of the subject's one 
repetition maximum (1 RM), pyramiding up to 1 RM within 4 sets). 
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Table 1: Physical characteristics of the two groups of subjects 
Placebo Group Creatine Group 
(n=11) (n=21) 
Pre Post Pre Post 
Age (yr) 24 ±5 24 ±5 
Height (m) 1.79 ± 0.08 - 1.79 ± 0.07 
Weight (kg) 80.1 ± 7.3 80.2 ± 7.1 84.1 ± 8.2 85.1 ±8.0 
Total Body Water (1) 48.4 ± 3.7 48.5 ± 3.9 49.9 ±4.1 50.4 ±4.2 
Total Body Water 60.0 ± 3.6 60.6 ± 2.8 59.5 ± 3.0 59.4 ±3.0 
Fat-free mass (kg) 69.3 ± 5.6 69.4 ± 5.8 71.9 ± 5.7 72.6 ± 5.7 
Fat-free mass 6.7 ±4.1 86.7 ±4.1 85.7 ± 3.5 85.5 ± 3.4 
Body Fat (kg) 10.9 ±3.8 10.8 ±3.7 12.2 ±3.9 12.6 ±3.8 
Body Fat (%) 13.4 ±4.1 13.3 ±4.1 14.3 ±3-5 14.5 ±3.4 
Peak power (N) 815 ± 255 - 812 ± 207 - 
Training history (yr) 5±2 5±2 
Values are presented as the mean ± s. d. 
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Experimental Design 
Prior to entering the experimental phase of the Experiment, subjects 
visited the laboratory on at least two occasions in order to become familiar with 
the isometric bench-press and related protocols. Familiarisation trials were 
carried out until the variability of two consecutive performances was within 
100 N for peak force. The test-retest reliability of the isometric bench-press 
revealed a high intra-class correlation (ICC) for both performance outcomes 
(Peak force ICC = 0.95, Total force ICC = 0.95; these test-retest reliability values 
are based on subjects having each undergone three familiarization tests). On the 
basis of the final familiarization results (peak force), subjects were assigned in a 
double-blind fashion to either a Cr group or a placebo group on a two to one 
ratio; this asymmetry was designed to accommodate for both "responders" and 
"non-responders" to Cr supplementation (Greenhaff et al, 1994). Following the 
familiarization period, all subjects performed two isometric bench-press tests at 
least five days apart. The first isometric bench-press test was conducted 48 hours 
after the subject's final familiarization trial. The supplementation period for both 
groups started on the day after the first isometric bench-press test and finished 
the day before the second isometric bench-press test. The experimental design is 
shown in Fig. 3.1. 
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Figure 3.1 The experimental design for Experiment 1 
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The Cr group ingested 22.8 g. d-1 Cr-H20 (equivalent to 10 g Cr x2 daily) for 5 
days before and after each daily trairting session. Each pre- and post-work out 
supplement dose consisted of 11.4 g of Cr-H20(equivalent to 10 g Cr) and 90 g of 
glucose polymer made up in 500 mls of warm to hot water. This regimen was 
adopted in fight of the work by Harris et al (1992) who found that this protocol 
increased resting muscle PCr levels within 5 days. Rossiter et al (1996) also used a 
5 day Cr supplementation period in trained individuals and found ergogenic 
effects. Dissolving Cr in warm to hot water prevented any detectable formation 
of creatinine (Crea), with no parts of the supplement remaining undissolved. The 
addition of dextrose to the Cr has been shown to significantly enhance the 
uptake of Cr (Green et A 1996; Steenge et al, 1998). On training days, subjects 
consumed the first Cr dose 1h prior to exercise and the second Cr dose 
immediately post-exercise. On non-training days subjects took the supplement ad 
libitum. The placebo group consumed 202.8 g-d-1 of glucose polymer (101.4 gx2 
daffy) for 5 days prepared and administered in an identical fashion to the Cr 
supplement. Both supplements had similar taste, texture and appearance and 
were placed in generic packets to ensure double-blind administration. 
Subjects were instructed to follow their normal diet (apart from the extra 
carbohydrate (CHO) contained in the experiment drinks) and to weigh and 
record all food and drink consumed. Subjects were also requested to eliminate 
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caffeine and caffeine-contaft-ting foods from their diet to minimize the possible 
inhibitory effects of caffeine on the ergogenic effect of Cr (Vandenberghe et al, 
1996). Throughout the duration of the experiment, subjects were encouraged to 
maintain their normal training habits. At the end of the experiment, all subjects 
gave verbal assurance that they had complied with these instructions. Subjects 
completed 7 separate 24-hour urine collections. The first was started on the day 
proceeding supplementation (baseline), then continued through the 5 days of 
supplementation and finished on the day following supplementation. 
Procedures 
Subjects reported to the laboratory on the morning of testing after a 
standardized meal and having refrained from alcohol intake, caffeine intake and 
strenuous exercise the day before. Following the measurement of height and 
body mass, percentage body fat, fat free mass and total body water (TBW) were 
measured (Bodystat-1500 Bioimpedance analyzer, Bodystat Ltd., Isle of Man) 
using a standard bioimpedance technique (Lukaski et al, 1985; Van Loan, 1990). 
The measurements were taken while the subjects lay comfortably in a supine 
position on a non-conductive surface, with their arms and legs slightly abducted. 
Before the start of the isometric bench-press test, aH subjects underwent a 
standardized warm-up consisting of 5 min of arm cranking at 25 Watts, followed 
by a series of stretches with an emphasis on stretching the musculature 
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associated with the bench-press manoeuvre. 
Each subject then performed five consecutive maximal isometric bench-presses. 
A padded bench was positioned over a calibrated force platform (Kistler type 
9281B, Kistler Instruments Corporation, Switzerland) so that the force platform 
was directly under the subject's shoulders. A weight stand of adjustable height 
was positioned on either side of the bench, and a1m bar was laid across the 
stands and permanently fixed in this position. Subjects were required to position 
themselves on the bench with their elbows at 900 flexion and with their hands 
positioned no more than 81 cm apart. Each subject was asked to assume a 
comfortable pressing position on the bench. The subject's hand, head and the 
stand height positions were noted and the subject was required to reproduce the 
same position on each testing occasion. For each isometric bench-press, subjects 
were given a5s count-down and told to press against the bar as hard as possible 
for 20 s, a duration that has been shown to depIete PCr stores by - 98 % (Tesch et 
al, 1989). The force exerted against the bar was transmitted by the bench to the 
force platform in the vertical plane, and the peak, total force (area under the 
curve) and fatigue index (the percent decline in force production within each 20 s 
period) for each bench-press was calculated using the Kistler software provided 
(Kistler BioWare, Version 2.22, Kistler Instruments Corporation, Switzerland). 
This manoeuvre was repeated a further four times, with 2 min recovery periods. 
This recovery period was adopted in light of the findings by Greenhaff et al 
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(1994) of increased rate of PCr rephosphorylation during the second n-tinute of 
recovery from intense muscular contractions following Cr supplementation. 
Subjects adopted the "ready" position in the last minute of each recovery period. 
All post-supplementation testing was carried out at the same time of day and in 
the same manner. Consumption of water (500 ml) was permitted during each 
bench-press test. Room temperature was maintained between 20-241 C. 
Data Analysis 
Data were expressed as the mean ± s. d. or median (range), following a test 
for the normality of distribution. Statistical analysis was carried out using two 
factor ANOVA for repeated measures, followed by paired t-test or two-sample 
t-test, as appropriate. Statistical significance was declared at P<0.05. 
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RESULTS 
Dietary Analysis 
During the experimental period, the daily diet of the Cr group comprised 
13.4 ± 2.5 Mj-d-1, of which 59 ± 6%, 27 ±6%, 14 ± 4% and 0 ±0 % of energy intake 
was in the form of CHO, fat, protein and alcohol, respectively. The daily diet of 
the placebo group comprised 13.3 ± 1.7 Mj-d-1, of which 59 ± 5%, 25 ± 6%, 14 ± 
4% and 2± 3% of energy intake was in the form of CHO, fat, protein and alcohol, 
respectively. 
Urinary Analyses 
In the placebo group, Crea excretion over the six days was not different 
from baseline. In the Cr group, Crea excretion increased from 1.6 ± 0.4 g-d-1 on 
the first day to 4.0 ± 1.1 g-d-1 on the final day of supplementation. Daily Cr 
excretion was therefore corrected for Crea excretion. Urinary Cr excretion also 
increased during the supplementation period in the Cr group. Estimated Cr 
uptake was greatest on the first day of supplementation (15 (7-20) g) and was 
lowest on the final day of supplementation (7 (-4-15) g) (median (range)). The 
estimated Cr uptake was calculated by subtracting the total Cr excreted 
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(corrected for Crea excretion) from the total amount supplemented per day. Of 
the 20 g of Cr administered each day, 75 (33-100) % was retained on the first day 
of supplementation and 34 (-18-77) % on the last day of supplementation. The 
total amount of Cr retained over the supplementation period was 45 ± 18 g of the 
total supplemented dose (i. e. 100 g), with an estimated increase in intramuscular 
Cr concentration of 43 (13-61) mmol-kg-1-dry weight muscle (based on an 
estimated muscle mass of 40% of body mass and an average muscle water of 77% 
of wet weight; Bergstrom et al (1971)). In the placebo group, no Cr was detected 
in the urine during the experiment. Out of the 21 subjects in the Cr group, 4 
subjects were classified as "non-responders" (5 21 mmol. kg-l-dry muscle weight 
increase following Cr supplementation) and the remaining 17 subjects were 
classed as "responders" (> 32 mmol-kg-1-dry weight muscle). The estimated Cr 
uptake for the "responders" group was 51 (32 - 61) mmol-kg-1-dry weight muscle 
compared to an estimated Cr uptake of 14 (13 - 21) mmol-kg-1-dry weight muscle 
for the "non-responders". These two distinct groups are evidence of an 
"ergogenic threshold". These estimated Cr uptakes are very similar to those 
measured by Greenhaff et al (1994). In that study, the "non-responders" had a Cr 
uptake of about 10 mmol. kg-1 dry weight muscle and all but one of the 
"responders" had a Cr uptake greater than 25 mmol-kg-1 dry weight muscle. 
Similarly, in the present experiment, A but one "non-responder" had a Cr uptake 
of about 13 mmol. kg-1 dry weight muscle and all "responders" had a Cr uptake 
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above 30 mmol-kg-1 dry weight muscle. 
Physical Characteristics 
The physical characteristics of the two groups of subjects were similar 
before supplementation (Table 3.1). In the Cr group, body mass increased 
significantly from 84.1 ± 8.2 kg to 85.1 ± 8.0 kg following supplementation 
(P<0.001), with no change in the placebo group (80.1 ± 7.3 kg to 80.2 ± 7.1 kg, 
P=0.76). The magnitude of change in body mass was significantly greater in the 
Cr group compared to the placebo group (P=0.003). Absolute and percentage 
body fat and TBW were not different between groups; however there was a 
significant increase in TBW in the "responders" over time (49.9 ± 4.3 L to 50.6 ± 
4.9 L, P=0.019). 
As with the Cr group as a whole, there was a significant increase in body mass in 
the "responders" to Cr following supplementation (84.1 ± 8.6 kg to 85.3 ± 8.3 kg, 
P<0.01). The gain in body mass over the supplementation period was also 
significantly greater (P<0.01) in the "responders" compared to the placebo group 
(Fig. 3.2). The change in FFM over the supplementation period was significantly 
greater (P=0.038) in the "responders" compared to the placebo group (Fig. 3.2). 
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Figure 3.2 Changes in body weight (BW), lean body mass 
(LBM), fat mass (BF) and total body water 
(TBW) (mean ± s. d. ) in the "responders" and 
placebo supplemented groups. * indicates a 
significantly greater increase in the 
"responders" group compared to the placebo 
group 
2.5 
2.0 
1.5 
1.0 
0.5 
0 
-0.5 
BW (kg) LBM (kg) BF (kg) TBW (1) 
* Responders 
* Placebo 
65 
Body mass for the "non-responders" did not increase following Cr 
supplementation (84.2 ± 7.9 kg to 84.2 ± 7.4 kg, P=0.94). The gain in body mass 
was thus significantly greater (P=0.017) in the "responders" compared to the 
"non-responders". There was no significant increase in average body fat for the 
"responders" or placebo group post supplementation (i. e. 12.2 ± 3.9 kg to 12.6 ± 
3.8 kg, P=0.237 and 10.9 ± 3.8 kg to 10.8 ± 3.7 kg, P=0.788, respectively). Figure 3.2 
shows less than 0.3 kg non-significant increase in body fat for the "responder" 
group and a non-significant decrease in body fat of 0.3 kg in the placebo group, 
both are within day to day measurement variation. 
Isometric Bench-press Performance 
Peak force and total force were not significantly different between the Cr 
and placebo groups prior to supplementation. In both groups, there was a 
significant decrease in peak force over the 5 repetitions during both the pre- 
supplementation and post-supplementation bench-press tests. There was a non- 
significant tendency for the magnitude of change (i. e. post-supplementation 
minus pre-supplementation) in peak force and total force to be significantly 
greater in the Cr group compared to the placebo group (P=0.054 and P=0.078 
respectively). However, when this analysis was repeated after removing the 
"non-responders" from the Cr group, the magnitude of change in peak force and 
total force was significantly greater in the "responders" compared to the placebo 
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group (P=0.003 and P<0.01) (Fig. 3.3). The percent decline in force production 
within each 20 s period (fatigue index) for each bench-press was not significantly 
different when comparing the pre- to the post-supplementation values in either 
group, or after excluding the "non-responders" from the Cr group. 
Correlations 
A significant negative correlation was found between estimated Cr uptake 
and training experience in the Cr group (r=-0.68, n=21, P=0.001) (Fig. 3.4a). 
Subjects in both the Cr group and the placebo group had, on average, 5±2 years 
heavy resistance training experience (P=0.22). Estimated Cr uptake was also 
positively correlated with the change (A) in body mass over the supplementation 
period (r=0.55, n=21, P<0.01) (Fig. 3.4b). Estimated Cr uptake was significantly 
correlated with the increase (pre to post) in total force for the first 4 repetitions 
(Repetition 1: r=0.53, P=0.013; Repetition 2: r=0.47, P=0.033; Repetition 3: r=0.44, 
P=0.044; Repetition 4: r=0.49, P=0.026). There was also a significant positive 
correlation between the magnitude of increase in total force over the 5 repetitions 
(total change in force for each repetition added together) and estimated Cr 
uptake (r=0.508, n=21, P=0.019) (Fig. 3.4c). No significant association was found 
when protein intake was correlated against estimated Cr uptake (P=0.79). 
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Figure 3.3 Change in peak force (top panel) and total 
force (bottom panel) in the Cr ("responders" 
and "non-responders") and placebo 
supplemented groups. * indicates a 
significantly greater increase in the 
"responders" group compared to the placebo 
group 
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Figure 3.4 Correlations between estimated Cr uptake and 
training experience (A), change in body weight 
(B) and change in total force (C) in the Cr 
group 
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0 9 
Side Effects 
In general, subjects tolerated the supplementation protocol well, with no 
reports of gastrointestinal distress or muscle cramping. Three subjects (i. e. 2 
subjects in the Cr group and 1 subject in the placebo group) reported 
experiencing mild headaches, possibly due to the high glucose concentration of 
the ingested supplements. 
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DISCUSSION 
In the present experiment, 5 days of Cr supplementation significantly 
increased peak isometric force and total force during repeated 20 s isometric 
bench press exercise in a group of 17 "responders" compared to the placebo 
group (Figure 3.3). As muscle biopsies were not obtained in this Experiment, one 
can only speculate on the potential mechanisms for this improvement in 
performance following Cr supplementation. Nevertheless, increased PCr 
availability and PCr resynthesis during recovery from maximal exercise of this 
type are the most plausible as muscle fatigue has previously been associated with 
a depletion of muscle PCr stores (Hultman et al, 1990; Tesch et A 1989). Cr 
supplementation has the potential to increase the basal levels of PCr and, by 
doing so, to delay the onset of muscle fatigue. A number of previous studies 
support this view (Balsom et al, 1995; Greenhaff et al, 1994). 
Since the seminal work of Harris et al (1992) and Greenhaff et al (1994), many 
investigators have tested the hypothesis that strength, power and/or work 
performed during repeated sets of maximal dynamic contractions can be 
improved by increasing total muscle Cr concentration by Cr ingestion. However, 
not all studies have reported an ergogenic effect. Of the 55 pertinent papers 
published to date (to our knowledge and not including abstracts), 40 have 
demonstrated an ergogenic effect. It is interesting to note that Greenhaff et al 
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(1994) found a substantial increase in total muscle Cr concentration only in 
subjects with a pre-supplementation total muscle Cr concentration of the order of 
120 mmol-kg-1-dry muscle weight or less, and that these same individuals 
demonstrated an accelerated rate of PCr resynthesis during the second minute of 
recovery from intense electricafly-evoked contractions of the vastus lateralis. 
Greenhaff et al (1994) and Casey et al (1996) subsequently showed an ergogenic 
effect of Cr supplementation when the post-supplementation increase in 
intramuscular [CrI exceeded 20 mmol-ke-dry muscle weight. For example, 
Casey et al (1996) reported that Cr supplementation produced a 23.1 ± 4.7 
mmol-kg-1-dry muscle weight increase in [Cr] and an increase in peak and total 
work produced during two bouts of 30 s maximal isokinetic cycling. Similarly, 
Maganaris & Maughan (1998) showed that Cr supplementation (10 g Cr-d-1 for 5 
days) increased the estimated muscle [Cr] by about 30 mmol-kg-1-dry muscle 
weight and increased isometric force generating capacity and isometric 
endurance. In contrast, however, Snow et al (1998) found only a small increase in 
muscle [Cr] following 30 g of Cr-d-1 for 5 days (i. e., 11.7 ± 2.4 mmol-kg-1-dry 
muscle weight) and no significant improvement in sprint-exercise performance. 
A similar outcome was reported more recently by Finn et al (2001) for 4x2O s all- 
out sprint performance in 8 endurance trained cyclists following 5 days of Cr 
supplementation. They too found only a small increase in muscle [Cr] (16.2 
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mmol-kg-1-dry muscle weight), with 3 out of the 8 subjects increasing [CrI by less 
than 10 mmol-kg-1-dry muscle weight. It should be pointed out that these authors 
could be making a Type II error (Tarnopolsky & MacLennan, 2000) consequent 
both to the small sample size and the low Cr retention that was particularly 
marked in 3 of their 8 subjects. 
These several observations emphasize the importance of recognizing that 
substantial individual differences can occur in intramuscular Cr uptake 
following Cr supplementation. The classification of subjects into "responders" 
and "non-responders" (Greenhaff et al, 1994; Casey et al, 1996) is suggestive of 
what might be termed an "ergogenic threshold" for Cr uptake of about 20 
mmol-kg-1-dry muscle weight, as proposed by Greenhaff et al (1994) and Casey et 
al (1996). Greenhaff et al (1994) showed an increased rate of PCr resynthesis 
during recovery following Cr ingestion in subjects those muscle Cr concentration 
increased by on average 20 mmol-kg-1-dry muscle weight, but conversely subjects 
whose muscle Cr concentration increased by < 10 mmol. kg-l-dry muscle weight 
following Cr supplementation showed very little or even a slower rate of PCr 
resynthesis during recovery. Our findings provide support for this contention. 
Only when the 4 "non-responders" (in whom the increase in intramuscular [CrI 
was estimated to be: 5 21 mmol-kg-1-dry muscle weight) were excluded from the 
Cr group did the improved isometric bench-press performance clearly emerge, 
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both in terms of peak force and total force. Furthermore, the finding of a 
significant correlation between estimated Cr uptake and delta total force in 
repetitions 1-4 would suggest that subjects with the greatest Cr uptake had the 
greatest performance benefit, and this is in agreement with previous published 
work (Casey et al, 1996). While these findings provide evidence consistent with 
an ergogenic threshold, assigning a specific threshold value is not possible as Cr 
uptake was only estimated in the present experiment. Nevertheless, these 
estimated Cr uptake values are very similar to those measured by Greenhaff et al 
(1994). 
One explanation for the two distinct groups (i. e. "responders" and "non- 
responders") with regard to Cr uptake may be the varying amount of 
intramuscular Cr prior to supplementation. This might reflect, for example, a low 
habitual dietary intake of Cr in the "responders" and/or conversely, a high 
dietary intake of Cr in the "non-responders". Whether this was the case in these 
particular subjects cannot be established. While our subjects carried out a 
weighed intake of food, it was not possible to meaningfully estimate the dietary 
Cr content as the amount of Cr in each item of food is dependent on many factors 
including food preparation. Even so, one might reasonably expect that subjects 
with a high protein intake might also have a high Cr intake. However, we found 
no significant correlation between protein intake and estimated Cr uptake 
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(P=0.79). Also, protein intake was not different in the "responders" and "non- 
responders". 
Another possible explanation could be the strength-training status of our 
subjects. MacDougall et al (1977) have reported that only 5 months of heavy 
resistance-training can increase resting muscle [Cr] by 39% and [PCr] by 22%. 
Our subjects had 5±2 years of heavy resistance training experience which could 
predispose them to high resting levels of intramuscular Cr and PCr. Variability 
in training status may therefore be another factor responsible for the conflicting 
results reported in the literature. Interestingly, a significant negative correlation 
was found between training experience and estimated Cr uptake (Fig. 3.4a). This 
is an area that we feel needs further investigation. 
Although other studies have found no significant difference in body mass 
following short-term Cr supplementation (20 - 30 g-d-1 for 5-7 days) (Grindstaff 
et A 1997; Steenge et al, 1998; Terrillion et al, 1997), the majority of studies have 
produced increases ranging from 0.6 - 1.8 kg following short-term Cr 
supplementation (Earnest et al, 1995; Green et al, 1996; Greenhaff et al, 1994; 
Maganaris & Maughan, 1998; TerriRion et al, 1997). Considering the short time 
course of this increase in body mass, some investigators have attributed these 
increases to increases in TBW. For example, Hultman et al (1996) found a 0.6 L 
decline in urinary volume following acute Cr supplementation (20 Cr g-d-1 for 6 
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days) and therefore attributed the increase in body mass to Cr-stimulated water 
retention. These authors also noted that the time course of urinary volume 
changes paralleled that of muscle Cr uptake. Furthermore, an increase in both 
total body and intracellular water was demonstrated by Ziegenfuss et al (1998) 
with acute Cr ingestion (0.35 g. kg fat free mass-d-1 for 3 days), with the increase 
in TBW accounting for approximately 90% of the acute gain in body mass. It 
remains to be determined whether this increase in water is associated with an 
increase in protein synthesis. The balance of available evidence from human 
performance studies using Cr supplementation and More direct evidence from 
animal in vivo and in vitro experiments would support the notion that increasing 
Cr availability may indeed increase protein synthesis (Francaux & Poortmans, 
1999; Ingwall et al, 1974; Kreider et al, 1998). In the present Experiment, 
supplementation with Cr increased body mass (84.1 ± 8.6 kg pre- 
supplementation to 85.3 ± 8.3 kg post-supplementation), with the mean increase 
in the "responder" group (1.2 ± 0.9 kg) being significantly greater (P<0.01) than 
that of the placebo group (0.1 ± 0.6 kg) (Fig. 3.2). The increase in body mass 
cannot be explained by the increases in TBW alone as a result of Cr stimulated 
water retention, as there was no significant increase in TBW as expressed as 
percentage of body mass. Despite a significant increase in TBW in absolute terms 
in the "responders" group (49.9 ± 4.3 L to 50.6 ± 4.9 L, P=0.019), if the relative 
volume of TBW remains constant (as in the present Experiment), the gain in 
body mass may not be attributed to water retention. The increase in absolute 
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TBW seen in this study following Cr supplementation may be indicative of 
intracellular water that normaRy accompanies dry matter growth. Francaux and 
Poortmans (1999) found similar results and interpreted their findings in a same 
manner. Cr supplementation also promoted significantly greater gains in FFM in 
the "responder" group compared to the placebo group (P=0.038). Resolution of 
this issue requires additional research using more precise and invasive methods. 
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CONCLUSION 
The results of this Experiment suggest that 20 g Cr-d-I for 5 days did not 
result in a significant increase in peak force or total work during repeated 
isometric contractions in resistance-trained individuals. However, this was due 
to the "non-responders" in the Cr group masking the effects of the remaining 
group. When the Cr group was considered with only "responders" to Cr in the 
group, Cr supplementation resulted in significant increases in peak force and 
totalforce. 
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CHAPTER FOUR 
(Experiment 2) 
Effects of Creatine on Body Composition and Strength 
Gains after Four Weeks of Resistance-training in 
previously Non-resistance-trained Humans 
INTRODUCTION 
The seminal work of Harris et al (1992) and Greenhaff et al (1994) 
instigated a number of studies that tested the hypothesis that strength, power 
and/or work, performed during repeated sets of maximal dynamic contractions, 
may be improved following an increase in total muscle [Cr] ([TCr]) by Cr 
ingestion. Not A studies, however, have reported an ergogenic effect. Of the 55 
pertinent papers published to date (to our knowledge and not including 
abstracts), 40 have demonstrated an ergogenic effect. The majority of the 
conflicting findings may be attributed in part to the failure Of many researchers 
to acknowledge the considerable inter-individual variation in muscle Cr uptake 
following Cr supplementation. Subjects were not, therefore, differentiated into 
"responders" and "non-responders" (< 21 mmol-kg-l-dry muscle weight increase 
following Cr supplementation; Greenhaff et al (1994)) on the basis of measured or 
estimated Cr uptake. In order to examine whether Cr supplementation can 
enhance performance, it is essential that experiments are designed to optimise Cr 
uptake and therefore potential to improve performance. 
Over the years, numerous strategies have emerged aimed at enhancing Cr 
uptake with Cr supplementation. The early work of Harris et al (1992) is one of 
only a few studies to examine whether Cr uptake by skeletal muscle can be 
increased by exercise. Harris et al (1992) employed 1 hour of one-legged cycling 
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exercise per day for 4-7 days and demonstrated enhanced Cr uptake in the 
exercising leg by 54% whilst little effect was observed in the non-exercising leg. 
The precise mechanism(s) for the exercise-induced increase in muscle Cr uptake 
is still unknown, although an increase in blood flow to the exercising muscle 
and/or changes in the transport kinetics of Cr across the sarcolemma were 
suggested by the authors as the most plausible explanations. 
An additional strategy to show enhanced Cr uptake is the ingestion of 
carbohydrate in combination with Cr. Ingestion of Cr, in combination with a 
carbohydrate-containing solution, resulted in a 60% greater increase in muscle 
[Cr] than when ingesting Cr on its own (Green et al, 1996). While the explanation 
for this carbohydrate-induced increase in muscle Cr uptake remains unclear, this 
response is most likely to be the result of an insulin-mediated increase in muscle 
Cr transport, rather than an effect on Cr delivery (Green et al, 1996; Steenge et al, 
1998). 
Training status is another factor with the potential to influence Cr uptake. 
Experiment 1 revealed a significant negative correlation between resistance 
training experience/ history and estimated muscle Cr uptake (Fig. 3.4a), 
suggesting the greater the resistance-training experience of the subjects, the 
lower the Cr uptake with Cr supplementation. This notion is also supported by 
the early work of MacDougall et al (1977), showing that only 5 months of heavy 
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resistance-training increased resting muscle [Cr] by 39% and [PCr] by 22%. 
Heavy resistance training experience could therefore predispose subjects to high 
baseline levels of intramuscular Cr and PCr and, therefore, to a reduced potential 
for Cr uptake. If correct, the likelihood of obtaining a large Cr uptake and, hence, 
greater performance gains wifl be increased in non-resistance-trained subjects. 
In light of the above, Experiment 2 was designed with these strategies in mind to 
order to help optimise muscle Cr uptake and, hence, the potential to enhance 
strength. The purpose of this experiment, therefore, was to investigate the effects 
of 4 weeks of Cr supplementation after four weeks of resistance-training in 
previously non-resistance-trained humans on isokinetic, isometric and isotonic 
strength. 
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METHODS 
Subjects 
Twenty healthy non-resistance trained males (Table 4.1) from whom 
written informed consent had been obtained, volunteered to take part in the 
present Experiment which was approved by the local ethics committee; one 
subject was unable to comply with all experimental procedures and was 
therefore excluded. No subject had a record of cardiovascular or respiratory 
disease and none had subjective evidence of musculoskeletal injury. Subjects 
were recruited on the basis that they were physically active but not engaged in a 
structured weight-training programme for at least 6 months prior to the start of 
the experiment and had not supplemented with Cr for at least 8 weeks before the 
experiment. The subject's eligibility was assessed by interview prior to their 
informed consent for participation in the experiment. 
Experimental Design 
Prior to the commencement of the experimental trials, subjects visited the 
laboratory on at least two occasions in order to become familiar with the 
isokinetic dynamometer, leg press and related protocols. Familiarization trials 
were carried out until the variability of two consecutive Performances was 
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within 5% for peak isokinetic force at a speed of 60'-s-1. The test-retest reliability 
of both the isokinetic and isometric assessments revealed a high intra-class 
correlation (ICC) for all strength measures (Isokinetic force ICC = 0.92 (60". s-1) 
and 0.89 (180'-s-1), Isometric force ICC = 0.93; these test-retest reliability values 
are based on subjects having each undergone two familiarization tests). Subjects 
were assigned in a double blind fashion to either a Cr group or a placebo group, 
based on the final familiarisation results: subjects were matched into pairs on the 
average of their peak force obtained during the 600-s-1,1800-s-1 isokinetic and 
isometric leg extension and randomly assigned so that one member of each pair 
was in the Cr group and the other in the placebo group. Following the 
familiarisation period, all subjects performed two tests carried out at least 28 
days apart. The first test was conducted 48 hours after the final familiarisation 
trial, and the final test was conducted 48 hours after the final training session. 
The 4-week supplementation and training period for both groups started on the 
day after the first test and finished the day before the second test. The 
experimental design is shown in Figure 4.1. 
The Cr group ingested 22.8 g-d-1 Cr-H20 (equivalent to 5g Cr x4 times daily) for 
the first 7 days. This loading phase has been shown to increase resting muscle 
PCr levels (Harris et al, 1992, Greenhaff et al, 1994, Hultman et al, 1996). From day 
8, subjects consumed 5.7 g-d-1 Cr-H20 (equivalent to 5g Cr daily) for the 
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Figure 4.1 The experimental design for Experiment 2 
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remaining 21 days. This maintenance dose was selected on the basis of published 
work by Hultman et al (1996) showing 2 g-d-1 Cr-H20 was adequate in 
maintaining elevated muscle PCr stores in subjects not involved in strenuous 
exercise. As the subjects in the present Experiment were training three times a 
week at high intensities, it was decided to increase the maintenance dose to 
5 g-d-1 Cr-H20 in an attempt to maintain muscle PCr stores. Each supplement 
consisted of 5.7 g of Cr-H20 and 35 g of glucose polymer made up in 500 ml of 
warm to hot water. Dissolving Cr in warm to hot water prevented any detectable 
formation of creatinine (Crea) and no parts of the supplement remained 
undissolved. The addition of glucose to the Cr has been shown to significantly 
enhance the uptake of Cr (Green et al, 1996; Steenge et al, 1998). Subjects were 
instructed to ingest the supplements at equal intervals throughout the day. On 
training days, subjects ingested one Cr supplement 1 hour prior to exercise and 
another Cr supplement immediately after exercise. The pre and post-training 
supplements were prepared and administered by the supervising investigator. 
The placebo group consumed 160 g-d-1 of glucose polymer (40 gx4 times daily) 
for the first 7 days, followed by 40 ga day for the subsequent 21 days. The 
placebo group followed the same procedure as the Cr group with regard to the 
preparation of the supplements. Both supplements had similar taste, texture and 
appearance and were placed in generic packets to ensure double-blind 
adn-dnistration. 
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Subjects completed 24 hour urine collections for the day preceding the start of 
supplementation (baseline), the first day of supplementation (start of loading), 
the final day of loading and once a week for the following 3 weeks. Subjects were 
also required to carry out a weighed intake of food at set intervals throughout 
the experimental period (i. e. 3 days prior to the start of the experiment followed 
by 1 day a week for the 4 weeks of the experiment). Subjects were instructed to 
follow their normal diet (apart from the extra carbohydrate contained in the 
experimental drinks) and to weigh and record all food and drink consumed. 
Digital weighing scales readable to 1g were used. Subjects were also requested 
to eliminate caffeine and caffeine containing foods from their diet over the 
loading phase to n-tinimize the possible inhibitory effects of caffeine on the 
ergogenic effect of Cr (Vanderberghe et al, 1996). At the end of the experiment, aH 
subjects gave verbal assurance that they had complied with all instructions. 
Procedures 
Subjects reported to the laboratory on the morning of testing after having 
refrained from alcohol, caffeine and strenuous exercise the day before. Following 
the measurement of each subject's stature and body mass, body water 
compartments were measured using a Bodystat Multiscan 5000 Bioimpedance 
analyzer (Bodystat Ltd., Isle of Man). This method allows total body water 
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(TBW) and extra-cellular water (ECW) to be estimated; from these measurements 
intra-ceffular water (ICW) can also be deduced. The bioirnpedance 
measurements were taken while the subjects lay comfortably in a supine position 
on a non-conductive surface with their arms and legs slightly abducted. 
FoRowing the bioimpedance measurement, subjects underwent a standardized 
warm-up which comprised of 5 min fight intensity cycling, followed by a series 
of stretches with an emphasis on stretching the musculature associated with the 
leg press and leg extension movements. 
FoRowing the standardized warm-up, isokinetic (60*-s-1 and 180'-s-1) and 
isometric strength was measured during 3 repetitions using a Kin-Com 11 
isokinetic dynamometer (Chattecx Corporation, Chattanooga, USA). Both the 
right and left knee extensors were tested in random order; with the order being 
replicated during the post-supplementation tests. The position of the subject on 
the isokinetic dynamometer was standardized; the anatomical axis of the knee 
joint was aligned with the rotational axis of the dynamometer by adjusting the 
seat position and the lever head of the dynamometer. Individual seat length and 
height were recorded for each subject and used in subsequent tests. Subjects 
were held in the seat position with Velcro belts around the waist, thigh and 
lower leg proximal to the ankle, this also allowed for complete isolation of the 
testing leg. During the measurement, subjects had their arms crossed over their 
chest while their non-involved leg and upper body was kept stationary. Subjects 
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were instructed to exert maximal effort throughout the full range of motion 
during each repetition. Verbal encouragement was given to maximise 
performance. The same investigator conducted aH tests. Subjects performed three 
maxhmal isokinetic concentric contractions at two speeds (6011-s-1 and 180'-s-1) 
with a 15 s rest period between repetitions (Cress et al, 1992). The two testing 
speeds were separated by a2 min resting period. Having completed the 
isokinetic testing and following an additional 2 min recovery period, subjects 
went on to complete three maximal 5s isometric contractions with a1 min rest 
period between repetitions. Keus et al (1994) reported that a 5s maximal 
voluntary isometric contraction provided the subject with ample time for the 
development of maximal contractile force while minimising the possibilities of 
any significant fatigue effects. All subjects will be given verbal encouragement 
throughout the tests and special care was taken in order that all subjects were 
offered the same instructions and the same degree of encouragement on all visits. 
The isokinetic dynamometer was then set up for testing the opposite leg and the 
same testing order and procedure was repeated (subjects dominant leg was 
always tested first). Knee extensor strength was evaluated using an isokinetic 
dynamometer due to the high reliability and reproducibility of this strength 
assessment (Pincivero et al, 1997). 
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Following a 10 min recovery period, subjects completed a1 RM on the isotonic 
leg press to measure the subject's maximal isotonic strength. Subjects began with 
a warm-up set of ten repetitions at 50% of their 1 RM (determined during their 
second familiarisation trial); this was followed by a 2-min recovery period. The 
position of the subject on the leg press machine was standardised; the subject's 
hip, knee and ankle were set at angles of 801,90* and 800 respectively using a 
goniometer and the foot position on the lifting plate was noted. Following the 
warm-up set, subjects attempted a1 RM. Subjects were required to raise and 
lower the weight in a controlled manner. The lifting weight was increased after 
each successful lift, until the subject could not lift the weight through the full 
range of motion. The 1 RM was determined after 3-5 attempts in all subjects. All 
post-supplementation testing was carried out at the same time of day and in the 
same manner. Consumption of water (500 ml) was permitted during each test. 
Room temperature was maintained between 20 - 240 C. 
Strength Training 
Prior to the start of each training session, A subjects underwent a 
standardised warm-up which comprised light intensity cycling for 5 min, 
followed by a series of stretches with an emphasis on stretching the musculature 
associated with the leg press. Subjects then performed one warm-up set of 8 
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repetitions at 50% of their predetermined 1 RM. FoRowing the warm-up set, 
subjects attempted to completed 3 sets of 8 repetitions at 80% of their 
predetermined 1 RM (Baechle et al, 2000) with 2 minutes rest between sets 
(Greenhaff et al, 1994). The training weight was progressively increased (- 5kg) 
as subjects successfully completed the required number of sets and repetitions. 
Subjects kept training logs throughout the duration of the Experiment detailing 
weight, sets and repetitions lifted during each training session. Subjects trained 
three times a week on non-consecutive days for 4 weeks (i. e. 12 sessions in total). 
AH training sessions were conducted at the same time of day for each subject and 
were supervised by at least two investigators. Subjects trained in pairs, with 
subjects matched for strength in order to add a competitive nature to the 
training. Training sessions lasted on average 50 min (including the 15 min warm- 
up and 10 min cool-down). 
Data analysis 
Data were expressed as the mean ± s. d. following a test for the normality 
of distribution. Statistical analysis was carried out using two factors ANOVA for 
repeated measures, followed by Student's t-test for paired data and two sample 
Mests for unpaired data, as appropriate. Total lifting volume was analyzed by 
ANCOVA to normalize differences between groups in pre-supplementation 
results using session 1 as the covariate. Pearson correlation analysis was used to 
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assess the relationship between variables. Statistical significance was declared 
when P<0.05. 
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RESULTS 
Physical Characteristics 
The physical characteristics of the two groups of subjects are presented in 
Table 4.1. There were no significant differences between groups in body mass or 
any of the body composition measurements pre-supplementation. in the Cr 
group, mean body mass increased 1.4 ± 0.9 kg after week 1 (loading phase) and 
2.0 ± 1.8 kg after 4 weeks of supplementation and training (maintenance phase). 
In the placebo group, mean body mass increased 0.8 ± 0.8 kg only after loading. 
The magnitude of change in body mass was greater in the Cr group over the 4 
weeks when compared to the placebo group (Figure 4.2); however, there was no 
difference following the loading period. Out of the 9 subjects in the Cr group, 2 
subjects were classified as "non-responders" based on their urinary and body 
mass data (i. e. :50.2 kg increase in body mass) and low Cr retention following Cr 
supplementation (see Urinary Analysis section in results) and the remaining 7 
subjects were classed as "responders". This is based on the results from 
Experiment 1 showing a positive correlation between estimated Cr uptake and 
change in body mass (r=0.55, n=21, P<0.001) (Figure 3.4b). As with the Cr group 
as a whole, there was a significant increase in body mass in the "responders" to 
Cr following loading and maintenance (Table 4.1). The gain in body mass over 
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Figure 4.2 Changes in body mass (A), TBW (B), ICW (C) 
and ECW (D) (Mean ± s. d. ) post-loading and 
post-maintenance. * indicates a significantly 
greater increase in the "responders" and/or Cr 
group compared to the placebo group 
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The loading and maintenance period was also significantly greater in the 
"responders" compared to the placebo group (Figure 4.2). 
In the Cr group, TBW and ICW increased after loading and maintenance (Table 
4.1). In the placebo group, increases in TBW and ICW were observed only after 
maintenance. There was no change in ECW in either group after loading; 
however ECW increased significanfly in both groups after maintenance. The 
magnitude of change in TBW and ICW was greater in the Cr group compared to 
the placebo group over the 4 weeks of the experiment (Figure 4.2). When the 
change in TBW and ICW was compared between the "responders" and placebo 
group, the magnitude of change was significantly greater over the loading period 
in the "responders" group with regard to ICW and over the maintenance phase in 
both TBW and ICW. 
Dietary Analysis 
During the experimental period, the normal daily diet of the Cr group 
comprised 10.9 ± 2.9 Nff-d-1, of which 55.8 ± 3%, 29.4 ± 3.8% and 14.8 ± 1.9% of 
energy intake was in the form of CHO, fat, and protein, respectively. The normal 
daily diet of the placebo group comprised 11.0 ± 1.4 Mj-d-1, of which 58.5 ± 4.9%, 
27.3 ± 4.4%, and 14.2 ± 1.9% of energy intake was in the form of CHO, fat, and 
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protein, respectively. There was no difference between groups in energy intake 
or diet composition over the duration of the Experiment. 
Muscle Strength 
Muscle strength was reported by averaging peak torque (i. e. three 
attempts with the dominant leg and three attempts with the non-dominant leg). 
Muscle strength was not different between groups prior to supplementation. In 
the Cr group, average peak torque during isokinetic (both 60 and 180'-s-1) and 
average peak force isometric concentric knee extensions increased post- 
supplementation and training compared to baseline; no increase in muscle 
strength was found in the placebo group (Figure 4.3). The magnitude of change 
in muscle strength (average peak torque during 60 and 1801-s-1 isokinetic and 
isometric concentric knee extensions) was not significantly different between 
groups (P=0.28, P=0.067 and P=0.21, respectively) (Figure 4.4). However, when 
the analysis was repeated excluding the two subjects classed as "non- 
responders", the magnitude of change in 180'-s-1 isokinetic force (P=0.029) and 
isometric force (P=0.036) in the "responders" was greater compared to the 
placebo group; no difference in 60'-s-1 isokinetic force (P=0.13) (Figure 4.4). 
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Figure 4.3 Isokinetic (600-s-1 and 1801-s-1) and 
isometric force in the Cr group, "responders" 
and placebo group (mean ± s. d. ) pre- and 
post-supplementation. * indicates a 
significantly increase from pre to post 
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Figure 4.4 Change in isokinetic (60'-s-1 and 180'-s-1) 
and isometric force in the Cr group, 
"responders" and placebo group (mean ± s. d. ). 
* indicates a significantly greater increase in 
the "responders" and/or Cr group compared to 
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Training volume 
Total lifting volume (calculated for every training session: weight lifted x 
repetitions x sets) increased significantly over the duration of the experiment in 
both groups, with no difference in the magnitude of the increase between groups 
(2149 ± 773 kg vs. 2578 ± 445 kg, P=0.27). Total lifting volume increased 
significantly over the duration of the experiment group in the "responders" 
group with a non-significant tendency (P=0.09) for there to be a significantly 
greater increase compared to the placebo group. 
1 RM for the leg press increased following 4 weeks of supplementation and 
training in both the Cr (252 ± 48 kg to 322 ± 56 kg) and placebo group (199 ± 57 
kg to 266 ± 45 kg); the magnitude of change between the two groups was similar. 
1 RM increased significantly in the "responders" group following 4 weeks of 
supplementation and traftiing (260 ± 42 kg to 327 ± 53 kg), with the magnitude of 
change not significantly different when compared to the placebo group (P=0.94). 
Urinary Analysis 
In the Cr group, Crea excretion increased from 1.5 ± 0.4 g-d-1 at baseline to 
3.3 ± 0.8 g-d-1 on the final day of loading, while in placebo group, Crea excretion 
over the 4 weeks was not different from baseline (1.5 ± 0.4 g-d-lon baseline to 1.6 
100 
± 0.3 g-d-1 on final day of loading). Daily Cr excretion was therefore corrected for 
this increase in Crea excretion in the Cr group, and Cr excretion increased 
compared to baseline at A time points; no urinary Cr was detected in the 
placebo group. The amount of Cr retained each day (i. e. only for days with 
urinary data) was calculated by subtracting the total Cr excreted (corrected for 
Crea excretion) from the total amount supplemented per day. The amount of Cr 
retained was 65 ± 11% (13.0 ± 2.1 g) of the supplemented dose (i. e. 20 g) on the 
first day of loading and decreased to 23 ± 27% (4.6 ± 5.4 g) on the final day of 
loading. Cr retention was 46 ± 41% (2.3 ± 2.0 g), 17 ± 34% (0-9 ± 1.7 g) and 58 ± 
32% (2.9 ± 1.6 g) of the supplemented dose (i. e. 5 g) on days 14,21 and 28, 
respectively. Estimated Cr uptake was calculated based on an estimated muscle 
mass of 40% of body mass and an average muscle water content of 77% of wet 
weight (Bergstrom et al, 1971). Estimated Cr uptake in the Cr group was 28.3 ± 
8.5 mmol-ke-dry muscle weight. In the "responders" (n=7), estimated Cr uptake 
was 31.5 ± 6.3 or 28.8 (25.6-43.9) (median (range)) mmol-kg-1-dry muscle weight 
compared to 18.7 and 14.8 mmol-kg-1-dry muscle weight in the two subjects 
classed as "non-responders". Over the duration of the experiment, urine volume 
was not dffferent between groups. 
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Correlations 
A significant positive correlation was found between change in body mass 
(loading phase) and change in 180'-s-1 isokinetic force (r=0.68, n=9, P=0.04) and 
isometric force (r=0.82, n=9, P<0.01), with a tendency for there to be a positive 
correlation with 60'-s-1 isokinetic force (r=0.61, n=9, P=0.079). The change in body 
mass over the maintenance phase was also correlated with 18(r. s-1 isokinetic 
force (r=0.70, n=9, P=0.037). Estimated Cr uptake was positively correlated with 
the change in body mass (loading phase) (r=0.75, n=9, P=0.02) (Figure 4.5a), 
600-s-1 isokinetic force (r=0.90, n=9, P=0.001) (Figure 4.5b), 1800-s-1 isokinetic force 
(r=0.68, n=9, P=0.043) (Figure 4.5c) and isometric force (r=0.71, n=9, P=0.033) 
(Figure 4.5d). No significant correlations were found in the placebo group. 
Side EffectslFreatment Identification 
Subjects tolerated the supplementation protocol well, with no reports of 
gastrointestinal distress, muscle cramping or any other side effects. Subjects were 
asked at the end of the experiment whether they were aware of the treatment 
they had received and all but two subjects reported that they were unsure about 
the treatment they received (one subjects from each group identified correctly the 
treatment they were on). 
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Figure 4.5 Significant correlations between estimated Cr 
uptake and changes in body mass (A), 
isokinetic 60'-s-1 force (B), isokinetic 180'-s-1 
force (C), and isometric force (D) in the Cr 
group. * indicates a significantly increase from 
pre to post 
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DISCUSSION 
The results of this experiment demonstrate that Cr supplementation is 
effective in increasing muscle strength in non-resistance trained subjects with 
significant Cr uptake during the supplementation period in conjunction with 4 
weeks of resistance training compared to resistance training alone. Four weeks of 
Cr supplementation significantly increased isokinetic torque (1801-s-1) and 
isometric force in a group of 7 "responders" compared with the placebo group 
(Figures 4.3 and 4.4). Without direct measurement of muscle [PCr], one can only 
speculate on the potential mechanisms for this improvement in muscle strength 
following Cr supplementation. Nevertheless, a number of previous studies 
suggest increased PCr availability and PCr resynthesis during recovery from 
maximal exercise as the most plausible (Balsom et al, 1995; Greenhaff et al, 1994). 
The results of the present Experiment are in agreement with a study by 
Maganaris & Maughan (1998); these authors found increases in MVC in subjects 
engaged in a weight-training program. These authors suggested that these 
increases could be a result of a Cr-stimulated increase in protein synthesis which, 
in turn, could lead to an increase in strength through muscle hypertrophy. 
However, the significance of such a mechanism during studies of this time scale 
(i. e. 5 days) remains unclear. Cr stimulated increase in protein synthesis could be 
a possible explanation for the increases in muscle strength observed in the 
present experiment due to the longer study duration (Kreider et al, 1998). 
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Despite many Cr supplementation studies showing an ergogenic effect on 
exercise performance, there are a significant number of studies which report no 
ergogenic effect (e. g. Cooke et al, 1995; Finn et al, 2001; McKenna et al, 1999; Snow 
et al, 1998). This is not surprising, however, as none of these studies differentiate 
subjects into "responders" and "non-responders" on the basis of measured or 
estimated muscle Cr uptake, or of changes in body mass. Had the subjects in the 
present experiment and in a previous experiment (Experiment 1) not been 
differentiated into "responders" and "non-responders", no ergogenic effect would 
have been detected (i. e. Type II error). However, classification of subjects into 
"responders" and "non-responders" should not simply be made on the basis of 
strength gains (as this would ahnost certainly increase the risk of producing a 
Type I error), but with good physiological justification. For example, there would 
be no obvious rationale for gains in strength if there was not a substantial 
increase in intramuscular [Cr] and, therefore the potential to increase PCr 
resynthesis following Cr supplementation. In the present experiment, subjects 
were differentiated into "responders" and "non-responders" on the basis of 
changes in body mass and not estimated muscle Cr uptake, as Cr uptake was 
calculated from urine samples collected only on days 1,7,14,21 and 28 rather 
than from the entire 28 days. Nevertheless, estimated Cr uptake in the 
"responders" was 28.8 (25.6 - 43.9) mmol-kg-1-dry muscle weight (median (range)) 
compared to 18.7 and 14.8 mmol-kg-1-dry muscle weight in the two subjects 
classed as "non-responders" showing two distinct groups as previously reported 
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(Greenhaff et A 1994; Experiment 1). This and the finding of a significant positive 
correlation between estimated Cr uptake and the change in body mass (Fig. 4.5a) 
is also in agreement with the results from Experiment 1 (Fig. 3.4c) and is further 
evidence supporting its use. Furthermore, a significant positive correlation was 
found between estimated Cr uptake and strength gains during 600-s-1 isokinetic 
force (r=0.90, n=9, P=0.001) (Figure 4.5b), 180'-s-1 isokinetic force (r= 0.68, n=9, 
P=0.043) (Figure 4.5c) and isometric force (r=0.71, n=9, P=0.033) (Figure 4.5d), 
indicating that subjects with the greatest Cr uptake had the greatest strength 
gains as previously found by Casey et al (1996), and also found in Experiment 1 
(Figure 3.4c). 
As training status has the potential to influence Cr uptake, non resistance-trained 
subjects were used in the present Experiment. Despite this, two out of the nine 
subjects supplemented with Cr were clearly "non-responders" based on changes 
in body mass and urinary data. However, the ratio of "non-responders" to 
"responders" in the present subjects (2: 9) was sin-dlar to the ratio previously 
reported in resistance-trained subjects (4: 21) (Experiment 1). This finding would 
suggest that other factors, in addition to training status/ experience, determine 
whether subjects will respond to Cr supplementation. One possible explanation 
for the two distinct groups (i. e. "responders" and "non-responders") may be the 
varying amount of intramuscular Cr prior to supplementation. For example, this 
may reflect a low habitual dietary intake of Cr in the "responders" and/or 
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conversely, a high dietary intake of Cr in the "non-responders". While subjects 
carried out a weighed intake of food, it was not possible to estimate accurately 
the dietary Cr content, as the amount of Cr in each food item is dependent on 
many factors including food preparation. Nevertheless, it would be reasonable to 
expect subjects with a high protein intake to also have a high Cr intake. 
However, no significant correlation between protein intake and estimated Cr 
uptake was found (P = 0.51). 
A consistent finding throughout the Cr literature (e. g. Cooke et al, 1995; Finn et al, 
2001; Ingwall et al, 1974) and in the present Experiment is a significant increase in 
body mass following both short and long term Cr supplementation. It has been 
suggested that the increase in body mass following Cr supplementation was due 
to an increase in water retention (Hultman et al, 1996), which could result in cell 
swelling, followed by an increase in protein synthesis (Haussinger et al, 1993). 
Others, however, have attributed the increase in body mass following Cr 
supplementation to an increase in protein synthesis and associated increase in 
water content (Kreider et al, 1998). Some of the justification for the increase in 
protein synthesis with Cr supplementation stems from the early work by Walker 
(1979), demonstrating that the amino acids glycine and arginine could stimulate 
protein synthesis. As dietary Cr consumption increases, endogenous production 
of Cr decreases, therefore allowing these amino acids to be conserved and 
therefore to be more freely available for protein synthesis (Walker, 1979). The 
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balance of available evidence from human performance studies using Cr 
supplementation and more direct evidence from animal in vivo and in vitro 
experiments would support the notion that increasing Cr availability may indeed 
increase protein synthesis (IngwaH et al, 1974; Kreider et al, 1998; Volek et al, 
1999). Supplementation with Cr in the present Experiment increased body mass, 
with the mean increase in the responder group being greater than that of the 
placebo group after loading and maintenance (Figure 4.2a). This increase in body 
mass cannot be explained by the increase in TBW, reflecting Cr stimulated water 
retention, as there was no significant increase in TBW expressed as percentage of 
body mass. Despite a significant increase in TBW in absolute terms in the Cr 
group (Figure 4.2b), if the relative volume of TBW remains constant (as in the 
present experiment), the gain in body mass need not be attributed to water 
retention. Instead, the increase in absolute TBW seen after Cr suPplementation 
may be indicative of intracellular water that normally accompanies dry matter 
growth. Similar results have previously been found and interpreted in the same 
manner (Francaux & Poortmans, 1999). 
An additional component of the present Experiment was to evaluate the effects 
of Cr supplementation in conjunction with resistance-training on 1 RM and 
training volume performed on an isotonic leg press as compared to strength 
training alone. The physiological basis for a possible ergogenic effect of Cr 
supplementation on strength training was primarily two-fold. Firstly, Cr 
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supplementation has been shown to increase the number of repetitions 
performed per set (Earnest et al, 1995; Volek et al, 1997). Secondly, Cr 
supplementation has been shown to increase the rate of PCr rephosphorylation 
during the second minute of recovery from intense intermittent-type exercise 
(Greenhaff et al, 1994). Theoretically, both these physiological changes would 
allow an individual to train at a greater intensity compared to training without 
the use of this putative ergogenic aid. In the present experiment, however, Cr 
supplementation (Cr group and "responders" group) in conjunction with 4 weeks 
of resistance-training did not induce greater gains in 1 RM or total lifting volume 
when compared to the placebo group; subjects in the Cr, "responders" and 
placebo group increased their 1 RM on the leg press by 27 %, 27% and 34 
respectively. There was however a tendency for the "responders" to have a 
greater total lifting volume compared to the placebo group (P=0.09); statistical 
significance may not have been reached due to the relatively small sample size 
("responders"=7). This is in agreement with previous studies by Francaux and 
Poortmans (1999) and Bermon et al (1998). Francaux and Poortmans (1999) 
examined the effects of 6 weeks of resistance-training in conjunction with Cr 
supplementation on isokinetic force and found that Cr ingestion did not induce a 
greater increase in force, compared to resistance training alone; isokinetic force 
increased by about 6% after training in both the placebo and Cr groups. 
However, there was no measure or estimate of Cr uptake, and questions must be 
asked about their training stimulus (i. e. only 30% of MVC in session 1, increasing 
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progressively to approximately 43% of MVC in the final training session). 
Similarly, Bermon et al (1998) examined the effects of Cr supplementation in 
conjunction with 7 weeks of resistance training on strength and strength 
endurance in 32 elderly subjects. They also found that Cr supplementation did 
not provide any additional benefit to body composition and maximal dynamical 
strength, compared to resistance-training alone. The majority of other studies 
have, however, found Cr supplementation in conjunction with resistance 
training (of varying duration from 4 weeks to 12 weeks) to have an ergogenic 
effect on performance (Becque et al, 2000; Kelly et al, 1998; Kreider et al, 1998; 
Vandenberghe et al, 1997; Volek et al, 1999). However the majority of these 
studies using short-duration training (4 -6 weeks) have used previously 
resistance-trained individuals (Becque et al, 2000; Kelly et al, 1998; Kreider et al, 
1998). A likely explanation for the findings of the present experiment (i. e. no 
effect of Cr supplementation and 4 weeks of resistance training on 1 RM and 
training volume) is the experimental duration (4 weeks) and subject group used 
(non resistance trained individuals). 
It is well established that the initial relatively large gains in muscle strength seen 
in individuals early on during resistance-training (as in the present Experiment) 
are mainly due to neural factors (Sale, 1988) such as increases in synchronisation 
of motor unit firing patterns, increased neural drive to the muscle, and inhibition 
of the protective mechanisms of the muscle (e. g. Golgi tendon organs). These 
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neural adaptations dominate early training gains, whereas, after approximately 8 
weeks, most of the changes that occur are associated with muscle hypertrophy 
(Sale, 1988). Future studies should therefore differentiate subjects into 
"responders" and "non-responders" and use training durations of greater than 8 
weeks in order to examine if Cr supplementation has any additive effect on 
training gains especially in non resistance-trained subjects. However, the present 
Experiment shows Cr supplementation is effective in increasing muscle strength 
in this subject group during this time scale. 
III 
CONCLUSION 
The results of this Experiment indicate that Cr supplementation in 
combination with strength training is effective in increasing muscle strength (as 
measured by isokinetic and isometric tests) but not 1 RM or training volumes in 
subjects whose intramuscular [Cr] and body mass are significantly increased; the 
greater the Cr uptake and associated body mass changes, the greater the 
performance gains. Cr supplementation studies should therefore differentiate 
subjects into "responders" and "non-responders" on the basis of measured or 
estimated Cr uptake and/or changes in body mass when assessing the effects on 
performance. 
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CHAPTER FIVE 
(Experiment 3) 
Effects of Creatine Supplementation on Thermoregulation 
and Exercise Performance in the Heat in Endurance- 
trained Humans 
INTRODUCTION 
The process of fatigue varies considerably with the mode, intensity and 
duration of exercise, as well as with environmental conditions. Fatigue in 
conditions ranging from short-duration, high intensity exercise to more 
prolonged endurance-type exercise performed in normal ambient temperatures, 
has been extensively studied and is well characterised. However, the 
mechanisms underlying fatigue during prolonged exercise in the heat remains 
uncertain, with theories ranging from the attainment of a critical core 
temperature (Nielsen et A 1993) to evidence of serotoninergic system 
involvement in the fatigue process (e. g. Pitsiladis et al, 2002). Others have 
suggested that fatigue during exercise in the heat is unlikely to be the result of 
glycogen depletion, and have attributed fatigue to factors such as 
hypohydration and/or some failure of the thermoregulatory system (e. g. 
Pitsiladis & Maughan, 1999). 
Irrespective of the cause of fatigue, temperature regulation and performance 
during exercise in the heat are critically dependent on hydration status (Sawka 
& Pandolf, 1990). Numerous strategies have been designed to improve exercise 
performance by minimising the detrimental effects of dehydration on 
metabolism and thermoregulation during exercise in the heat. Such strategies 
include pre-cooling (01schewski & Bruck, 1988; Lee & Haymes, 1995), fluid 
ingestion (Galloway & Maughan, 2000), and plasma volume expansion (Watt et 
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al, 2000). The effectiveness of some of these strategies during exercise in the heat 
remains to be determined. 
Creatine supplementation has been widely used to improve performance 
during high-intensity, short duration exercise. Increasing intramuscular [TCr] 
by oral Cr supplementation (Harris et al, 1992) has been shown to increase 
intramuscular phosphocreatine levels and accelerates the PCr resynthesis rate 
following high-intensity, short-duration exercise (Greenhaff et A 1994). There is 
evidence from Cr supplementation studies that oral Cr loading can increase 
muscle Cr content (Harris et al, 1992), improve anaerobic exercise performance 
(Casey et al, 1996; Green et al, 1996) and promote greater gains in strength 
(Kreider et al, 1998; Maganaris & Maughan, 1998). A Cr-stimulated increase in 
body mass has been consistently reported following Cr supplementation, but 
the precise mechanism of this remains unclear. The increase in body mass 
following Cr supplementation may be due to water retention (Hultman et al, 
1996), cell swelling and a consequent increase in protein synthesis (Haussinger 
et al, 1993). Others have, however, suggested the reverse, i. e., an increase in 
protein synthesis and associated increase in water content (Kreider et al, 1998). 
Despite the uncertainty of the primary and secondary effects, Cr 
supplementation has consistently been shown to increase total body water 
(TBW), and more specifically, intracellular water (ICW) (e. g. Francaux & 
Poortmans, 1999; Experiment 2). Thus, it seems logical that Cr supplementation 
and the resulting cellular hydration may be beneficial in prolonging exercise in 
the heat. 
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Based, on the potential of Cr to increase TBW and ICW, the aim of this study 
was therefore to examine the effects of a Cr-induced hyperhydration on 
cardiovascular, metabolic, and thermoregulatory responses, and on the capacity 
to perform prolonged exercise in the heat. 
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METHODS 
Subjects 
Twenty one endurance-trained male volunteers had written informed 
consent obtained (Table 5.1). The study was approved by the local ethics 
conm-iittee. Subjects were recruited from local athletics and cycling clubs, and 
none were acclimatised to exercise in the heat. Subject eligibility was initially 
assessed by interview. No subject had a history of cardiovascular or respiratory 
disease and/or evidence of musculoskeletal injury. All subjects were Cr-free for 
at least 8 weeks prior to the study. The investigators did not reveal prior to 
interview that subjects would be excluded if they had supplemented with Cr in 
the 8 weeks preceding the study. One subject from the placebo group had 
previously supplemented with Cr. No Cr was detected in the baseline urine 
samples of any subject. 
Experimental Design 
Subjects initially underwent a continuous incremental test to volitional 
exhaustion in order to determine the lactate threshold (LT), ýIo 2max and WR 
max. LT was estimated non-invasively as the 
ý70 
2 at which: (a) the break-point in 
the relationship between C02 output (ýIco, ) and Vo, ("V-slope" technique, 
Beaver et al, 1986) occurred and (b) the ventilatory equivalent for 02 ('ýE / 
ý702) 
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Table 5.1: Physical characteristics of the two groups of subjects 
Placebo Group Creatine Group 
(n=10) (n=11) 
Pre Post 13- K-fr Post 
Age (yr) 27 ±4 27±5 
Height (m) 1.81±0.04 1.78 ± 0.07 
Body mass (kg) 71.0±6.0 71.2±6.0 72.7± 6.6 73.4 ± 6.6* 
Total body water P 40.4 ± 3.3 40.5 ± 3.2 41.0 ± 3.1 41.6 ± 3.2* 
Intracellular water (L) 21.9±1.8 21.9±1.8 22.2 ±1.8 22.7 ±1.9* 
Extracellular water (L) 18.5 ±1-5 18.5 ±1.4 18.8 ±1.4 18.9 ±1.5 
ýFo2max (L/min) 4.3 ± 0.4 - 4.5 ± 0.4 - 
ýro, max (ml -kg min-') 60.5 ±4.7 - 61.4 ±4.6 - 
Work rabemx (W) 350 ±34 373 ±31 
Values are presented as the mean ± s. d. 
* Indicates a significant difference from pre-supplementation values 
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started to increase systematically without a concomitant increase in the 
ventilatory equivalent for C02 (ýE / 
ý7CO 
2) (Whipp et al, 1986). 
An electrically-braked cycle ergometer (Bosch Erg-551 Forckenbecksti, Berlin, 
Germany), was set at an incrementation rate of 20 W min-' (starting at 20 W). 
Expired gases were collected for one minute during each incremental stage 
using Douglas bags and analysed within 5 min of collection for mixed expired 
[02] (Servomex 570A, East Sussex, UK), mixed expired [C021 (Servomex 1400 
B4, East Sussex, UK), gas volume (dry gas meter, Harvard Apparatus Ltd., 
Hertfordshire, UK), and expired gas temperature (C6600 10-channel 
microprocessor, Comark, Hertfordshire, UK). The gas analysis system was 
calibrated before each test, with theC02 and 02analyzers calibrated using a 
two-point measure: a calibration gas (CO27.5%, 0216%, N2balance, certified 
standard gas) and a reference gas (room air). Barometric pressure was 
measured using a standard mercury barometer. 
Following the maximal incremental exercise test, subjects visited the laboratory 
on at least two occasions in order to become familiar with the exercise protocol 
and experimental procedures, in addition to establishing a suitable work rate 
that would elicit fatigue in 40 - 60 minutes. This was achieved by setting the 
work rate at 20% A (i. e. 20% of the difference between the ý10, at the LT and 
ýFo 
2max which is subsequently added 
back on to the 
ý102 
at the LT) during the 
initial familiarisation session and, where necessary, adjusting the work rate for 
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subsequent trials to achieve the desired duration. This intensity of exercise was 
chosen to avoid fatigue occurring as a result of muscle glycogen depletion. 
Following the fan-ffliarisation period, all subjects performed two constant-load 
exercise tests to volitional exhaustion pre- and post-supplementation. The first 
test was conducted not less than 48 hrs after the subject's final fan-dliarisation 
trial. The supplementation period for both groups started on the day after the 
first test and finished the day before the second test. 
Cr supplementation consisted of 22.8 g-d-1 Cr-H20 (equivalent to 5g Cr x4 
daily) and 35 g of glucose polymer made up in 500 mls of warm to hot water for 
7 days taken at equal intervals throughout the day. This protocol has been 
shown to increase resting muscle PCr levels within 5 days (Harris et al, 1992). 
The addition of dextrose to Cr significantly enhances the uptake of Cr (Green et 
al, 1996). The placebo group consumed 160 g-d-1 of glucose polymer (40 gx4 
daily) for 7 days, prepared and administered in an identical fashion to the Cr 
supplement. Both supplements had similar taste, texture and appearance and 
were placed in generic packets to ensure double-blind administration. 
Subjects otherwise followed their normal diet and weighed all food and drink 
consumed during the supplementation period using digital weighing scales 
readable to 1 g. The diet was analysed for energy intake and macronutrient 
content (Holland et A 1991). Subjects elin-dnated caffeine and caffeine- 
containing foods from their diet to minin-dse the possible inhibitory effects of 
caffeine on the ergogenic effect of Cr (Vandenberghe et al, 1996). Subjects 
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maintained their normal training habits for the duration of the study. At the 
end of the study all subjects gave verbal assurance that they had complied with 
these instructions. Subjects completed 8 separate 24 hr urine collections. The 
collection began on the day preceding supplementation (baseline), then 
continued through the 7 days of supplementation. The urine volume for each 24 
hr period was measured and mixed thoroughly, with a representative 20 mL 
sample being stored at -20 IC for subsequent analysis (ABX Mira Plus 
Spectrophotometer, ABX Diagnostics, UK) of [Cr] and [creatininel ([Creal) 
using a spectrophotometric enzymatic Crea Kit (MPR1 - Kit no. 839434, Roche 
Diagnostics Ltd., East Sussex, UK). Estimated Cr uptake was calculated by 
subtracting the total Cr excreted, corrected for Crea excretion, from the total 
amount supplemented per day. Estimated intramuscular [Cr] (mmol-kg-1-dry 
weight muscle) was calculated based on an estimated muscle mass amounting 
to 40% of body mass and average muscle water approximating 77% of wet 
weight (Bergstrom et al, 1971). 
Procedures 
All exercise tests were carried out between 16: 00 and 20: 00 hr. Subjects 
reported to the laboratory on the day of testing after a standardised meal and 
having refrained from alcohol, caffeine and strenuous exercise the day before. 
Height and nude body mass were measured, and TBW, ICW and ECW 
estimated using a standard bioimpedance technique (Bodystat-5000 
Bioirnpedance analyser, Bodystat Ltd., Isle of Man) (Van Loan et al, 1990). A 
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flexible rectal thermistor was inserted 10 cm past the anal sphincter to measure 
rectal temperature (Trec), an index of core temperature. A heart rate (HR) 
monitor (Polar Sports Tester, Polar Electro Oy, Kempele, Finland) was 
positioned, and thermistors (C6600 10-channel n-dcroprocessor, Comark, 
Hertfordshire, UK) attached to the chest, upper arm, thigh and calf for the 
determination of weighted mean skin temperature (Týkj,, ) (Ramanthan, 1964). A 
5 ml arterialised-venous (Forster et al, 1972) resting blood sample (heating lamp) 
was obtained from a superficial vein on the dorsal surface of the hand. The 
subject was transferred to the climatic chamber (ambient temperature of 30.3 ± 
0.5 IC with a relative humidity of 70 ± 2% and air velocity of approximately 3.6 
m-s-1) and remained seated on the cycle ergometer for a further 5 min while 
resting HR, Lec, T,, kin and gas collections were obtained. Subjects were then 
instructed to begin 5 min of unloaded cycling before further measurements and 
another blood sample were obtained. After 5 min of unloaded cycling, the work 
rate was increased in a "single step" to the predetermined power output and 
subjects maintained a pedal cadence of 60 - 90 rpm throughout the test. Subjects 
exercised at 16 ± 11% A or 63 ± 5% ý7o 2max. Exhaustion was defined as the 
point at which the subject could no longer maintain the pedal cadence above 60 
rpm. Blood samples and measurements of HR, Trec and Týkjn were obtained at 5 
min intervals throughout exercise and at exhaustion. One minute expired gas 
collections were made every 5 min and analysed within 5 min for the 
determination of VO , 
ýTo 
, and respiratory exchange ratio (RER). Subjective 
ratings of perceived leg tiredness and breathlessness were recorded every 5 min 
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until exhaustion using the Borg category scale (Borg, 1982). After exercise, nude 
body mass was measured. The difference in body mass before and after exercise 
was calculated and subsequently used to estimate sweat rate and sweat loss 
after correcting for respiratory water loss and substrate oxidation (Mitchell et al, 
1972). Time to exhaustion was recorded but withheld from the subject until all 
exercise tests had been completed. 
Blood Treatment and Analysi's 
Blood was drawn into dry syringes and 5 ml, dispensed into a tube 
containing K3EDTA. Duplicate aliquots (400 pL) of whole blood from the 
K3EDTA tube were rapidly deproteinised in 800 gL of ice cold 0.3 mol-L-1 
perchloric acid, centrifuged and the supernatant was used for the measurement 
of glucose and lactate (Maughan, 1982). Blood from the K3EDTA tube was 
analysed for haemoglobin (Hb) (cyarunethaemoglobin method, Sigma Chemical 
Company Ltd., Dorset, UK) and packed cell volume (PCV) (conventional 
microhernatocrit (Hct) method). All blood analyses were carried out in 
duplicate with the exception of PCV, which was analysed in triplicate. Plasma 
volume changes were calculated from changes in Hb and PCV relative to initial 
baseline values (Dill & CostiII, 1974). 
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Calculations 
Weighted mean skin temperature [Tskjn=0.3(Tchest+T. ) +0.2(Tthigh+Tcalf)] 
(Ramanathan, 1964) and mean body temperature (Tb) [0.87Trec+0.13Tskin] 
(01schewski & Bruck, 1988) were calculated for each time point. Metabolic rate 
was calculated for each time point using the following equation: metabolic rate 
=[4.686+(RQ-0.707/0.293)0.3611 ý102 (Ravussin et al, 1985). Mechanical efficiency 
(ME=(WR/69.67)/[ý702 ((1.1891RQ)+3.851)1100), and net mechanical efficiency 
(NME=(WR/69.67)/[( ý10 2-(BMO. 004))((1.1891RQ)+3.851)]100) were also 
calculated. 
Data Analysis 
Data were expressed as the mean ± s. d. or median (range), following a 
test for the normality of distribution. Subjects in the Cr group were classified as 
"responders" and "non-responders" based on estimated Cr uptake (Greenhaff et 
al, 1994; Casey et al, 1996; Experiment 1; Experiment 2), and both Cr group as a 
whole and "responders" were compared to the placebo group. Statistical 
analysis was carried out using two factor ANOVA for repeated measures, 
followed by students paired Mest (within treatment effect, i. e. pre- vs. post- 
supplementation) and two-sample t-test (between treatment effect, i. e. 
magnitude of change (A) in the Cr group or "responders" vs. A in the placebo 
group) if a main treatment or interaction effect was observed. An ANCOVA 
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was used where necessary to normalise for differences in pre-supplementation 
results using the baseline value as the covariate. Pearson's correlation analysis 
was used to assess the relationship between selected variables. Statistical 
significance was declared at P: 50.05. 
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RESULTS 
Estimated Cr Uptake 
In the Cr group, Crea. excretion increased from 1.4 ± 0.4 g-d-1 pre- 
supplementation to 2.4 ± 1.0 g-d-1 on the final day of supplementation. There 
was no increase in Crea excretion in the placebo group (1-5 ± 0.4 g-d-1 to 1.4 ± 0.4 
g-d-1). Cr excretion increased from 8.7 ± 3.7 g-d-1 pre-supplementation to 17.4 ± 
1.9 g-d-1; no Cr was detected in the urine of the placebo group. Estimated Cr 
uptake was maximal on the first day of Cr supplementation (12 (6 - 15) g, 61 (32 
- 77) % being retained) and was lowest on the final day (3 (-2 - 4) g, 16 (-8 - 21) % 
being retained). The total amount of Cr retained over the supplementation 
period was 39 ± 14 g, with an estimated increase in intramuscular [CrI of 51 (21 
- 61) mmol-kg-1-dry weight muscle. Based on these estimates, 3 subjects were 
classified as "non-responders" (21 (21 - 25) mmol-kg-l-dry weight muscle) and 
the remaining 8 subjects were classified as "responders" (53 ±5 mmol. kg-l-dry 
weight muscle). 
Time to Exhaustion 
Time to exhaustion (TTE) was not significantly different between the 
groups prior to supplementation (P=0.27). Pre- compared to post- 
supplementation, TTE were not significantly different in either the placebo (50.4 
± 8.4 min to 51.2 ± 8.0 min, P=0.119,95 % C. I. 1.8 to -0.3) nor Cr (47.0 ± 4.7 min 
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to 49.7 ± 7.5 min, P=0.095,95% C. I. 6.0 to -0.6) group; A exercise performance 
was also not different between groups (P=0.24). TTE was significantly increased 
following supplementation in the "responders" (47.3 ± 4.9 min to 51.7 ± 7.4 n-dn, 
P=0.031,95% C. I. 8.3 to 0.5), with a tendency (P=0.066) for A exercise 
performance to be greater in the "responders" (Figure 5.1). 
Diet, Body Mass and Body Water Compartments 
The physical characteristics of the two groups of subjects were similar 
before supplementation (Table 5.1). In the Cr group, body mass increased 
significantly following supplementation, with no change in the placebo group 
(A body mass was greater in the Cr group, Figure 5.2). There was no difference 
pre-supplementation in TBW, ICW and ECW between groups (Table 5.1). In the 
Cr group, TBW and ICW increased significantly following supplementation. 
TBW and ICW were unaltered by supplementation in the placebo group (A 
TBW and ICW were greater in the Cr group, Figure 5.2). There was no 
significant increase in ECW in either group following supplementation (Figure 
5.2). Following supplementation in the "responders", there was a significant 
increase in body mass (72.7 ± 7.8 kg to 73.5 ± 7.8 kg) (A body mass was greater 
in the "responders" compared to the placebo group). In the "responders", TBW 
and ICW increased significantly from 40.9 ± 3.5 L to 41.7 ± 3.7 L and 22.1 ± 2.0 L 
to 22.7 ± 2.1 L, respectively following supplementation (A TBW and ICW were 
greater in the "responders"). There were no significant differences in the daily 
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Figure 5.1 Time to exhaustion (mean ± s. d. ) in the Cr, 
"responders" and placebo supplemented 
groups. * indicates a significant difference 
between pre- and post-supplementation 
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Creatine Group "Responders" Group Placebo Group 
Figure 5.2 Changes in body weight (BW), total body 
water (TBW), intracellular water (ICW) and 
extracellular water (ECW) (mean ± s. d. ). t 
indicates a significant greater change in the Cr 
group compared to the placebo group 
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BW (kg) TBW (L) icw P ECW (L) 
diet between the two groups (Cr: 14.0 ± 1.6 Mj-d-1,66 ± 5% carbohydrate, 21 ± 
6% fat, 13 ± 2% protein; Placebo: 12.7 ± 2.3 Mj-d-1,63 ± 3% carbohydrate, 23 ± 3% 
fat, 14 ± 2% protein). 
Work Efficiency during Exercise. 
Mechanical and net mechanical efficiency increased in all groups during 
exercise and no difference was found between groups or following 
supplementation. Mechanical efficiency increased from approximately 9% at 
unloaded exercise to 20% at the end of exercise, and net mechanical efficiency 
increased from approximately 13% at unloaded exercise to approximately 22% 
at the end of exercise on all trials. 
Heart Rate and Rating of Perceived Exertion during Exercise. 
There was no difference in resting heart rate between the two groups of 
subjects before or after supplementation (Figure 5.3). During exercise, there was 
a uniform increase in HR in both placebo trials (Figure 5.3). In the Cr group, HR 
during exercise following supplementation was significantly lower from 35 min 
of exercise until exhaustion compared to pre-supplementation (Figure 5.3) (A 
HR was greater in the Cr group at 40 n-dn of exercise and at exhaustion). There 
was no significant difference in exercising heart rate between "responders" and 
the placebo group. A progressive increase in RPE both for breathlessness and 
perceived leg fatigue was found during exercise 
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Figure 5.3 Heart rate (top panel), RPE (breathing) (middle 
panel) and RPE (legs) (bottom panel) in the Cr 
(left side) and placebo (right side) 
supplemented groups during exercise. 
indicates a significant difference between pre 
to Post supplementation. t indicates a 
significant greater change in the Cr group 
compared to the placebo group. 
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reaching near maximum ratings at exhaustion (Figure 5.3). Both in the Cr group 
as a whole and in the "responders", significantly lower ratings of perceived leg 
fatigue were found after 25 min of exercise (P=0.01 and P=0.008, respectively), 
with tendencies at the 10 min (Cr group, P=0.068) and 15 min (Cr group, 
P=0.076; "responders", P=0.097); no such effect was found in the placebo group. 
There was also a tendency for less breathlessness in the Cr group (P-0.067). Five 
out of the eleven subjects in the Cr group reported that they found the post- 
supplementation trial easier, while two out of the ten subjects in the placebo 
group rated the post-supplementation trial to be easier. All other subjects rated 
both trials similarly (including the 3 "non-responders" to Cr supplementation). 
Metabolic Rate and Body Temperature Response 
Metabolic rate did not differ in the placebo group pre. and post. 
supplementation (Table 5.2). In the Cr group a significantly lower metabolic 
rate was found post-supplementation at 20 min, 25 min, 30 min and 40 min 
(Table 5.2) (A metabolic rate tended (P=0.096) to be greater in the Cr group), In 
the "responders", metabolic rate was significantly lower post-supplementation 
from 20 min to 40 min inclusive (A metabolic rate tended (P=0.094) to be greater 
in the "responders"). Rectal (T,,! c), mean skin (Tskin) and mean body (Tb) 
temperature responses are shown in Figure 5.4. In the placebo group, all three 
body temperature measurements increased during exercise with no significant 
differences between trials. In contrast, in the Cr group, T,.,, was lower at 35 min, 
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Figure 5.4 Rectal temperature (top panel), mean skin 
temperature (middle panel) and mean body 
temperature (bottom panel) in the Cr (left side) 
and placebo (right side) supplemented groups. 
* indicates a significant difference between pre 
to post supplementation. t indicates a 
significant greater change in the Cr group 
compared to the placebo group 
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40 min and at exhaustion following supplementation compared to pre- 
supplementation (AT,, was greater in the Cr group from 35 min of exercise 
until exhaustion). Similarly, in the "responders", Trec was lower at 40 min of 
exercise and at exhaustion following supplementation compared to pre- 
supplementation (AT,,,. c was greater in the "responders" at 40 min of exercise and 
at exhaustion). 
In the Cr group, a significantly lower Tb was found following supplementation 
at 35 min of exercise and at exhaustion, with tendencies for lower Tb at 30 min 
(P=0.065) and 40 min (P=0.056) (ATb was greater in the Cr group at 20 min, 25 
min, 30 min, 35 n-dn and at exhaustion). In the "responders", a significantly 
lower Tb was found following supplementation at exhaustion (P=0.014) (ATb 
tended (P=0.083) to be greater in the "responders"). There was a significant 
increase in mean Tskin with no significant differences between groups or 
following supplementation. 
Sweat Rates and Total Sweat Loss during Exercise 
There was a significant reduction in sweat rate following Cr 
supplementation (32.3 ± 7.0 n-d min-1 vs. 28.2 ± 3.9 ml min-'; P=0.02) (Figure 5.6), 
no such reduction was observed in the placebo group (27.1 ± 9.8 ml min-' vs. 
26.2 ± 8.4 ml min7l; P=0.42) (A sweat rate tended (P=0.09) to be greater in the Cr 
group). Total sweat loss was not significantly different between trials in either 
the Cr (1.5 ± 0.4 L vs. 1.4 ± 0.2 L; P=0.17) or placebo (1.4 ± 0.5 L vs. 1.3 ± 
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Figure 5.5 Changes in plasma volume during pre and 
post supplementation in the Cr (top panel 
left) and placebo (top panel right) group. 
Changes in plasma volume (re-calculated for 
all groups using their respective [Hb] and [Hctl 
measured during the pre-supplementation 
tests as baseline) during pre and post 
supplementation in the Cr (bottom panel left) 
and placebo (bottom panel right) group. 
* Indicates a significant difference post- 
supplementation compared to baseline 
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0.5 L; P=0.81) groups. Both sweat rate and sweat loss were similar pre- 
compared to post-supplementation in the "responders". 
Blood Metabolite Concentrations at rest and during Exercise 
Resting blood metabolite concentrations were not different between 
groups or following supplementation (Table 5.3). During exercise (all time 
points), blood [glucose] and [lactate] increased compared to rest and there were 
no differences between groups or following supplementation (Table 5.3). Blood 
[glucose] and [lactate] also increased in both trials in the "responders" with no 
difference between the trials. 
Plasma Volumes Changes 
Plasma volume fell by 11 - 14% within the first 10 min of exercise and 
thereafter remained largely unchanged; there were no differences between 
conditions or following supplementation (Figure 5.5). However, there was a 
near-statistically significant increase in [Hb] post Cr-supplementation compared 
to pre-supplementation (P=0.055) (A [Hb] was not different). No such effect was 
observed in the "responders" or placebo groups. Plasma volume changes during 
exercise following supplementation were also calculated for all groups using 
their respective [Hb] and [Hct] measured during the pre-supplementation tests 
as baseline, assuming no change in red cell mass during the 7 day 
supplementation regimen (Fortney et al, 1981). Using this method of analysis, 
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plasma volume decreased to a greater extent at almost all measured time points 
post-supplementation compared to pre-supplementation in the Cr group, with 
no such finding in the placebo group (Figure 5.5). 
Correlation analysis 
In the Cr group, estimated Cr uptake was positively correlated with A 
body mass (r=0.68, n=ll; P=0.021) and A TTE (r=0.75, n=ll; P=0.008). A 
significant positive correlation was found between A body mass and A TTE 
(r=0.73, n=ll; P=0.011). 
Side effects 
In general, subjects tolerated the supplementation protocol well, with no 
reports of gastrointestinal distress or muscle cramping. Two subjects from each 
group correctly identified the treatment they were receiving, while all other 
subjects were unsure of the treatment they received. 
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Figure 5.6 Sweat rate responses pre and post 
supplementation in the Cr and placebo group. 
* Indicates a significant difference post- 
supplementation compared to baseline 
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DISCUSSION 
This study has demonstrated that a standard Cr supplementation 
regimen (Harris et al, 1992) increased TBW and ICW, reduced cardiovascular 
and some thermoregulatory (Tre, ) responses during exercise, and increased 
exercise performance in a group of "responders" to Cr supplementation (pre to 
post). Cr supplementation resulted in a significant increase in TIE, but only in 
subjects whose intramuscular Cr uptake was significantly increased following 
the supplementation. A highly significant positive correlation was found 
between estimated Cr uptake and A TTE (r=0.75, n=ll; P=0.008), indicating that 
subjects with the largest Cr uptake had the greatest performance gains. This 
finding is in agreement with other previously published studies (e. g. Casey et 
1996; Experiment 1). 
It is well established that there are "responders" and "non-responders" to Cr 
supplementation, with a proposed ergogenic threshold for intramuscular Cr 
uptake of 20 mmol kg7l dry muscle weight following Cr supplementation 
(Casey et al, 1996; Greenhaff et al, 1994). In Experiment 1, subdividing the Cr 
group into "responders" and "non-responders" on the basis of a physiological 
measurement (e. g., estimated muscle Cr uptake) confirmed the ergogenic 
potential of Cr supplementation. Failure to discriminate between those who 
respond and those who do not would therefore diminish any effect due to Cr 
supplementation. This may account for the confounding reports in the literature 
on the ergogenic potential of Cr supplementation. In the present study, 8 
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subjects were classed as "responders" based on estimated muscle Cr uptake. The 
average muscle Cr uptake for the "responders" was 53 ±5 mmol kg-1 dry muscle 
weight compared to Cr uptake ranging from 21-25 mmol kg-1 dry muscle 
weight in the "non-responders". While these findings provide evidence 
consistent with an ergogenic threshold, assigning a specific threshold value is 
not possible as Cr uptake was only estimated and not directly measured in the 
present study. Nevertheless, estimated Cr uptake in the present study was very 
similar to other studies (Greenhaff et al, 1994). 
Cr supplementation in the present study was successful in attenuating 
cardiovascular and some thermoregulatory responses during exercise (i. e. 
decreased HR, Trec, Tb, sweat rate). Metabolic rate during exercise was also 
reduced post-supplementation in the Cr group despite no differences in ýIo, 
mechanical efficiency, and RER. This difference in metabolic rate may reflect the 
non-significant reduction in RER during exercise after Cr supplementation, 
possibly as a result of the significantly lower 
ýIC02 
post-Cr supplementation. 
Differences in substrate utilisation are unlikely to be the cause as there was no 
difference in blood metabolites. Although some of the differences in 
cardiovascular and thermoregulatory responses between the Cr and placebo 
groups were not detected in the "responders" (i. e., HR and sweat rate), possibly 
due to the smaller subject number, the increase in exercise performance found 
in the "responders" is most likely to be due to the Cr-induced attenuated 
physiological responses. Subjects who had supplemented with Cr reported, on 
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average, significantly lower ratings of perceived leg fatigue after 25 min of 
exercise, suggesting they were able to discern the benefit of this putative 
hyperhydration strategy. Five out of the eight "responders" reported that they 
found the post-supplementation trial to be easier; these same five subjects also 
showed the greatest estimated Cr uptake and performance gains. 
From the measurements obtained and/or derived in the present study, one can 
only speculate on the potential mechanisms for the improvement in exercise 
performance in the heat following Cr supplementation. Many hyperhydration 
methods (e. g. plasma volume expansion, glycerol hyperhydration, fluid 
consumption) have been tested during conditions of heat stress in an attempt to 
enhance cardiovascular/ thermoregulatory responses, and consequently, 
improve exercise performance. Despite considerable potential and some 
positive results (e. g., Galloway & Maughan, 2000; Anderson et al, 2001), these 
strategies have frequently failed to improve exercise performance (Latzka et A 
1997; Latzka et al, 1998; Watt et al, 2000). For example, Watt et al, (2000) 
demonstrated that a 13% acute plasma volume expansion, a level similar to that 
observed after heat acclimatisation, had no effect on core temperature, skin 
blood flow, heart rate or exercise performance. These authors concluded that 
plasma volume expansion might not be critical for changes in thermoregulation 
and exercise performance in the heat. 
We have demonstrated that Cr supplementation is an effective hyperhydration 
strategy. Cr supplementation has previously been shown to increase body mass 
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(Balsom. et al, 1993; Greenhaff et al, 1994; Green et al, 1996; Experiment 1; 
Experiment 2), although whether this is due to an increase in water content 
associated with an increase in protein synthesis (Ingwall et al, 1974), or a result 
of water retention causing an increase in protein synthesis through cell swelling 
(Haussinger et A 1993) is unclear. Recently, Saab et al, (2002), using magnetic 
resonance imaging, attempted to resolve this by examining the impact of Cr 
supplementation on water compartments within skeletal muscle using the 
transverse relaxation distribution of skeletal muscle to model water 
compartments within the cell and/or tissue. An increase in ICW was found to 
be the primary cause of the initial changes in body mass during Cr 
supplementation, but these authors were unable to identify the exact 
mechanism behind this increase. In the present study, supplementation with Cr 
was successful in increasing TBW by an estimated 800 ml on average, of which 
600 rrd could be accounted for by the increase in ICW. The increase in plasma 
volume was approximately 60 n-d assuming 7.5% of this is plasma (Latzka & 
Sawka, 2000). This increase in plasma volume is unlikely to be of physiological 
significance. The overall level of dehydration attained by the end of exercise 
was not affected as indicated by a similar sweat loss and reduction in plasma 
volume between trials. This may be due to the attenuated physiological 
responses, or reflect the longer exercise time in the "responders" post-Cr 
supplementation. 
Two other studies have assessed the effect of Cr supplementation on 
performance during exercise in the heat (Volek et al, 2001; Kern et al, 2001). 
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Volek et al (2001) examined the effects of Cr supplementation on acute 
cardiovascular, renal, temperature and fluid-regulatory hormonal responses 
during 35 min of exercise followed immediately by three 10 s maximal sprints 
on a cycle ergometer in the heat. Significant increases in body mass and peak 
power during all three 10 s sprints were found following Cr supplementation, 
compared to no change in the placebo group. No differences, however, were 
found in HR, blood pressure, and sweat rate following Cr supplementation. 
More recently, Kern et al (2001) exan-dned the effects of 28 days of Cr 
supplementation on HR and Trec during 60 min of cycling exercise at 60% V02 
max in the heat. Significantly greater gains in body mass and TBW were found 
compared to the placebo group, with a consequent attenuation of T, ec post- 
supplementation. The increases in body mass and TBW, and the attenuation in 
T, e, observed were of a similar magnitude as observed in the present study. 
However, subjects in the study by Kern et al (2001) exercised for a fixed period 
of time (i. e. 60 min) and the effects of Cr supplementation on exercise 
performance could, therefore, not be evaluated. 
Previous studies investigating the effects of Cr supplementation on muscle 
bioenergetics during submaximal exercise have produced conflicting results, 
with two reports of no effect of Cr loading on whole-body ý10, during exercise 
of varying intensity (Balsom et al, 1993; Stroud et al, 1994), but also reduced ý70 
and blood lactate accumulation during steady-state exercise at 50% A Gones et 
al, 2002). Jones et al (2002) attributed the lower V02 and blood lactate 
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accumulation following Cr supplementation to a change in the pattern of fibre- 
type recruitment and/or a reduction in the number of muscle fibres recruited. 
Within the present investigation, however, the absence of any differences in 
metabolic variables such as blood [lactate], RER and, importantly, V02 Iwould 
suggest that altered muscle bioenergetics is unlikely to be the primary 
determinant of the enhanced exercise performance in the heat following Cr 
loading. 
A significant finding of the present study was the lower T,,,, c at exhaustion post- 
supplementation in the Cr group, and in the "responders" despite the longer 
exercise time to exhaustion. In contrast, subjects in the placebo group fatigued 
at a similar Lec on the two trials which is in agreement with the results of many 
previous studies which have proposed the attairunent of a critical high 
temperature, typically 39.6 'C, as the main factor limiting exercise performance 
in the heat (e. g. Nielsen et al, 1990; Nielsen et al, 1993). Other studies have 
shown fatigue to occur over a range of core temperatures (Le. 38 - 401C), 
implying that fatigue in the heat is multifactorial in aetiology (Latzka et al, 
1998). A clear attenuation in the rise in Trec was observed in the present study. 
Although the exact cause of this cannot be explained, specific heat of the 
individual may provide some insight. For example, 0.83 Kcal of heat production 
per kg of body mass is required to increase Trec by 11C, therefore an expansion 
of TBW resulting in an increase in body mass could lead to an increased 
distribution of heat within the body. Thus the overall temperature increase 
would be attenuated by water expansion. 
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The finding of a lower Trec at exhaustion post-Cr supplementation in the present 
study, combined with the failure to characterise the fatigue process in terms of 
peripheral factors (e. g. similar blood metabolite levels), may suggest that a 
major central fatigue component may be involved. 
Recently, the role of central neural mechanisms in the fatigue process during 
exercise in the heat has been studied (Nielsen et al, 2001; Pitsiladis et al, 2002). 
Nielsen et al (2001) suggested that fatigue may occur at a critical brain 
temperature. Nielsen et al (2001) observed changes in EEG activity in the frontal 
area of the brain, possibly indicating hyperthern-tia-associated fatigue. Whether 
hyperthermia induces fatigue directly via an increase in brain temperature or 
indirectly, via afferent signals originating from skeletal muscle, cardiac muscle 
or internal organs in response to a rise in local temperature is unclear. Further 
support for a central fatigue component is the observation that peripheral 
markers of central 5-HT activity, such as prolactin and cortisol, are elevated 
during exercise in the heat (Frewin et al, 1976; Pitsiladis et al, 2002). Pitsiladis et 
al (2002), showed that serum [prolactin] was significantly higher at exhaustion 
during exercise in the heat compared to exercise in the cold, and correlated with 
only during exercise in the heat. These findings provide evidence, although 
indirect, that the serotoninergic system and/or another closely related 
neurotransn-dtter systems (e. g. the doparninergic system) may be involved in 
fatigue during exercise in the heat. At present, it is unknown what effect Cr 
supplementation has on the CNS, and in particular, on thermoregulatory 
control. Cr supplementation has been shown to gradually increase brain [Cr], 
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indicating that the blood-brain barrier is partly permeable to Cr (Schulze et al, 
1997). It remains to be determined what effect, if any, increased CNS [Cr] has on 
the central fatigue process. 
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CONCLUSIONS 
In the present study, 22.8 g-d-1 Cr-H20 for 7 days was effective in 
increasing predominantly ICW and reducing cardiovascular and 
thermoregulatory responses during prolonged exercise in the heat. The 
attenuation of these responses resulted in a significant increase in time to 
exhaustion, but this effect was only seen in subjects whose intramuscular Cr 
levels were significantly increased following Cr supplementation (i. e. 
"responders" to Cr supplementation). 
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CHAPTER SIX 
(Experiment 4) 
Effects of Short and Long Term Creatine Supplementation 
on Body Composition and Muscle Strength in Patients 
with Moderate to Severe COPD 
INTRODUCTION 
Chronic obstructive puhnonary disease (COPD) is a disabling condition, 
which is predicted to become the 4th most common cause of death world-wide by 
2020 (Lopez & Murrey, 1998). Skeletal muscle dysfunction, which adversely 
affects skeletal muscle strength (Hamilton et A 1995; Gosselink et al, 1996) and 
mass (Arora& Rochester, 1982), is frequently observed in patients with COPD. 
These changes are recognised as important factors in COPD, as they directly 
contribute to the handicap and disability seen within this group. Other 
alterations in skeletal muscle metabolism have also been observed within this 
patient population, such as significantly longer half-time recovery of 
phosphocreatine following intense exercise as compared to a control group 
(Payen et al, 1993; Sala et al, 1999), and also studies showing lower resting levels 
of PCr (Gertz et A 1977; Jakobsson et al, 1990), with these abnormalities possibly 
contributing to the overall exercise intolerance observed in patients with COPD. 
Cachexia, another consequence of this disease, has also been shown to be an 
independent predictor of mortality in this patient population (Schols et al, 1998). 
In recent years, researchers have attempted to reverse abnormalities in muscle 
mass, muscle strength and muscle metabolism using numerous strategies 
ranging from appetite stimulators (Weisberg et al, 2002), anabolic steroids 
(Ferreira et al, 1998), to more recently recombinant human growth hormone 
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(rhGH) (Burdet et al, 1997). However, despite the majority of these strategies 
leading to an increase in muscle mass, there have been no observed increases in 
muscle strength (Burdet et al, 1997; Ferreira et al, 1998; Weisberg et al, 2002). For 
example, Burdet et al (1997) examined the effects of 0.15 IU-kg-1 rhGH per day for 
3 weeks on lean body mass, muscle strength and exercise tolerance in 
underweight patients with COPD. In this study, despite a significant increase in 
lean body mass (2-3 ± 1.6 kg), daily administration of rhGH did not increase 
maximal respiratory pressures, handgrip strength, maximal exercise capacity or 
subjective well being. 
Creatine (Cr) supplementation has been shown in the majority of studies carried 
out in healthy subjects to have the ability to alter skeletal muscle metabolism 
(Greenhaff et al, 1994; Balsorn et al, 1995), and to increase body mass (Greenhaff et 
al, 1994; Balsom et al, 1995; Experiment 1-3), fat-free mass (Kreider et al, 1998; 
Becque et al, 2002; Experiment 1), muscle strength (Kreider et al, 1998; Maganaris 
& Maughan, 1998; Experiment 1; Experiment 2) and muscle endurance 
(Experiment 1). Researchers have also examined the effects of Cr 
supplementation on body composition and muscle strength in older subjects (i. e. 
with age-related alterations in their skeletal muscle metabolism), with the 
majority of studies indicating an ergogenic effect of Cr loading on body 
composition (jakobi et A 2001; Gotshalk et al, 2002), muscle endurance (Rawson 
et al, 1999; Gotshalk et al, 2002), muscle strength (Gotshalk et al, 2002) and also 
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when used in conjunction with a resistance training programme (Chrusch et al, 
2001). For example, Gotshalk et al (2002) examined the effects of 7 days of Cr 
supplementation (0.3 g-kg-I-d-1) on body mass, FFM (estimated using hydrostatic 
weighting), maximal dynamical strength (upper and lower body), maximal 
isometric strength and lower extremity functional capacity in normally active 
older men (59 - 72 yr). The results of this study (Gotshalk et al, 2002) indicated 
that 7d of Cr supplementation was effective at increasing several of the indices 
of muscle performance, including functional tests, with no adverse side effects. 
However, two studies have indicated that Cr supplementation does not have a 
beneficial effect on performance in older subjects (Bermon et al, 1998; Jakobi et al, 
2001). For example, Bermon and co-workers (1998) indicated that Cr 
supplementation had no effect on body composition, maximal dynamical 
strength, dynamical and isometric endurance in healthy elderly subjects, whether 
or not it was associated with an effective strength training programme. 
Based on this work in relation to both healthy young and older populations and 
also on the proposed benefits of Cr supplementation on body composition, 
muscle function and muscle metabolism, some researchers have examined the 
role of Cr supplementation in patient populations. Previously, researchers have 
examined the effects of this putative ergogenic aid in patients with chronic heart 
failure (CHF) (Gordan et al, 1995; Andrews et al, 1998), myasthenia gravis (Stout 
et al, 2001), rheumatoid arthritis (WiHer et al, 2002) and patients with 
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mitochondrial cytopathies (Tamopolsky et al, 1997), for all of which positive 
benefits of Cr supplementation on body composition and/or skeletal muscle 
function have been reported. 
The aim of the present study was therefore two-fold: firstly, to determine the 
effects of Cr loading on upper and lower body strength, upper and lower body 
strength endurance and body composition; and, secondly, to examine the effects 
of Cr supplementation in conjunction with standard pulmonary rehabilitation on 
the above-mentioned variables in a group of patients with moderate to severe 
COPD. 
154 
METHODS 
Patients 
Twenty-nine patients (11 females and 18 males) with established clinical 
and functional diagnosis of moderate-to-severe COPD (FEV, < 60% predicted 
and FEVl/FVC ratio < 70%) (American Thoracic Society, 1987) comprised the 
study group (Table 6.1). Inclusion criteria were absence of locomotor or 
neurological diseases, and no change in medication dosage or exacerbation of 
symptoms in the preceding four weeks. AH patients were optimised in terms of 
standard medical therapy: maintenance medications included short and long 
acting P2-agonists, anticholinergics, theophylline, and inhaled steroids. Patients 
were excluded if they had taken oral prednisolone within the proceeding four 
weeks. The patients' eligibility was assessed by interview prior to their informed 
consent for participation in the study. Before the tests, the procedures, including 
the known risks, were described in detail and written informed consent (as 
approved by the North Glasgow Hospital Ethics Committee) was obtained from 
all patients. 
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Table 6.1: Baseline Characteristics of the two groups of patients 
Placebo Group Creatine Group 
(n=15) (n=14) 
Baseline 
Age (yr) 
Height (m) 
FVC (L) 
FEV1 (L) 
FEV, (% pred) 
FEV1 /FVC (% 
TLC (% pred) 
65 ±10 
1.64 ± 10 
2.7 ± 0.8 
1.1 ± 0.4 
42.5 ± 14.6 
38.9 ± 8.4 
128.0 ±17.4 
Baseline 
61 ±8 
1.62 ±6 
3.0 ± 0.6 
1.1 ± 0.3 
44.4 ±14.4 
36.4 ± 11.2 
124.6 ±18.7 
Values are presented as the mean ± s. d. 
Definition of abbreviations: FVC: forced vital capacity; FEV1: forced expiratory 
volume in one second; TLC: total lung capacity: pred: predicted values. 
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Experimental Design 
Prior to the commencement of the experimental trials, patients visited the 
laboratory in order to become familiar with the isokinetic and handgrip 
dynamometer. Familiarisation trials were carried out until the variability of three 
consecutive performances was within 5% for peak isokinetic force at a speed of 
700-s-1. The test-retest reliability of isokinetic assessments performed in our 
laboratory has revealed a high intra-class correlation (ICC) for strength measures 
(Isokinetic force ICC = 0.92 (700-s-1)), these test-retest reliability values are based 
on subjects having each undergone two familiarisation tests). Patients were 
assigned in a double blind fashion to either a Cr group or a placebo group, 
stratified according to their body composition: body mass index (BMI) and/or 
fat-free mass index (FFMI) with random assignment so that one member of each 
pair was in the Cr group and the other in the placebo group. This was done by 
dividing the patients into depleted and non-depleted patients, with patients 
considered as nutritionally depleted if they had a BMI of < 21 or an FFMI of < 15 
(females) or < 16 (males) (Van Itallie et al, 1990). Following the familiarisation 
period, all patients performed three tests (baseline, post-loading and post- 
rehabilitation). The first test was conducted at least 48 hours after the 
familiarisation. trial, and the final test was conducted at least 48 hours after the 
final rehabilitation session. 
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The Cr group ingested 17.1 g-d-1 Cr-H20 (equivalent to 5g Cr x3 times daily) for 
the first 14 days (loading). From day 15, patients consumed 5.7 g-d-1 Cr-H20 
(equivalent to 5g Cr daily) for the remainder of the study (maintenance). This 
maintenance dose was selected on the basis of published work by Hultman et al 
(1992) showing 2 g-d-1 Cr-H20 was adequate in maintaining elevated muscle PCr 
stores in patients not involved in strenuous exercise. As the patients in the 
present study were training twice a week at high intensities, it was decided to 
increase the maintenance dose to 5 g-d-1 Cr-H20 in an attempt to maintain muscle 
PCr stores. The addition of glucose to the Cr has been shown to significantly 
enhance the uptake of Cr (Green et al, 1996; Steenge et al, 1998). Patients were 
instructed to ingest the supplements at equal intervals throughout the day. The 
placebo group consumed 120 g-d-1 of glucose polymer (40 gx3 times daily) for 
the first 14 days, followed by 40 ga day for the subsequent duration of the study. 
The placebo group followed the same procedure as the Cr group with regard to 
the preparation of the supplements. Both supplements had similar taste, texture 
and appearance and were placed in generic containers to ensure double-blind 
administration. Patients were also requested to eliminate caffeine and caffeine 
containing foods from their diet over the loading phase to minimize the possible 
inhibitory effects of caffeine on the ergogenic effect of Cr (Vandenberghe et al, 
1996). At the end of the study, all patients gave verbal assurance that they had 
complied with aR instructions. 
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Procedures 
Patients reported to the laboratory on the day of testing, after having 
refrained from strenuous activity the day before. Following the measurement of 
stature and body mass, body composition was measured using bioelectrical 
impedance. 
FoRowing the measurements of body composition, patients underwent a 
standardised warm-up on the isokinetic dynamometer. Patient's isokinetic peak 
torque (700-s-1) was then measured during 5 repetitions using a Kin-Com II 
isokinetic dynamometer (Chattecx Corporation, Chattanooga, USA). The 
dominant leg was tested. The position of the patients on the isokinetic 
dynamometer was standardised; the anatomical axis of the knee joint was 
aligned with the rotational axis of the dynamometer by adjusting the seat 
position and the lever head of the dynamometer. Individual seat length and 
height were recorded for each patient and used in subsequent tests. Patients 
were held in the seat position with Velcro belts around the waist, thigh and 
lower leg proximal to the ankle, this also allowed for complete isolation of the 
testing leg. During the measurement, patients had their arms crossed over their 
chest while their non-involved leg and upper body was kept stationary. Patients 
were instructed to exert maximal effort throughout the full range of motion 
during each repetition. Verbal encouragement was given to maximise 
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performance. The same investigator conducted all tests. Having completed the 
peak torque isokinetic testing and following a5 min recovery period, patients 
went on to complete five sets of 15 repetitions at a speed of 150'-s-1 as a measure 
of strength endurance of the quadriceps. Patients were given 2 min rest between 
sets (Greenhaff et al, 1994). FoRowing a further 10 min rest, handgrip strength 
and strength endurance was tested on there dominant and non-dominant hand. 
Following a handgrip specific warm-up, patients completed 5 maximal voluntary 
isometric contractions with 30 s rest between each contraction, patients dominant 
hand was always tested first followed by there non-dominant hand, with the 
order kept the same for all subsequent tests. Having completed this measure of 
grip strength, patients went on to perform 3 sets of contractions to exhaustion 
with the intensity set at 70% of their pre-determined 1 repetition maximum 
(1RM). Again the dominant hand was tested first, with patients receiving 2 min 
rest between each set of contractions (Greenhaff et al. 1994). Fatigue was defined 
as the failure to exert the required intensity in 3 contractions in a row. Patients 
received verbal encouragement throughout all testing. Following two weeks of 
loading, patients returned to the laboratory and completed the same tests as on 
there baseline measurement day. Patients then entered a standard pulmonary 
rehabilitation programme for 8 wk, and following this 8 wk of training returned 
to the laboratory to complete the battery of tests identical to those at baseline and 
post-loading. 
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Body Composition Estimation 
Body composition was performed on the same day as the strength 
measures by the same investigator. Height was measured (to the nearest . 01 m) 
using a stadiometer, with patients standing barefoot. Body mass was assessed (to 
the nearest 0.1 kg) with patients wearing only a swimsuit. 
Bioelectrical ImRedance (BW 
Measurement of FFM by bioelectrical impedance (FFMBIA) (Bodystat-5000, 
Bodystat Ltd, Isle of Man, UK) was performed on the right side, with patient's 
supine, and with their limbs slightly apart from the trunk. After the skin had 
been cleaned with 70% alcohol, two injector electrodes were placed on the dorsal 
surface of the right hand and foot, and two detector electrodes were placed 
between the radius and ulna and on the ankle between the medial and lateral 
maHeoh. The impedance to current flow (50 kHz) between the injector and 
detector electrodes was determined. A patient-specific prediction equation based 
on resistance (R), body mass (BM), height (H) and sex (S, males =1 and females = 
0) was used to determine FFM (Kyle et al, 1998): 
FFM (kg)= -6.06 + (H x 0.283) + (BM x 0.207) - (R x 0.024) + (S x 4.036). 
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Pulmonary Rehabilitation Programme 
The programme consisted of 2 weekly sessions of 1 hr for 8 wks (i. e. 16 
sessions in total). The exercise was conducted by a physiotherapist and consisted 
of a warm-up, multimodality upper and lower limb exercises such as walking, 
stair climbing, cycle ergometry, upper and lower body strength exercises, and 
breathing exercises with appropriate rest intervals between activities. The 
intensity and load of all exercises were individualised, with training targeted so 
that patients exercised at, or just below, the Borg breathlessness rating 
corresponding to their symptom-limited maximal rating; based on these ratings, 
subjects trained at the highest attainable work level during each session (e. g. 
progression and overload principle). Patients were also given a copy of 
alternative exercises, so they could train at home. 
Prior to the start of each exercise session, aH patients underwent a standardised 
warm-up which comprised light intensity exercise for 5- 10 min, followed by a 
series of stretches with an emphasis on stretching the musculature associated 
with the exercises that were to follow. The training intensity was progressively 
increased as patients successfully completed the required number of sets and 
repetitions. Patients kept training logs throughout the duration of the study 
detailing rating of dyspnoea during exercise sessions and the weight, sets and 
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repetitions lifted during strength training of the upper and lower extremities. 
Exercise sessions lasted on average 60 min (including the 10 min warm-up and 
10 min cool-down). The compliance of the subjects was good, with only 4 
withdrawals during the training period due to non-compliance, however five 
other patients dropped out during the pulmonary rehabilitation period due to an 
increased number of exacerbation's. The pulmonary rehabilitation programme 
carried out at Glasgow Royal Infirmary is in line with the general guidelines set 
out by British Thoracic Society position statement on Pulmonary rehabilitation in 
2001 (BTS, 2001). 
Data Analysis 
Data were expressed as the mean ± s. d. following a test for the normality 
of distribution. Statistical analysis was carried out using two factor ANOVA for 
repeated measures, followed by Student's t-test for paired data and two sample 
t-test for unpaired data, as appropriate. Pearson correlation analysis was used to 
assess the relationship between variables. Statistical significance was declared 
when P<0.05. 
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RESULTS 
1. Cr Loading (14 days) 
Physical Characteristics 
The physical characteristics of the two groups of patients were not 
significantly different before supplementation (Table 6.2). In the Cr group, body 
mass increased significantly from 60.9 ± 11.5 kg to 61.9 ± 11.2 kg following Cr 
loading (P<0.001), with no change in the placebo group (66.7 ± 22.2 kg to 66.8 ± 
22.0 kg, P=0.73). The magnitude of change in body mass was significantly greater 
in the Cr group compared to the placebo group (P=0.002) (Table 6.2). In the Cr 
group, FFM increased significantly post-loading (Table 6.2), with no increase 
observed in the placebo group (Table 6.2). The change in FFM over the 
supplementation period was significantly greater in the Cr group compared to 
the placebo group (Table 6.2). 
There was no significant increase in body fat as estimated by BIA in the placebo 
group following loading (Table 6.2), in the Cr group there was an observed 
increase in body fat as estimated by BIA (P=0.015). However, the magnitude of 
this increase was not significantly greater when compared to the placebo group 
(P=0.18). 
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Lower Body Strength and Endurance 
Average peak torque (average of the 5 repetitions) increased significantly 
following Cr loading in the Cr group (86.7 ± 27.8 Nm to 90.1 ± 26.6 Nm, P=0.001), 
with no increase in the placebo group (79.0 ± 32.3 Nm to 78.0 ± 32.1 Nm, 
P=0.376). The magnitude of the increase was significantly greater than that 
observed in the placebo group (P=0.0032) (Table 6.3). 
Peak torque (highest score obtained during the 5 repetitions) also significantly 
increased following supplementation in the Cr group (90.6 ± 27.8 Nm to 93.6 ± 
26.6 Nm, P<0.001), with no increase observed in the placebo group (83.5 ± 32.9 
Nm to 82.0 ± 33.8 Nm, P=0.246). The magnitude of the increase observed regard 
to peak torque was significantly greater in the Cr group compared to the placebo 
group (P=0.0036) (Figure 6.1a). 
The Cr group produced significantly greater total work (TW) during all 5 sets of 
15 contractions (P=0.032, P=0.006, P=0.012, P=0.022 and P=0.016, respectively) 
following loading. In the placebo group patients produced similar amounts of 
work pre and post-loading (P=0.202, P=0.788, P=0.774, P=0.134 and P=0.091, 
respectively). When the magnitude of change was compared between both 
groups, the Cr group improved to a greater extent than the placebo group in 4 
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out of the 5 sets (set 2: P=0.0059, set3: P=0.012, set 4: P=0.014 and set 5: P=0.0099) 
(Figure 6.2a). 
Combined TW (A 5 sets added together) increased from 1996 ± 746 j to 2471 ± 
764 j (P=0.014) in the Cr group, compared to no significant increase in the 
placebo group (1670 ± 855 j to 1675 ± 835 J, P=0.516). The magnitude of the 
increase was significantly greater in the Cr group, compared to the placebo 
group (475 ± 626 j vs. -13.1 ± 76.4 J, P=0.012) (Figure 6.3a). 
Upper Body Strength and Endurance 
There was no significant increase in average or peak hand grip strength in 
either the Cr or placebo group following supplementation (as measured on both 
right and left hand) (Table 6.3). There was no significant increase in the number 
of repetitions performed post-loading, compared to pre-loading, in the placebo 
group in any of the 3 sets on the right or left hand. In the Cr group, patients 
produced a significantly greater number of repetitions in sets 2 (14.9 ± 5.8 to 17.4 
± 7.1, P=0.006) and 3 (11.8 ± 4.3 to 13.6 ± 4.7, P=0.009) following supplementation 
on their right hand. Similar findings were observed with regard to patients left 
hand also (sets 2: 14.4 ± 5.0 to 16.5 ± 4.4, P=O. 008 and set 3: 11.5 ± 4.0 to 13.6 ± 4.0, 
P=0.005). The magnitude of the increase was significantly greater in the Cr 
group, compared to the placebo group, in set 2 only (Pý0-044), with a strong 
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tendency observed in set 3 (P=0.051) with regard to the right hand. While on the 
left hand the magnitude of the increase was significantly greater during set 2 
(P=0.008) and set 3 (P=0.007) (Figure 6.4). Total repetitions (sum of all 3 sets) was 
significantly greater in the Cr post-loading compared to the placebo group in 
both the left and right hand (Table 6.3). 
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2. Cr Supplementation Combined with Pulmonary Rehabilitation 
FoRowing the two weeks of Cr, patients entered a standard 8-week 
pulmonary rehabilitation programme. However, due to an increase in the 
number of exacerbations and non-compliance to the pulmonary rehabilitation 
programme, only 21 patients completed this phase of the study (11 patients in 
the Cr group and 10 in the placebo group). 
Physical Characteristics 
In the Cr group, there was no significant change in body mass following 
supplementation and rehabilitation (Table 6.4) or when confined to the change 
from post-loading to the end of rehabilitation (rehab-load) (62.8 ± 12.6 kg to 61.8 
± 13.9 kg, P=0.079). In the placebo group, again, there was no significant change 
in body mass following supplementation and rehabilitation (P=0.447) or as 
measured from rehab-load (P=0.486). 
In the Cr group, FFM increased significantly over the 
supplementation/ rehabilitation period, with no change in the placebo group 
(Table 6.4). In the placebo group, no changes in FFM were observed over this 
period (Table 6.4). 
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There was a significant reduction in FM over both the 
supplementation/ rehabilitation and rehab-load periods in the Cr group, with 
this reduction only seen over the supplementation/ rehabilitation period in the 
placebo group (Table 6.4). As a result, the magnitude of the reduction was 
significantly greater in the Cr group over both periods, when compared to the 
placebo group (Table 6.4). 
Upper Body Strength Endurance 
Average hand grip strength (right and left hand) increased following 
supplementation/ rehabilitation in the Cr group and also when measured from 
rehab-load. In the placebo group, there was no significant increase over the 
supplementation/ rehabilitation period (P=0.227) for either hand, but there was a 
significant increase over the rehab-load period (P<0.001) with regards to the right 
hand. The magnitude of the increases were significantly greater over both 
periods (P=0.034 and P=0.024, respectively) in the Cr group, compared to the 
placebo group, but only in the right hand (dominant hand). 
Peak hand grip strength (right and left) also increased significantly over both the 
supplementation/ rehabilitation and rehab-load periods in the Cr group. In 
contrast, for the placebo group, an increase was observed only over the rehab- 
load period (P=0.002) on the right hand. The magnitude of the increase was 
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significantly greater only over the supplementation/ rehabilitation period 
(P=0.040) in the Cr group, compared to the placebo group, but only with regard 
to the right hand (Table 6.5). 
Total repetitions (sum of all 3 sets) (right and left hands) was significantly greater 
in the Cr and placebo groups following supplementation/ rehabilitation and 
rehab-load, with the magnitude of the increase being significantly greater in the 
Cr group, compared to the placebo group over both periods (Table 6.5). 
Lower Body Strength and Endurance 
Peak torque increased significantly in both the Cr and placebo groups 
following supplementation/ rehabilitation (P<0.001 and P<0.001) and from 
rehab-load (P<0.001 and P<0.001). The magnitude of the change was significantly 
greater during both periods in the Cr group, compared to the placebo group 
(P=0.020 and P=0.050) (Figure 6.1b). 
Average peak torque also increased significantly in both the Cr and placebo 
groups following supplementation/rehabilitation (P<0.001 and P<0.001) and 
from rehab-load (P<0.001 and P<0.001), with the magnitude of the change being 
significantly greater during both periods in the Cr group compared to the 
placebo group (P=0.009 and P=0.030, respectively). 
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The Cr group produced significantly greater total work (TW) during all 5 sets of 
15 contractions following supplementation/ rehabilitation. In the placebo group 
patients produced significantly greater TW during sets 2 and 3, with strong 
tendencies during the final two sets also (sets 3 and 5). When the magnitude of 
change was compared between both groups, the Cr group improved to a greater 
extent than the placebo group in all 5 sets (Figure 6.2b). 
Combined TW (all 5 sets added together) significantly increased in the Cr 
following supplementation/ rehabilitation (P=0.002) and during the rehab-load 
period (P=0.001), a strong tendency was observed in the placebo group to have 
increased TW over the supplementation/rehabilitation period (P=0.054) and 
there was a significant increase over the rehab-load period (P=0.034). The 
magnitude of the increase was significantly greater in the Cr group compared to 
the placebo group over both periods (P=0.014 and P=0.042, respectively) (Figure 
6.3b). 
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Figure 6.1 Peak Isokinetic Force in the Cr and Placebo 
supplemented groups post-loading (top 
panel) and post-rehabilitation (bottom 
panel) * indicates a significant difference from 
pre to post supplementation. t indicates a 
significant greater change in the Cr group 
compared to the placebo group 
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Cr group (n=14) Placebo group (n=15) 
Cr group (n=11) Placebo group (n=10) 
Figure 6.2 Change in Total in the Cr and Placebo 
supplemented groups post-loading (top 
panel) and post-rehabilitation (bottom 
panel). t indicates a significant greater 
change in the Cr group compared to the 
placebo group. 
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-0- Cr Group (n= 14) 
-0- Placebo Group (n= 15) 
Cr Group (n=l 1) 
Placebo Group (n= 10) 
Figure 6.3 Combined Total Work (sets 1 to 5) in the Cr 
and Placebo supplemented groups post- 
loading (top panel) and post-rehabilitation 
(bottom panel). * indicates a significant 
difference from pre to post supplementation. t 
indicates a significant greater change in 
the Cr group compared to the placebo group 
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Figure 6.4 Handgrip Endurance for right (top panels) and 
left hands (bottom panels) in the Cr (left side) 
and Placebo (right side) supplemented 
groups post-loading (top panel) and post- 
rehabilitation (bottom panel). * indicates a 
significant difference from pre to post 
supplementation. t indicates a significant 
greater change in the Cr group compared 
to the placebo group 
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DISCUSSION 
The results of the present study demonstrate that 14 days of oral Cr 
supplementation (15 g-d-1) was effective in increasing body mass, FFM, lower 
body muscle strength, upper and lower body muscle endurance in patients with 
moderate to severe COPD during 14 days of supplementation. Additionally, this 
study also highlights a potential role for Cr supplementation when combined 
with a standard pulmonary rehabilitation programme. With respect to this aspect 
of the study, Cr supplementation combined with a pulmonary rehabilitation 
programme was more effective in increasing muscle strength (lower and upper 
body), muscle endurance (lower and upper body), FFM and FM (significant 
decrease) than pulmonary rehabilitation alone. 
The present study demonstrated a significantly greater increase in body mass 
and, more importantly, FFM following short-term Cr supplementation (loading) 
compared to the placebo group. While there was no significant increase in body 
mass over the whole duration of the study (supplementation/ rehabilitation), this 
was probably due to the observed decrease in FM, while the significant increase 
in FFM remained. The importance of this finding can be seen from a recent study 
by Schols et al (1998). In that study the authors demonstrated that patients whose 
body weight increased significantly following intervention (> 2kg/8 wks) had a 
decreased mortality risk as compared to patients whose body weight did not 
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increase following this intervention. In this study, the researchers retrospectively 
analysed 400 patients with COPD, and they found weight gain (> 2kg/8 wk) in 
both depleted and non-depleted patients were significant predictors of survival, 
and also as part of the same study they also reported that low BMI was a 
significant independent predictor of increased mortality. For these reasons, 
many researchers have examined numerous intervention strategies in an attempt 
to increase body mass and, more importantly, FFM in patients with COPD. These 
strategies ranged from nutritional intervention and appetite stimulators to, more 
recently, rhGH and anabolic steroids. For example, Bumet et al (1997) and Yeh et 
al (2002) used rhGH and an anabolic agent (Oxandrolone), respectively, to 
increase FFM in fl-tis patient group. However while both of these interventions 
were successful in increasing FFM, not all patients could tolerate these 
interventions, with many reporting a range of side-effects. In the present study, 
we have shown short-term and long-term Cr supplementation to be an effective 
strategy in increasing FFM in this patient population with patients reporting no 
treatment associated side-effects. The findings of the present study are in 
agreement with previously published work in healthy young subjects 
(Experiment 1; Experiment 2) and healthy older subjects (Gotshalk et al, 2002; 
Chrusch et al, 2001; Jacobi et al, 2001). 
Another significant finding in the present study was a significant greater increase 
in lower body strength following Cr loading (14 days), with no such increase 
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observed in upper body strength during this period. While this might seem 
contradictory at first, it has been shown in the past that lower limbs are affected 
to a greater extent than the upper limb muscles with regard to muscle strength 
(Hamilton et al, 1995; Gosselink et al, 1996), with this difference attributed to the 
greater reduction in activity of the lower limbs compared to the upper limbs in 
this patient population. 
To date, this is the first intervention study in COPD to show a positive outcome 
with regard to muscle strength (lower body). Previously, researchers have used 
such strategies as anabolic steroids and rhGH in an attempt to increase muscle 
strength in this patient group but with no significant effect For example, in the 
study by Burdet et al (1997), rhGH was used in an attempt to increase muscle 
mass and muscle strength. While these interventions were successful at 
increasing muscle mass, there was no change in muscle strength. 
It has also been reported that there is reduced muscle endurance in this patient 
group (Serres et al, 1998). Serres et al (1998) reported that COPD patients achieved 
fewer dynamic contractions of the quadriceps when matched for maximal 
strength than controls. In addition to the observed changes in muscle strength 
following Cr loading, a significantly greater increase in muscle endurance was 
also observed (as measured by total work and total repetitions) in the Cr group 
compared to the placebo group. This finding is in agreement with previously 
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published data with respect to observed increases in muscle endurance in 
healthy resistance-trained humans (Experiment 1), healthy older subjects 
(Rawson et A 1999; Gotshalk et al, 2002) and heart failure patients (Gordan et al, 
1995; Andrews et al, 1998). 
The exact mechanisms behind these observed increases are still not clear. As 
muscle biopsies were not obtained in this study, one can only speculate on the 
potential mechanisms for this improvement in muscle strength and muscle 
endurance following Cr supplementation. However it has also been shown that 
patients with COPD have peripheral muscle abnormalities. For example studies 
by Gertz et al (1977) and Jakobsson et al (1990) have demonstrated lower 
concentrations of ATP and PCr at rest using muscle biopsies, and other studies 
have also shown lower intracellular pH and slower PCr resynthesis during 
recovery from exercise (Payen et al, 1993; Sala et A 1999). Two of the possible 
mechanisms behind the ergogenic effect of Cr supplementation are its ability to 
increase resting levels of PCr and also increase the rate of PCr resynthesis 
following intense exercise. Therefore, theoretically Cr supplementation should be 
able to rectify these abnormalities in skeletal muscle, and hence increase muscle 
endurance and muscle strength. In addition, because fatigue during the types of 
tests (maximal and strength endurance) utilized in the present study have 
previously been attributed to depletion of muscle PCr stores (Hultman et al, 1990; 
Tesch et al, 1989), Cr supplementation has a greater potential to increase muscle 
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performance. A number of previous studies support this view (Balsom et al, 1995; 
Greenhaff et al, 1994; Experiment 1). 
A second and very important component of the present study was to evaluate 
the effectiveness of Cr supplementation when combined with a standard 
pulmonary rehabilitation programme, compared to pulmonary rehabilitation 
alone. With respect to this aspect of the study, the Cr group had significantly 
greater increases in hand grip strength (dominant hand only) over the 
supplementation/ rehabilitation and rehab-load periods compared to the placebo 
group. Upper and lower body endurance as measured by total repetitions and 
total work respectively was also significantly increased in both groups over the 
supplementation/ rehabilitation and rehab-load periods, with the magnitude of 
the increase being significantly greater in the Cr group compared to the placebo 
group. These results may indicate that Cr acted as an extra stimulus during 
training aHowing patients in the Cr group to train at a greater intensity and thus 
improve their muscle strength a greater degree. Unfortunately, in the present 
study there was no measure of work completed per training session, however the 
significantly greater loss of FM observed in the Cr group would suggest this. 
The physiological basis for a possible ergogenic effect of Cr supplementation on 
strength training is primarily two fold. Firstly, Cr supplementation has been 
shown to increase the number of repetitions performed per set (Earnest et al, 
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1995; Volek et al, 1999). Secondly, Cr supplementation has been shown to 
increase the rate of Cr rephosphorylation during the second minute of recovery 
from intense internuttent-type exercise (Greenhaff et al, 1994). Theoretically, both 
these physiological changes would allow an individual to train at a greater 
intensity compared to training without the use of this putative ergogenic aid. The 
enhanced muscle performance seen in the present study when combined to 
training (pulmonary rehabilitation) has also been observed in both healthy 
young subjects (Vandenberghe et al, 1996; Kreider et al, 1998; Volek et al, 1999) 
and healthy older subjects (Chrusch et al, 2001). The present study is the first to 
examine the effectiveness of Cr supplementation combined with a training 
stimulus in a patient population. 
As already mentioned, following Cr loadin& patients entered into a standard 
pulmonary rehabilitation programme. However during this programme a 
number of patients dropped out due to an increase in exacerbations or inability 
to cope with the training sessions. It is worth noting that the majority of the 
patients who dropped out were in the placebo group, with only one dropout 
during the programme in the Cr group (two others dropped out at the very end, 
but had completed the training). The reason for this is not clear however it could 
be linked to the already mentioned increase in body mass and/or an increased 
ability to cope with the training demands. 
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CONCLUSION 
in conclusion, although this present study demonstrates some very 
positive outcomes with regard to the ergogenic effects of Cr in COPD patients 
(both short- and long-term), it still remains to be determined whether or not the 
observed benefits in the present study will have a positive impact on the daily 
activities and, more importantly, the quality of fife of this patient population. 
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CHAMR SEVEN 
General Discussion 
GENERAL DISCUSSION 
The primary objectives of all four Experiments were to determine the 
effects of Cr supplementation on body composition and exercise performance in 
subjects of varying training and health status. 
The aim of Experiment 1 was to determine the effects of Cr supplementation on 
body composition, muscle strength and muscle endurance in a group of highly 
resistance-trained male subjects. The results of this study suggested that 20 g 
Cr-d-I for 5d resulted in an increase in peak force and total work during repeated 
isometric bench-press contractions but only when "non-responders" were 
removed. A negative correlation between estimated muscle Cr uptake and 
training status (Figure 3.4a) and also a positive correlation between estimated 
muscle Cr uptake and increase in exercise performance (Figure 3.4c) were also 
observed in Experiment 1. An explanation for the demonstration of "responders" 
and "non-responders" to creatine supplementation was therefore sought in 
Experiment 2. This second study was designed to optin'tise muscle Cr uptake 
during Cr supplementation using strategies previously shown in the literature 
(e. g. exercise, carbohydrate ingestion) to enhance muscle Cr uptake, using a 
group of non-resistance trained subjects. As was the case for Experiment 1, 
Experiment 2 also showed large inter-individual response to Cr 
supplementation, with a performance benefit being only seen once the Cr group 
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was subdivided into "responders" and "non-responders" (as in Experiment 1). 
These two studies argue strongly for the issue of "responders" and "non- 
responders" being multifactorial in nature. 
A further outcome of Experiments 1 and 2 was that Cr supplementation 
stimulated an increase in body mass. Experiment 2, further, was able to ascribe 
this (in part, at least) to increases in total body water (TBW) and intracellular 
water (ICW). Experiment 3 was therefore designed to determine the effects of 
these Cr-stimulated increases in body water compartments on the ability of 
trained endurance cyclists to perform cycling exercise to exhaustion during heat 
exposure. The results from this study argue for a possible role for Cr 
supplementation for prolonging time to exhaustion (TTE) during exercise in the 
heat. Again, however, these results only became clear once the Cr group was 
divided into "responders" and "non-responders". 
FinaRy, Experiment 4 examined whether the increases observed in Experiments 1 
and 2 with regard to body composition, muscle strength and muscle endurance 
in healthy subjects could lead to similar increases in patients with moderate to 
severe Chronic Obstructive Pulmonary Disease (COPD). The outcome of the 
study was that Cr loading lead to significantly greater increases in body mass, 
fat-free mass, lower body muscle strength, upper and lower body muscle 
endurance compared to the placebo group. Following Cr and rehabilitation the 
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increases observed with regard to muscle strength and muscle endurance was 
significantly greater than those observed in the placebo group. 
The major findings from these several studies are discussed collectively in this 
chapter and, as appropriate, conclusions made regarding the factors that may 
limit exercise performance in health and disease. 
Cr Supplementation and Muscle Cr Uptake (responders" and "non-responders") 
As previously mentioned, the results of the first three experiments 
demonstrated that Cr supplementation was effective at increasing exercise 
performance in healthy young subjects, but only for those in whom muscle tow 
[Cr] ([TCr]) was significantly increased following supplementation 
("responders"). The concept of "responders" and "non-responders" was first 
proposed by Greenhaff et al (1994) and subsequently by Casey et al (1996). 
implicit in the classification of subjects into "responders" and "non-responders" 
(Greenhaff et A 1994; Casey et al, 1996) is the e)dstence of what has been termed 
an "ergogenic threshold" for Cr uptake, which has been demonstrated to occur at 
about 20 mmol-kg-1-dry muscle weight (Greenhaff et al, 1994 and Casey et 
1999). The rationale for this assertion was the demonstration by Greenhaff et al 
(1994) that an increased rate of PCr resynthesis during recovery from exercise 
following Cr ingestion was evident in subjects those muscle Cr concentration 
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was increased by on average 20 mmol-kg-1-dry muscle weight, but not in those 
whose muscle Cr concentration increased by < 10 mmol-kg-1-dry muscle weight 
Our findings provide support for this contention. However, we were not able to 
assign a specific threshold value as intramuscular Cr uptake was only estimated. 
Two very distinct groups were evident in aH three Experiments (1 - 3), giving 
support to the proposed "ergogenic threshold". The estimated Cr uptakes in all 
three Experiments were simflar to those measured by Greenhaff et al (1994). 
However although Greenhaff et al (1994) and Casey et al (1996) proposed the 
existence of subpopulations of "responders" and "non-responders", the present 
set of Experiments (1 - 3) were the first to further subdivide the Cr group into 
"responders" and "non-responders" based on estimated or measured muscle Cr 
uptake following Cr supplementation and to reanalyse the data based only on 
the "responders" data only. Therefore it is perhaps not surprising that, despite 
many Cr supplementation studies showing an ergogenic effect on exercise 
performance (Harris et A 1992; Greenhaff et al, 1993; Soderlund et al, 1994; 
Balsom et al, 1993; Balsom et al, 1995; Greenhaff et al, 1994; Casey et al, 1996; 
Green et al, 1996; Earnest et al, 1995), there are still a significant number of studies 
which have not reported an ergogenic effect (e. g. Cooke et al, 1995; Odland et al, 
1997; Snow et al., 1998; McKenna et al., 1999; Gilliam et al., 2000; Deutekom et al., 
2000; Finn et al, 2001). It is tempting to speculate that this lack of effect (Cooke et 
al, 1995; Odland et al, 1997; Snow et al, 1998; McKenna et al, 1999; Gfiliam et al, 
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2000; Deutekom et al, 2000; Finn et al, 2001) may reflect, in part at least, there 
having been no differentiation of subjects into "responders" and "non- 
responders" on the basis of measured or estimated muscle Cr uptake. That is, 
many studies failed to sample skeletal muscle changes in [TCr], either directly or 
indirectly (Cooke et al, 1995; Odland et al, 1997; Gilliam et al, 2000; Deutekom et 
al, 2000), and thus verify the efficacy of their supplementation protocols. This 
represents an important omission, as the potential ergogenicity of Cr 
supplementation has been shown to be dependent on the magnitude of the [TCr] 
increase following Cr supplementation (Casey et al, 1996, Snow et al, 1998). This 
point is supported by the demonstration in Experiments 1 and 2 (Figure 3.4c, 
Figure 4.5b-d) of positive correlations between estimated muscle Cr uptake and 
improvement in exercise performance. 
Two recent studies further highlight this point. Snow et al (1998) and McKenna et 
al (1999) both examined the effects of short-term Cr supplementation (30g Cr d-1 
for 5 days) on 20 s maximal sprint and five 10 s maximal sprints, respectively. 
Neither study could demonstrate any additional effects of Cr loading on any of 
the variables measured, including body mass. However, closer inspection of the 
results of these studies do reveal that Cr supplementation did induce modest 
increases in [TCr]: 11.7 ± 2.4 mmol-kg-l-dry muscle weight in the case of Snow et 
al (1998), and 23 mmol-kg-1-dry muscle weight for McKenna et al (1998). 
Furthermore, the inter-individual responses showed a wide variability: a range 
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of 2.9 - 19.9 mmol-kg-1-dry muscle weight for Snow et al (1998), and 7- 40 
mmol-kg-l-dry muscle weight for McKenna et al (1999). One wonders what the 
outcomes of these two studies might have been if the researchers had subdivided 
their Cr group into "responders" and "non-responders". A further limitation of 
these studies is the small sample size (n= 8, Snow et al, 1998 and n=7, McKenna et 
al, 1999) which, coupled with lack of consideration of "responders" and "non- 
responders", could have increased the chance of both studies producing a Type 11 
error. 
Cr Loading and Muscle Strength and Muscle Endurance 
As previously mentioned, not all studies in the literature have 
reported an ergogenic effect following Cr supplementation, with many of these 
negative results potentially explicable by relatively small increases in muscle Cr 
uptake foHowing supplementation. However, 40 out of the 55 pertinent 
published studies on this topic have reported an ergogenic effect following Cr 
supplementation. Experiments 1,2 and 4 examined the effects of Cr loading on 
muscle strength and endurance. In Experiments 1 and 2 Cr supplementation led 
to a significant increase in muscle strength and endurance (Figure 3.3 and Figure 
4.4). However, the results of these studies only became clear when subjects were 
divided into "responders" and "non-responders" based on their estimated muscle 
Cr uptake. This finding was further supported by the positive correlations 
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observed in both Experiments 1 and 2 between estimated muscle Cr uptake and 
i. inprovement in exercise performance (Figure 3.4c & Figure 4.5b-d, respectively), 
and Experiment 3 between estimated muscle Cr uptake and delta TTE (r=0.75, 
n=11, P=0.008), showing again that performance benefits are highly dependent 
on muscle Cr uptake. The results from Experiinents 1 and 2 thus support the 
work of previous researchers with regard to the ergogenic effect of Cr 
supplementation on muscle strength and muscle endurance (Casey et al, 19%; 
Green et al, 1996, Kreider et al, 1998; Maganaris & Maughan, 1998; Volek et al, 
1997). 
In Experiment 4, the effects of Cr supplementation on body composition, 
muscle strength and endurance were examined in patients with moderate to 
severe COPD. Previously researchers have used controlled trials using such 
strategies as anabolic steroids (Yeh et al, 2002) and rhGH (Burnet et al, 1997) in an 
attempt to increase muscle mass and strength, while both these strategies have 
demonstrated improvements in muscle mass, no discernible effect on muscle 
function were demonstrated. Although researchers have previously examined 
the effect of Cr supplementation on muscle strength and muscle endurance in 
healthy older subjects (Rawson et al, 1999; Gotshalk et al, 2002) and in heart 
failure patients (Gordan et al, 1995; Andrews et al, 1998), Experiment 4 is the first 
study to examine the role of Cr supplementation in this patient population 
(COPD). Furthermore, the positive results obtained from Experiment 4 with 
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regard to muscle strength and endurance is, to our knowledge, the first showing 
positive effects on muscle strength and endurance of this patient group. 
However, the extent to which patients varied in their capacity to take up Cr is 
unclear at present, as we were not in a position to estimate Cr uptake in our 
patients. The important issue raised by this is that the potential for rehabilitation 
and reduced mortality in COPD may be influenced by intramuscular Cr uptake 
characteristics. 
As muscle biopsies were not obtained in any of the present studies, one 
can only speculate on the potential mechanisms for the demonstrated 
unprovement in exercise performance following Cr supplementation. We 
speculate that increased intramuscular PCr availability and PCr resynthesis 
during recovery from maximal exercise of the type employed in Experiments 1,2 
and 4 is perhaps the most plausible explanation, given that muscle fatigue has 
previously been associated with a depletion of muscle PCr stores (Hultman et al, 
1990; Tesch et al, 1989). Cr supplementation has the potential to increase the basal 
levels of PCr and, would therefore be expected tc) better maintain the required 
ATP resynthesis rates during exercise (Harris et al, 1992) which, in tum, could 
lead to delayed onset of muscle fatigue. Also, the accelerated rate of PCr 
resynthesis during recovery from intense muscle contractions (Greenhaff et al, 
1994) could consequently lead to an increased ability to rephosphorylate ADP. 
This suggestion by Greenhaff et al (1994) was further supported by their finding 
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of Icrwer plasma ammonia accumulation during the repeated bouts of exercise 
following Cr ingestion, despite the Cr group producing higher work output. 
Effects of Cr suppk-mentation on body composition 
Ihe results of all 4 experiments demonstrate that short-term (5 - 14 d) Cr 
supplementation (15 - 20 g Cr d-1) can lead to significant increases in body mass 
(Figure 3. Z Figure 4.2a, Figure 5.2 and Table 6.2). This finding has also been 
consistently observed throughout the Cr fiterature (Greenhaff et al, 1994; Eamest 
et al, 1995; Cooke et al, 1995, Green et al, 1996; Terrilhon et al, 1997; Maganaris & 
Maughan, 1998; Krieder et al, 1998; Becque et al, 2000; Finn et al, 2001). Although 
the results of all 4 of the present studies support the theory that Cr 
supplementation is effective at increasing body mass under the conditions of the 
present studies, the exact mechanism behind this increase still remains unclear. 
To date, there have been two mechanisms proposed for this Cr-stimulated. 
increase in body mass. It has been suggested that the increase in body mass 
following Cr supplementation was due to an increase in water retention 
(Hultman et al, 1996) which could, in turn, result in cell swelling and an increase 
in protein synthesis (Haussinger et al, 1993). Others, however, have attributed the 
increase in body mass following Cr supplementation tc) an increase in protein 
synthesis and the associated increase in water content (Kreider et al, 1998). The 
balance of available evidence from human performance studies using Cr 
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supplementation and more-direct evidence from animal in vivo and in vitro 
experiments supports the notion that increasing Cr availability may indeed 
increase protein synthesis (Ingwall et al, 1974, Kreider et al, 1998, Volek et al, 
1999). However, not all studies have found significant differences in body mass 
following short-term Cr supplementation (Grindstaff et al, 1997, Steenge et al, 
1998, Terrillion et al, 1997, McKenna et al, 1999; Snow et al, 1998). These negative 
findings could reflect negligible increases in [TCr] following Cr supplementation, 
with increases in body mass therefore not being expected. Taken together, the 
results of Experiments 1-3 demonstrated a positive correlation between 
estimated muscle Cr uptake and increase in body mass (r=0.499, n-41, P-0.001) 
(Figure 3.4b, Figure 4.5a) provides further support for the proposal that increases 
in body mass may provide an indirect measure of muscle Cr uptake. 
As already mentioned, Cr loading increased body mass in all four of the present 
Experiments with subjects varying in training status and background, ranging 
from highly resistance trained individuals (Experiment 1), non-resistance trained 
individuals (Experiment 2), endurance trained subjects (Experiment 3) to patients 
with moderate to severe COPD (Experiment 4). The observed increases in body 
mass were similar between all three groups studied in Experiments 1-3, 
showing Cr to be effective at increasing body mass these particular populations, 
and were of similar magnitude to those previously reported (Greenhaff et al, 
1994; Earnest et al, 1995; Cooke et al, 1995, Green et al, 1996, Terrillion et al, 1997; 
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Maganaris & Maughan, 1998; Krieder et al, 1998; Volek et al, 1999; Becque et al, 
2000; Finn et al, 2001). 
In Experiment 4, there was also a significant increase of body mass following 
short-term Cr supplementation in the group of patients with moderate to severe 
COPD. The importance of this finding can be seen from a recent study by Schols 
et al (1998). These authors demonstrated that COPD patients whose body weight 
increased significantly following administration of anabolic steroids (> 2kg/8 
wks) had a decreased mortality risk compared to patients whose body weight 
did not increase following the intervention. For this reason, the observed 
increases in body mass following Cr supplementation during Experiment 4 are of 
particular clinical importance. 
Cr supplementation combined with resistance training 
Experiments 2 and 4 examined the effects of Cr supplementation 
combined with resistance training (Experiment 2) and a standard pulmonary 
rehabilitation programme (Experiment 4) compared to subjects training 
combined with placebo. While no additional increase in exercise performance 
was observed during Experiment 2 (possibly due to training status of the subjects 
and study duration), Cr supplementation led to significantly greater increase in 
muscle strength and endurance in patients with moderate to severe COPD. As 
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previously mentioned, many researchers have examined strategies for improving 
muscle function during pulmonary rehabilitation in patients with COPD. 
However, this present study is the first study to best of our knowledge to show a 
positive effect on muscle function in addition to the increases observed following 
pulmonary rehabilitation alone. The physiological basis for this ergogenic effect 
of Cr supplementation when combined with pulmonary rehabilitation is 
primarily two-fold. Firstly, Cr supplementation has been shown to increase the 
number of repetitions performed per set (Earnest et al, 1995; Volek et A 1997). 
Secondly, Cr supplementation has been shown to increase the rate of PCr 
rephosphorylation during the second minute of recovery from intense 
intermittent exercise (Greenhaff et al, 1994). Theoretically, both of these 
physiological changes could allow patients to train at a greater intensity than 
without this putative ergogenic aid. During the pulmonary rehabilitation 
programme in Experiment 4, a number of patients dropped out due to an 
increase in exacerbations or an inability to cope with the training sessions. 
Interestingly, the majority of the patients who dropped out were in the placebo 
group, with only one dropout from the Cr group. The reason behind this is 
unclear, but could be linked to the already-mentioned increase in body mass 
and/or an increased ability to cope with the training demands. If it can be shown 
convincingly that Cr supplementation increases the compliance of patients to 
rehabilitation programmes, this would represent a very important effect of Cr 
supplementation in the patient population. 
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Statistical Limitations of Previous Studies 
As previously mentioned, one possible explanation for the conflicting 
results in the literature with regard to the ergogenic potential of Cr 
supplementation has been the failure of many researchers to identify "non- 
responders" within their Cr group. 
Recently, another possible explanation has been offered for these conflicting 
findings. Thus, Gilliam et al (1999) questioned the statistical techniques employed 
by many researchers in the "Creatine supplementation" field. They suggested 
that the multiple Mests; used by researchers such as Greenhaff et al (1993), Birch 
et al (1994) and Harris et al (1992) inflated the chance of producing a Type I error, 
and they therefore suggested that researchers in the future should use ANOVA 
(Gilliam et A 1999). They also suggested this as a possible reason behind many of 
the conflicting findings with regard to the ergogenic potential of Cr 
supplementation. Studies that have previously used ANOVA's and found 
negative effects include these of Burke et al (1996), Odland et al (1997) and 
Redondo et al (1996). In all four experiments completed in this thesis, pre- 
planned statistical analysis was carried out (ANOVA). Furthermore, sensitivity 
was improved by expressing the responses not simply as absolute values but also 
as "post-pre" (delta). The use of delta takes into consideration any "placebo" effect 
that might be observed in the placebo group, therefore reducing the chance of a 
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Type I error. Another analytical consideration that may contribute to the 
contradictory findings of many previous studies is the small sub*t number 
used by many studies in the Cr literature. A small sample size, combined with 
the possibility of the Cr group comprising of "non-responders" could increase the 
chance of many studies producing a Type 11 error. These shortcomings were 
taken account of in the design of the present studies: the relatively large sample 
sizes and the identification of the "non-responders" within the Cr group help 
prevent the present Experiments for making a Type Il error (Tamopolsky & 
MacLennan, 2000). 
Directions for Future Research 
The results from Experiments 1-3 only became apparent when the Cr 
group was subdivided into "responders" and "non-responders" based on their 
estimated muscle Cr uptake and, as already mentioned, this is one of the possible 
factors behind the conflicting results obtained wiffiin the literature with regard to 
the ergogenic potential of Cr supplementation. Therefore researchers should try 
and further identify factors contributing to the "responders" and "non- 
responders" issue, such as the mechanisms behind intramuscular Cr uptake, and 
the adaptive potential of these mechanisms to different forms of training and 
exercise-related dietary regimens. It is important to point out, also, that there is 
uncertainty as to whether an intramuscular [Cr] in the region of 20 mmol-kg-1 -dry 
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muscle weight represents the actual threshold value (Greenhaff et al., 1994) or 
whether more detailed investigations might show this to be somewhat lower. 
Furthermore, the evidence for there being an actual threshold characteristic 
rather than a simple proportional graded relationship between intramuscular 
[Cr] and PCr resynthesis capacity has not convincingly been presented to date. In 
addition, future studies could attempt to eliminate the "responders" issue a 
priori. For example, researchers could supplement their subjects for 2-3 days 
with Cr supplementation and based on their individual responses separate their 
subjects into "responders" and "non-responders". Then after the 4-6 wk washout 
period include only the "responders" to Cr supplementation in their study. 
Experiment 4 was the first intervention study to show positive effects on muscle 
strength and muscle endurance in patients with COPD. However, additional 
more comprehensive experiments are needed to resolve the extent to which Cr 
supplementation may facilitate the rehabilitation and mortality of this patient 
group. Although the overall effect on body mass, muscle strength and muscle 
endurance were positive, we were not in a position to assess how quality of life 
was affected. A further, important observation that requires more attention is 
whether Cr supplementation in this patient group does indeed influence 
compliance with pulmonary rehabilitation and, if so, the extent to which this is a 
consequence of an increase in body mass or an increased ability to cope with the 
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training demands. Finally, the extent to which the disease process in COPD may 
influence Cr transport capacity also requires attention. 
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GENERAL CONCLUSIONS 
From this series of experiments a number of conclusions can be made. These 
conclusions apply specifically to the protocols applied in the present set of 
experiments. 
* From the results of all 4 experiments it can be concluded that short-term 
Cr supplementation significantly affects body mass and body 
composition, although the exact mechanism behind these observed 
increases are still under debate. 
* From the results of experiments 1 and 4 it can be concluded that short- 
term Cr supplementation is effective at increasing muscle strength and 
endurance probably due to increased resting [PCr] and/or increased rates 
of PCr resynthesis. 
9 From the results of experiment 4 it can be concluded that Cr 
supplementation was an effective strategy for increasing muscle strength 
and endurance to a significantly greater extent when combined with a 
pulmonary rehabilitation program than pulmonary rehabilitation alone. 
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* From the positive correlations found in experiments 1 -3 between 
estimated muscle Cr uptake and performance it can be concluded that the 
performance benefit obtained from Cr supplementation is very dependant 
on initial [PCr] and the level to which these are increased following Cr 
supplementation. 
e From the results on experiment 3 it can be concluded that exercise in the 
heat is not adversely affected by Cr supplementation and that the 
preliminary results on this experiment suggest a potential role for Cr 
supplementation during exercise in the heat, although much research is 
stiH required. 
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